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ABSTRACT
Lysophospholipid concentrations were shown to increase 
following coronary artery ligation of the isolated rat 
heart, prior to the development of arrhythmias, reaching 
a maximal concentration by 30 minutes post ligation. No 
changes in the parent phospholipids were seen.
Changes in the perfusate ionic composition that 
increased the severity of i s c h a e m i c a l l y  induced 
arrhythmias caused an increase in control concentrations 
of l y s o p h o s p hatidylcholine (LPC) , a m a x i m a l  LPC 
concentration being attained by either 20 minutes 
coronary artery ligation or increased perfusate calcium 
and decreased perfusate potassium concentrations. No 
significant changes were seen in tne parent phospholipids 
or lysophosphatidylethanolamine (LPE).
LPC was shown to be arrhythmogenic in the in v ivo 
cat heart, final blood concentrations of 500pM LPC 
infused via the coronary artery producing severe 
arrhythmias and death. Pal mi toylcarnitine (PAL), of 
similar structure to LPC, was also arrhythmogenic but 
apparently by a different mechanism as PAL appeared to 
produce ischaemia. This was unlikely to be due to a 
direct effect on platelet aggregation. The time courses 
of LPC and PAL induced arrhythmias were similar to those 
induced by coronary artery ligation.
Phospholipase A 2 activity was depressed in the 
ischaemic area of the isolated rat heart in both the 
homogenate and the mitochondria following 20 minutes 
coronary artery ligation, but not in the sarcolemma. This 
is possibly due to washout of inhibitory substances from 
the latter during the isolation procedure. LPC and PAL, 
when added exogenously, both showed an inhibitory effect
on P L A 2 activity and thus may contribute to P L A 2  
inhibition during ischaemia.
Reperfusion of the ischaemic isolated rat heart 
produced PLA 2 activation in the non-ischaemic,and to a 
lesser extent in the ischaemic, area. This may be due to 
free radical production as reduced glutathione limited 
these effects. It is also possible that endothelial 
damage produced by high flow rates may cause this change 
in PLA2 activity as increased flow rates produced changes 
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1.1 Coronary artery disease-clinical implications
Coronary artery disease is one of the most common 
single causes of death in the Western world with a third 
of all deaths in the USA in 1976 being attributable to 
it (Stallones 1980). Complications of coronary artery 
disease include angina pectoris, heart failure, 
myocardial infarction and sudden death. Although it had 
been suspected that an association existed between 
coronary artery obstruction, anginal pain and sudden 
death, it was not until 1912 that there was wide 
acceptance that myocardial infarction was produced by 
c o r o n a r y  t h r o m b o s i s  ( H e r r i c k  1 91 2 ) .  In m a n  
atherosclerosis is the most frequent cause of coronary 
artery obstruction, atherosclerotic plaques being almost 
always present in cases of thrombosis (Schwartz, 
Chandler, Gerrity and Naito 1978). Flow changes resulting 
from plaque form a ti on  increase the risk of both 
endothelial damage and platelet contact with the vessel 
wall leading to platelet aggregation and thrombus 
formation (Azuma and F u ku sh im a  1976). In patients 
s u f f e r i n g  f r o m  a c u t e  m y o c a r d i a l  i n f a r c t i o n  
atherosclerosis is usually widespread and diffuse,however 
certain arterial s e g m en t s appear predisposed to 
narrowing. The majority of thrombi are found in the left 
anterior descending, right and circumflex coronary
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arteries in their first 2cm of length and at branch 
points (Davies, Woolf and Robertson 1976, Silver, Baroldi 
and Mariani 1980). Thrombi are rarely found in intramural 
coronary arteries (Roberts and Buja 1972, Ridolfi and 
Hutchins 1977).
In the majority of cases when a thrombus is found at 
post mortem it is in the vessel supplying the infarcted 
area (Silver et.al. 1980). However varying proportions of 
occlusive coronary thrombi have been found in patients 
with myocardial infarcts or at post mortem in sudden 
death cases, ranging from 36% (Branwood 1978) to 96% 
(Ridolfi and Hutchins 1977). It is thought that although 
thrombosis is a major cause of myocardial infarction 
other factors may be involved (MacAlpin 1974).
Sudden cardiac death, defined as where death occurs 
within an hour of being last seen alive is associated 
with a low incidence of thrombi (Reichenbach, Moss and 
Meyer 1977). Such death has been attributed to many 
different causes (review Podrid 1985), resulting in 
ventricular fibrillation (Armstrong, Duncan, Oliver, 
Julian, Donald, Fulton, Lutz, and Morrison  1972). 
Attention has also centred on the role of coronary 
artery spasm in producing sudden cardiac death (Oliva, 
Potts and Pluss 1973, Engel, Page and Campbell 1976). 
This is d i f f ic ul t to s ub s ta nt ia te  after the event 
a l t h o u g h  s p a s m  has b e e n  s e e n  d u r i n g  c o r o n a r y  
arteriography with the use of contrast material (Oliva
20
et.al. 1973) and also at post mortem (El-Maraghi and 
Sealy 1980). The cause of this type of spasm is, as yet, 
unknown (review Kalsner 1982).
1.2 Metabolic events in myocardial ischaemia
Ischaemia is produced in myocardial tissue by a 
reduction in arterial flow due to a thrombus or spasm of 
the artery, or to an increase in myocardial work and 
oxygen demand greater than the arterial blood flow can 
supply (Jennings 1970). Ischaemia differs from hypoxia, 
where there is low oxygen delivery to the tissue with 
adequate perfusion, in that local accu mu la t io n of 
metabolites can occur due to reduced perfusion. In 
hypoxia there is no such accumulation as perfusion, and 
therefore washout, is maintained. The degree of reduction 
in arterial flow needed to induce ischaemia is not known 
because partial reductions may result in a heterogenous 
p e r f u s i o n  w h o s e  p a t t e r n  c a n n ot  be d e t e r m i n e d  
(Steenbergen, DeLeeuw, Barlow, Chance and Williamson 
1977). Following obstruction of a major coronary artery 
in the dog it has been shown that the blood flow in the 
s u be ndocardium falls from 1-2 to 0-0.07m l / m i n / g , 
providing virtually no oxygen (Reimer and Jennings 1979).
When oxygen c o n c en tr at io ns  fall the rate of 
oxidative phosphorylation is reduced and an increase in 
the NADH/NAD ratio is produced. This leads to inhibition 
of aerobic m e t a b o l i s m ;  pyruvate dehydrogenase and
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glyceraldehyde- 3- phosphate dehydrogenase both being 
inhibited by NADH (review Neely and Morgan 1974). The 
rate of the latter enzyme appears to be controlled 
primarily by product inhibition. Reduced ATP generation 
by oxidative phosphorylation gives an increased ADP/ATP 
ratio and thus an increase in glycolytic rate due to 
activation of phosphofructokinase, an important control 
point in glycolysis (Newsholme 1971/72). This increase in 
glycolysis is transient due to the accumulation of 
lactate (Liedtke, Hughes and Neely 1976). Lactate cannot 
be m e t a b o l i s e d  due to i n h i b i t i o n  of p y r u v a t e  
dehydrogenase, and it suppresses glycolysis, this being 
independent of changes in pH (Rovetto, Lamberton and 
Neely 1975). It also suppresses breakdown of glycogen to 
release glucose (Dobson and Mayer 1973). Thus even if 
substrate supply is plentiful it cannot be utilised.
Lactate a c cu m ul a t i on  leads to a reduction in 
intracellular pH due to the concomitant production of 
protons (review Neely and Morgan 1974, Hillis and 
B ra u nw al d 1977) which also leads to glycolytic 
inhibition.
As very little ATP is being produced by oxidative 
phosphorylation and glycolysis the demand for ATP will 
exceed its production after a few minutes of ischaemia. 
To m a i n t a i n  the c o n ce nt ra ti on  of ATP the level of 
phosphocreatine falls (Braasch, Gudbjarnason, Puri, 
Ravens and Bing 1968, Garlick, Radda and Seeley 1979)
22
and this is followed by a continual decline in ATP 
(Braasch et.al. 1968, Allison, Ramey and Holsinger 1977, 
Jennings, Reimer, Hill and Mayer 1981). ADP content rises 
and the adenine nucleotide pool is rapidly destroyed with 
m e t a b o l i s m  to inosine, hypoxanthine and xanthine 
(Jennings, Reimer and Steenbergen 1985).
Fatty acid oxidation, which normally provides the 
major energy source in the myocardium (Neely, Rovetto and 
Oram 1972), is reduced (Opie 1968) due to the increased 
NADH/NAD ratio which causes inhibition of one of the 
oxidative steps (Moore, Radloff, Hull and Sweeley 1980). 
There is also a decrease in the transport of fatty acids 
into the mitochondria (Wood, Sordahl, Lewis and Schwartz 
1973) and therefore cytosolic accumulation of acyl CoA 
and acyl carnitine occurs (Idell-Wenger, Grotyohann and 
Neely 1978).
1.3 Electrophysiology of myocardial ischaemia
Following coronary artery occlusion there are three 
distinct phases of rhythm disturbances.
Phase 1 arrhythmias begin within minutes (Kaplinsky, 
Ogawa, Balke and Dreifus 1979) and terminate within 30 
minutes. Phase 2 arrhythmias appear 12-24 hours later 
and phase 3 weeks after myocardial infarction. The 
mechanisms involved in phase 1 arrhythmias are thought to 
differ from phase 2 and 3 (Corr and Sobel 1979).
Phase 1 arrhythmias are thought to be due to re­
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entry mechanisms operating (review Corr and Sobel 1980, 
Janse, Kleber, Capucci, Coronel and Wilms-Schopman 1986). 
Ischaemic cells have a reduced action potential duration, 
upstroke velocity and amplitude and a reduced resting 
membrane potential (Russell, Oliver and Wojtczak 1977), 
these being thought to lead to the production of 
arrhythmias. Re-entrant mechanisms rely on the presence 
of unidirectional conduction block and are promoted by 
slow conduction and inhomogeneities in refractory periods 
of adjacent areas, all of which occur in ischaemic tissue 
(Downar, Janse and Durrar 1977a, Elharrar, Foster, Jirak, 
Gaum and Zipes 1977, Russell et.al. 1977). Triggered 
a c t i v i t y ,  g e n e r a t e d  by e a r l y  or d e l a y e d  
afterdepolarizations (Cranefield 1977) may also be a 
possible mechanism of ectopic impulse formation during 
ischaemia (Janse et.al. 1986).
The m et a b o l i c  changes leading to these early 
arrhythmias are incompletely understood but it is thought 
that arrhythmogenic metabolites accumulate within the 
myocardium. The ischaemic heart, where metabolite 
retention occurs due to reduced flow, is more vulnerable 
to ventricular fibrillation than the hypoxic heart 
(Bagdonas, Stukey, Piera, Amer and Hoffman 1961).
Electrophysiological changes induced by ischaemia in 
an intact heart can be reversed by reperfusion with 
saline saturated with nitrogen. Under these circumstances
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the tissue is still hypoxic suggesting that a deleterious 
metabolite is being washed out (Downar et.al. 1977). 
Venous blood from ischaemic regions is also capable of 
producing electrophysiological changes characteristic of 
ischaemic tissue in normoxic endocardium (Downar, Janse 
and Durrar 1977b).
There are many candidates in the search for the 
metabolites responsible for arrhythmogenesis including;
1) elevated extracellular potassium
2) catecholamines
3) elevated intracellular calcium
4) free fatty acids and their esters
5) prostaglandins
6) lysophospholipids
1-4 Possible mediators of early ischaemic arrhythmias
1) Elevated extracellular potassium
Extracellular potassium begins to rise within 15 
seconds of the interruption of myocardial perfusion (Hill 
and Gettes 1980) reaching a plateau after 10-15 minutes 
(Hill and Gettes 1980, Hirche, Franz, Bos, Bissig, Lang 
and S c h r a m m  1980). This increase in p o t a s s i u m  is 
reversible upon reperfusion. During early ischaemia the 
extracellular potassium concentration may increase from 
4mM to lOmM. This loss of potassium from the cells was
25
originally thought to be a result of reduced sodium / 
potassium ATPase activity, however evidence suggests that 
the sodium / potassium ATPase still operates (Kleber 
1983) and therefore increased potassium efflux is likely 
to be the main cause (Rau, Shine and Langer 1977). There 
may be a role for ATP regulated potassium channels, which 
in cardiac muscle have been shown to produce an outward 
current which is inhibited by intracellular ATP (Noma
1983). During ischaemia, when intracellular ATP 
concentration falls these channels are likely to be 
activated and lead to potassium efflux. It has also been 
s u g g e s t e d  that the increased p o t a s s i u m  efflux and 
membrane conductance to potassium (Vleugels, Vereecke and 
Carmeliet 1980) is due to the decrease in fixed negative 
charge in the cell due to b u ffering of protons by 
intracellular proteins. This causes an outward movement 
of anions (lactate and inorganic phosphate) and cations 
(K+) (Kleber 1984).
Increased extracellular potassium decreases the 
resting membrane potential and maximum velocity of the 
action potential upstroke (Morena, Janse, Fiolet, 
Krieger, Crijns and Durrer 1980). Hypoxia and acidosis 
accentuate these changes (Janse et.al. 1986).
Local differences in potassium concentration occur 
within the ischaemic tissue and these may be responsible 




The a u t o n o m i c  nervous system is believed to 
influence arrhythmia production during ischaemia (review 
Verrier and Hagestad 1985).
Myocardial ischaemia is accompanied by increased 
blood catecholamine concentrations (Ceremuzynski 1981) 
and in dogs this increase has been shown to precede the 
development of arrhythmias (Prakash, Parmley, Horvat and 
Swan 1972). In addition to release of noradrenaline and 
a d r e n a l i n e  fr o m  the adrenal m e d ulla in i s chaemia 
(Staszewska-Barczak and Ceremuzynski 1968) local release 
of n o r a d r e n a l i n e  w i t h i n  h e a r t  t i s s u e  has been 
demonstrated (Carlsson, Abrahamsson and Almgren 1985).
It has been suggested that c a t e c h o l a m i n e s  are 
arrhythmogenic due to them elevating cellular cyclic AMP 
(cAMP) concentrations. This occurs due to binding of the 
catecholamine to beta receptors and subsequent adenylate 
cyclase activation. Evidence for the role of cAMP is 
conflicting. cAMP has been reported to be elevated in 
hearts s u c c u m b i n g  to ventricular f i brillation in 
comparison to those with other types of arrhythmias 
(Corr, Witkowski and Sobel 1978) and dibutyryl cAMP 
decreases the ventricular f i brillation threshold 
independently of beta blockade (Lubbe, Podzuweit, Daries 
and Opie 197 8). However other reports (Bricknell and Opie 
1978, Kane, Morcillo-Sanchez, Parratt, Rodger and Shahid
27
1985) have not demonstrated a clear relationship between 
elevated cAMP concentrations and the production of 
arrh y t h m i a s .  It is possible that cAMP may be the 
initiator of a chain of events that do not then require 
the continued presence of cAMP. cAMP is able to modulate 
the activity of the slow calcium channel in myocardial 
cells (Watanabe and Besch 1974) and increase calcium flux 
(review Green and Watanabe 1985) by phosphorylation of 
the calcium channel by cAMP dependent protein kinase 
(Osterreicher, Brum, Hescheler, Trautwein, Flockerzi and 
Hofmann 1982). This increased calcium influx may also be 
involved in the production of arrhythmias.
3) Elevated intracellular calcium
During ischaemia there is an abnormal rise in 
intracellular calcium (review Jennings et.al. 1985) 
leading to a reduction in the cell resting membrane 
potential. This can produce a flow of current to the 
nor m a l  tissue and initiate extrasystoles (Clusin, 
B u c h b i n d e r  and H a r r i s o n  1983). Local release of 
catecholamines can stimulate calcium influx via the slow 
inward current and calcium efflux is depressed during 
ischaemia due to a decrease in active calcium transport. 
This is due to a reduction in cellular ATP and to reduced 
Na+ / Ca^+ exchange (Bersohn, Philipson and Fukushima
1982). Increased cellular calcium also regulates inter­
cellular communication in cardiac muscle by controlling
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the permeability of the intercalated discs (reviewed by 
DeMello 1982). Calcium increases the rate of healing of 
myocardial cells by a sealing process halting the spread 
of depolarising current (DeMello, Motta, Chapeau 1969) 
and intracellular injection of calcium decreases the 
electrical coupling between the cells (DeMello 1975). An 
increase in cellular calcium may therefore contribute to 
the i m p a i r e d  conduction seen in i s c h a e m i c  tissue. 
Acidosis inhibits Na+ / Ca^ + exchange (review Eisner, 
Allen and Orchard 1985) and thus ischaemic conditions may 
lead to elevated intracellular calcium producing electro- 
p h y s i o l o g i c a l  a b n o r m a l i t i e s  w h i c h  m a y  le a d  to 
arrhythmias.
Calcium accumulation has been suggested to be 
augmented by ot -adrenergic activity (review Corr and 
Sharma 1984) with the number of a-receptors in ischaemic 
tissue increasing two fold (Corr, Shayman, Kramer and 
K i p n i s  1981). A l p h a  b l o c k a d e  has p r o v e d  to be 
antiarrhythmic (Davey 1980, Sheridan, Penkoske, Sobel and 
Corr 1980, Pogwizd, Sharma and Corr 1982) lending support 
to this hypothesis. Alpha adrenergic stimulation will 
also result in an increased slow inward current in 
ischaemic tissue (Miura, Inui and Imamura 1978). It is 
thought responses to catecholamines in ventricular tissue 
that are normally ft receptor mediated are, in ischaemic 
tissue, a  mediated (review Corr and Sharma 1984), such as 
the slow inward current (Miura et.al. 1978) and these
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predispose to the development of arrhythmias.
4) Free fatty acids and their esters
Catecholamine release during ischaemia stimulates 
triglyceride lipolysis (Kruger, Leighty and Weissler 
1967, Steinberg and Khoo 1977) from adipose tissue 
l eading to elevated circulating free fatty acid 
concentrations (Oliver, Kurien and Greenwood 1968). These 
have been correlated with the incidence of arrhythmias 
(Kurien, Yates and Oliver 1971) however conflicting 
results have been found (Opie, Norris, Thomas, Holland, 
Owen and van Noorden 1971). It is possible that the 
absolute c o n c e n t r a t i o n  of free fatty acid is less 
important than the ratio of free fatty acids to albumin 
(Willebrands, Ter Welle and Tasseron 1973) however 
ventricular fibrillation did not occur in isolated rat 
hearts if the ratio was increased to 12:1 (Evans, Opie 
and Shipp 196 3).
Fatty acid metabolism by q  oxidation is inhibited 
during ischaemia (review Neely and Morgan 1974) due to 
the increased NADH/NAD ratio and this leads to the 
accumulation of long chain fatty acyl derivatives such as 
acyl CoA and acyl carnitine (Liedtke, Nellis and Neely
1978). These are capable of exerting deleterious effects 
on myocardial membranes by detergent-like actions (Corr 
and Sobel 1981) and may therefore mediate part of the 
arrhythmogenic effects of free fatty acids.
30
5) Prostaglandins / Thromboxanes
Prostaglandins are synthesised from C 2 0  unsaturated 
fatty acids released from membrane phospholipids by 
phospholipases. Although there is a large family of 
prostaglandins the physiologically important ones in 
ischaemia are thought to be prostacyclin (PGI2 ) an<3 
thromboxane A2 (TXA2 ). Both PGI2 and TxA2 have been shown 
to be released from the ischaemic myocardium (Coker, 
Parratt, Ledingham and Zeitlin 1981).
T x A 2 is a potent v a s o c o n s t r i c t o r  and platelet 
aggregator, whilst PGI2 is a potent vasodilator and 
inhibits platelet aggregation (Moncada and Vane 1978). 
TxA2 and PGI 2 have been suggested to be pro- and anti- 
arrhythmic respectively (Coker et.al. 1981) and evidence 
for the suppression of ischaemically induced arrhythmias 
by increased prostacyclin production (Starnes, Primm, 
Woosley, Oates and Hammon 1982, Coker and Parratt 1984) 
or reduced thromboxane A 2 production (Smith, Lefer and 
Smith 1980, Coker 1984) has been obtained.
The action of thromboxane A2 is possibly indirect by 
the aggravation of existing ischaemia by vasoconstriction 
and the formation of platelet aggregates. Due to the 
opposing actions of PGI2 and T xA2 it is likely that the 
balance between the two determines any pro- or anti- 
a r r h y t h m i c  activity of the p r o s t a g l a n d i n s  during 
myocardial ischaemia (Coker et.al. 1981).
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Despite substantial evidence for the involvement of 
this balance in influencing the production of arrhythmias 
conflicting results have also been obtained. It has been 
reported that although infarcted canine myocardium has an 
increased synthetic capacity for TXA2 , its presence does 
not directly influence arrhythmogenesis or electro- 
physiological p a r a m e t e r s  late (3-7 days) during 
infarction (Kramer, Davies, Dean, McCluskey, Needleman 
and Corr 1985). TXA 2  has also been shown to have no 
involvement in the development of reperfusion arrhythmias 
in the dog (Burke, Antonaccio and Lefer 1982). These 
results may reflect differences in the aetiology of late 
and reperfusion arrhythmias respectively, in comparison 
to those produced by acute ischaemia.
6) Lysophospholipids
The accumulation of lysophospholipids in ischaemia 
due to the breakdown of membrane phospholipids is thought 
to have a role in m e d i a t i n g  i s c h a e m i c  damage and 
subsequent production of arrhythmias as detailed below.
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1.5 LYSOPHOSPHOLIPIDS
1) Hyocardial phospholipid composition
The major ph o s p h o l i p i d s  of m a m m a l i a n  tissue are 
phosphatidylcholine (PC) and phosphatidylethanolamine 
(PE) which together comprise approximately 7 0% of the 
total phospholipid in human (Gloster and Harris 1969) and 
rat (Gloster and Harris 1970) myocardial fractions. 
Similar proportions have been found in rat sarcolemma 
(Tibbits, Sasaki, Ikeda, Shimada, Tsuruhara and Nagatomo 
1981) and in pig myocardium (Shaikh and Downar 1981).
The remainder of the phospholipid is composed of 
phosphatidylserine (PS), pho s pha t i dy 1 i no s i t o 1 (PI)*
s phingom y e l i n ,  cardiolipin (1-3-bis (phosphatidyl) - 
glycerol), and the lysophospholipids, lysophosphatidy1“ 
choline (LPC) and lysophosphatidylethanolamine (LPE). PS 
and PI total less than 10% of total phospholipids but are 
thought to be important in calcium binding to sarcolemmal 
membranes (Philipson, Bers and Nishimoto 1980). PI is 
involved in receptor stimulated intracellular signalling 
(review Berridge 1984, Ransas, Gjorstrup, Hjalmarson, 
Sjorren and Jacobsson 1986) however little of this work 
has been done in myocardial tissue.
Lysophospholipids are present at concentrations less 
than 5% of total phospholipids however they have strong 
cytolytic properties (Weltzien 1979) and small increases
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in their concentration are thought to have profound 
effects on membrane structure and function.
2) Structure and properties of lysophospholipids
Lysophospholipids are produced by the hydrolysis of 
membrane phospholipids by phospholipases (FIG 1). Most 
m e m b r a n e  phospholipids are c o m p o s e d  of a 3 carbon 
glycerol backbone to which two hydrophobic fatty acids 
and a polar, phosphate containing hydrophilic head group 
are esterified.
The action of phospholipase A^ or A 2 produces a free 
f a t t y  a c i d  a n d  a l y s o p h o s p h o l i p i d  ( F I G  1). 
Lysophospholipids can also be produced by the hydrolysis 
of plasmalogens. Plasmalogens are glycerophospholipids 
with a 1-alkenyl group and can be d e a c ylated by 
plasmalogenase or phospholipase A 2 * The pathways for 
p l a s m a l o g e n  m e t a b o l i s m  have not been c o m p l e t e l y  
elucidated but evidence does exist for different 
metabolism of plasmenylcholine and plasmenylethanolamine 
in guinea pig heart (Arthur, Page, Mock and Choy 1986).
Lysophospholipids are amphiphilic molecules, having 
a hydrophilic head group and a hydrophobic acyl group. 
This leads to their properties enabling interactions with 
biological membranes (Helenius and Simons 1975). At low 
concentrations they are incorporated into the lipid 
bilayer as monomers. This incorporation can change the 
physical properties of the bilayer (Fink and Gross 1984)
and the activity of membrane bound enzymes (Weltzien 
1979). Incorporation of low concentrations of amphiphiles 
can expand the m e m b r a n e  area, possibly due to a 
transition from the gel to liquid state (Chapman, Urbina 
and Keough 1974) and this may cause conformational 
changes in ion channel proteins within the membrane.
Evidence exists that the activities of intrinsic 
membrane proteins are regulated by the phospholipid 
environment around the protein (Warren, Houslay, Metcalfe 
and Birdsall 1975) and thus the interactions of an 
amphiphile with this lipid annulus can potentially modify 
the protein function.
At higher concentrations amphiphiles aggregate into 
micelles in which the hydrophobic regions are clustered 
together in a core with the hydrophilic groups exposed 
externally to the aqueous environment. These micelles are 
able to incorporate into membranes and aggregate with the 
membrane lipids to form mixed micelles. This depletion of 
m e m b r a n e  p h o s p holipids can produce a variety of 
functional changes and destroy the integrity of the 
membrane. In the heart this could lead to calcium influx 
and cell death (review Katz and Reuter 197 9).
Compounds of amphiphilic nature such as lysophospho­
lipids are therefore able to exert effects on membrane 
structure and function, and at sufficiently high 
concentrations can lead to disruption and loss of the 
ability of the cell membrane to act as a barrier.
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3) Evidence for accumulation of lysophospholipids 
ip ischaemia
Lysophospholipid accumulation has been shown to 
occur in the ischaemic pig myocardium (Shaikh and Downar
1981), increases of 60% in LPC and LPE being seen 
following 8 minutes coronary artery ligation. In the cat 
myocardium increases of 53% in LPC plus LPE have been 
reported in the ischaemic area following ten minutes 
coronary artery occlusion in comparison to controls 
(Corr, Snyder, Lee, Gross, Keim and Sobel 1982), LPC + 
LPE increasing from 4.9 +/- 0.27 to 7.5 +/- 0.33 nmol/mg 
protein, the ratio of LPC + LPE to the corresponding 
diacylphospholipids (PC + PE) increasing by 89% although 
there was no significant decrease in PC + PE. In an in 
Y_i_tX£ p r e p a r a t i o n  of the dog heart, involving the 
production of global ischaemia by incubating tissue at 
37°C in isotonic KC1 under anaerobic conditions in sealed 
bags, a gradual increase of LPC with time from 1 to 24 
hours has been demonstrated (Steenbergen and Jennings
1984) .
Correlation of LPC + LPE concentration with the 
production of ventricular fibrillation following coronary 
artery ligation has been made in the anaesthetized cat, 
animals undergoing spontaneous ventricular fibrillation 
having the highest tissue LPC + LPE concentration (Corr, 
Sharma and Sobel 1983). One of the aims of this thesis
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was to measure lysophospholipid concentrations in the 
isolated rat heart during ischaemia. This model is very 
well d o c u m e n t e d  with a well defined progress of 
arrhythmias and therefore it should be possible to 
compare the two.
Increased lysophospholipid concentrations in the 
effluent from ischaemic cat myocardium In vivo have also 
been reported (Snyder, Crafford, Glashow, Rankin, Sobel 
and Corr 1981), the increase in LPC concentration being 
almost 100% following 10 minutes ischaemia. Difficulties 
arise in i n t e r p r e t i n g  m e a s u r e m e n t s  of effluent 
concentration in this report due to the use of a washout 
technique to collect released LPC. It is unlikely that 
equilibrium would be established between the interstitial 
fluid and effluent during the washout however comparison 
with control washout for the percentage increase in LPC 
is valid.
4) Elg.ctrophysiological and arrhythmogenic 
properties of lysophospholipids
Lysophospholipids have been shown to produce marked 
electrophysiological changes when added exogenously to 
isolated tissue.
In s o l u t i o n s  c o n t a i n i n g  0 . 4 m M  a l b u m i n  at 
physiological pH, 1.2mM LPC induces changes resembling 
those seen in ischaemic tissue i_n vivo (Corr, Cain, 
Witkowski, Price and Sobel 1979). These changes are
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reversible by superfusion with LPC free medium.
Clarkson and Ten Eick (1983) observed a decrease in 
resting membrane potential on exposure of cat papilliary 
muscle to 2 0 - 2 0 0 p M  LPC. This was a s s o ciated w i t h  
shortening of the action potential duration and a 
decrease in action potential amplitude. Again this could 
be reversed with LPC free perfusion. These changes were 
thought to be specific rather than being due to general 
membrane disruption as the membrane resistance increased 
and there was no change in the internal p o t a s s i u m  
concentration (Clarkson and TenEick 1983, Nakaya, Kimura 
and Kanno 1984).
In canine Purkinje fibres LPC produced concentration 
dependent decreases in the maximal diastolic potential, 
action potential amplitude and maximal rate of rise of 
p h a s e  0 ( N a k a y a  et.al. 1984). The h i g h e s t  LPC 
concentration used, 80pM, reduced action potential 
duration and increased the rate of spontaneous discharge. 
This was also seen by Arnsdorf and Sawicki (1981). Such 
abnormal automaticity is known to occur in partially 
depolarised Purkinje fibres on the border of the infarct 
zone (Dangman and Hoffman 19 83).
The electrophysiological effects of LPC are enhanced 
by acidosis, Purkinje fibres having a three fold increase 
in sensitivity to LPC on reduction of pH from 7.4 to 6.7 
(Corr, Snyder, Cain, Crafford, Gross and Sobel 1981) 
which was not due to increased cellular LPC incorporation
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(Gross, Corr, Lee, Saffitz, Crafford and Sobel 1982). LPC 
is capable of producing changes in electrophysiological 
characteristics In vitro that have been shown to occur in 
ischaemic tissue in ylyfi, changes that its major 
metabolites glycerophosphorylcholine and free fatty acids 
do not produce (Corr et.al. 1979). Albumin binding of LPC 
a p p e a r s  i m p o r t a n t ,  w i t h  10 f o l d  g r e a t e r  LPC 
concentrations needed to produce the same effects in the 
presence of albumin (Corr et.al. 1981). It has been 
suggested that LPC acts as a non specific depressant of 
conductance as membrane resistance at potentials near the 
normal resting potential increased in cat papilliary 
muscle and LPC had an inhibitory effect on time dependent 
potassium conductance (Clarkson and Ten Eick 1983). IOjjM 
LPC has been shown to produce an increased conduction 
time and spontaneous firing when perfused through the 
isolated rabbit heart (Nakaya, Ozaki, Kimura, Gotoh and 
Kanno 1984) and has been shown to produce arrhythmias in 
the isolated hamster (Man and Choy 1982) and rabbit 
(Bergmann, Ferguson and Sobel 1981) hearts.
Again the free concentration of LPC appears to be 
important as Man and Choy found a 10 fold increase in LPC 
concentration was required to achieve the same effects in 
the presence of albumin.
The c r i t i c a l  m i c e l l e  c o n c e n t r a t i o n ,  the 
concentration at which LPC forms micelles as opposed to
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remaining as monomers, was thought to be related to the 
arrhythmogenic nature of the LPC (Bergmann et.al. 1981) 
but more recent studies have cast doubt on this because 
different acyl chain length LPC species with different 
critical micelle concentrations were shown to have 
similar arrhythmogenic properties (Man, Wong and Choy
1983). The type of polar head group and the degree of 
unsaturation of the acyl group also bore little relation 
to their arrhythmogenic action.
LPC has been shown to produce a r r h y t h m i a s  in 
isolated rat hearts, the ability to produce ventricular 
fibrillation being dependent on LPC concentration and 
perfusion time. This generation of fibrillation was 
dependent on the presence of external calcium however it 
did not appear to be dependent on the slow inward current 
as verapamil did not have a protective effect (Man and 
Lederman 1985).
Thus l y s o p h o s p h o l i p i d s  have been shown to be 
a r r h y t h m o g e n i c  in a n u m b e r  of i s o l a t e d  h e a r t  
preparations. One of the aims in this thesis was to 
assess the arrhythmogenic effects of LPC in an in vivo 
model to see if arrhythmias could be produced in a model 
more physiologically relevant to the clinical situation.
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5) Effects o f lysophospholipids on ion transport 
s y stems
Lysophosphatidylcholine has been shown to have 
effects on ion transport and conductance in a number of 
systems.
Potassium efflux is increased in isolated rabbit 
hearts by lOpM LPC (Nakaya and Ozaki et.al. 1984). 
Although this increase was only slight due to continual 
perfusion it may represent a marked extracellular 
potassium accumulation if perfusion ceases as during 
ischaemia. The same workers also looked at the effect of 
LPC on intracellular p o t a s s i u m  activity in canine 
Purkinje fibres but found no decrease during perfusion 
with 1 60 jjM LPC (Nakaya, Ki m u r a  and Kanno 1 984), 
supporting the results of Clarkson and Ten Eick (1983). 
This may be due to the high intracellular potassium 
concentration, where small decreases sufficient to 
s i g n i f i c a n t l y  i n c r e a s e  e x t r a c e l l u l a r  p o tassium 
concentration would not be detectable. Lysophospholipids 
have also been shown to increase potassium efflux from 
erythrocytes (Lawrence, Moores and Steele 1974) and 
therefore any accumulation of lysophospholipids in 
ischaemia may contribute to the potassium efflux seen.
Inhibition of sarcolemmal Na+ / K+ ATPase by 10-60pM 
LPC has been shown (Karli, Karikas, Hatzipavlou, Levis 
and Moulopoulos 1979), this inhibition being reversed by
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incubation with albumin. LPC is thought to act 
specifically at the sodium binding site w h i c h  may 
contribute to the decrease in the Vmax of the upstroke 
seen on treatment of isolated tissue with LPC.
Calcium transport is also aff e c t e d  by LPC. In 
cultured rat cardiac myocytes LPC at 60-80jjM is able to 
increase the rate of bidirectional calcium flux whilst at 
I O O jjM there is an increase in total cell calcium 
concentration (Sedlis, Corr, Sobel and Ahumada 1983). The 
increase in cell calcium seen after 5 minutes perfusion 
with I O O jjM LPC could be reversed by washing and 
was prevented by verapamil preincubation. Accumulation of 
calcium over longer periods of lOOpM LPC exposure could 
not be reversed or prevented by v e r a p a m i l  and was 
a c c o m p a n i e d  by irreversible morphological changes. 
Calcium accumulation induced by LPC has also been shown 
in pigeon erythrocytes (Lee, Ting and Vidaver 1986). The 
calcium accumulation may occur through the slow calcium 
channel (Corr and Snyder et.al. 1982). LPC has been shown 
to increase the cAMP content of myocardium by stimulation 
of adenylate cyclase (Ahumada, Bergmann, Carlson, Corr 
and Sobel 1979) and this can cause elevation of the 
inward calcium current by cAMP dependent phosphorylation 
of the ion channel (Watanabe and Besch 197 4).
Sodium / calcium exchange has been shown to be 
inhibited in sarcolemma isolated from ischaemic hearts 
and in sodium loaded canine sarcolemmal vesicles treated
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with 30pM LPC (Bersohn and Philipson 1983). Although the
Na+ / Ca^+ exchange normally operates in the direction of
calcium extrusion from the cell it is reversible (Bridge
and Bassingthwaite 1982) thus if LPC causes inhibition of
Na+ / K+ ATPase and produces an increased internal sodium
+ 2+concentration calcium influx could occur through Na / Ca 
exchange.
LPC has been shown to affect Ca2"^  M g ^ T P a s e  activity 
in human erythrocyte membranes, with long chain (C^g anc  ^
Cjg) unsaturated LPC molecules being stimulatory. These 
effects were highly dependent on the nature of the 
hydrophobic group and chain length (Tokumura, Mostafa, 
Nelson and Hanahan 1985).
LPC-induced changes may contribute to the changes 
seen in ion c o nductances during ischaemia. Recent 
evidence has pointed to a role of lysophospholipids in 
increasing a  receptor number (Sharma, Ahumada, Sobel and 
Corr 1983), a change that also occurs in ischaemia (Corr, 
Shayman, Kramer and Kipnis 1981) and is thought to be 
pro-arrhythmic (Davey 1980).
6) E vidence for the site of action of lysophospho- 
lipids
Although the effects of exogenously added lyso­
phospholipids on tissue excitability and function have 
been extensively studied this may not reflect their
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effects when liberated endogenously. When membrane 
hydrolysis is carried out In vitro changes in fluidity 
do not occur unless the products are washed out of the 
membrane (Storch and Schachter 1985). The source of 
increased lysophospholipids during ischaemia is uncertain 
although there is evidence for it having a vascular or 
endothelial source. Increased LPC concentrations have 
been found in the coronary effluent from rat hearts (Stam 
and Hiilsmann 1981) although this was under conditions of 
hormonal stimulation (noradrenaline or glucagon) rather 
than ischaemia. Venous effluent LPC concentrations 
increase during ischaemia (Snyder et.al. 1981) which 
could indicate vascular production or movement to the 
extracellular space (Stein and Stein 1965). Extracellular 
addition of LPC to isolated tissues would be expected to 
mimic closely the effects of LPC in ischaemia if it does 
act extracellularly. LPC in concentrations known to occur 
in ischaemia does exert similar electrophysiological 
changes to those seen in ischaemia. Exogenously added LPC 
has been shown to incorporate into isolated tissues, the 
concentrations in the sarcolemma being the greatest . 
Incorporation of 1.5nmol LPC / mg protein, which was less 
than 2% of the total phospholipids, caused ma r k e d  
electrophysiological changes (Gross et.al. 1982).
LPC is unlikely to be distributed homogenously 
within the cell, due to its lipid nature, therefore 
concentrations measured in ischaemic tissue are likely to
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be an underestimate of the membrane concentration. As the 
sarcolemma of the rat heart comprises only 4% of its 
total membrane surface (Anversa, Olivetti, Melissari and 
Loud 1980) cellular concentrations probably give a very 
inaccurate measurement of the concentration in the 
sarcolemma.
The effects of LPC when added exogenously do not 
require incorporation of micelles (Bergmann et.al. 1981) 
although micelles may act as a reservoir providing 
monomers (Weltzien 1979). It is assumed that on initial 
exposure of a membrane to LPC monomers will incorporate 
into the outer layer of the lipid bilayer but then 
p e n e t r a t e  into the inn e r  layer. For m a m m a l i a n  
erythrocytes the rate constant for this movement is less 
than 0.03hr”l (Bergmann, Dressier, Haest and Deuticke
1984) .
It is therefore possible that LPC produced in the 
vasculature during ischaemia could incorporate into cell 
membranes of myocytes and so alter their functional 
properties.
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1.6 Production and metabolism of lysophospholipids
The major pathways of LPC metabolism are illustrated 
in FIG 2. Under normal physiological conditions phospho­
lipids are undergoing continual turnover (review van den 
Bosch 1980) but accumulation of LPC does not occur 
because any produced is reacylated to PC or hydrolysed to 
glycerophosphorylcholine. As LPC accumulation has been 
shown to occur in ischaemia the relative rates of these 
processes must change. Increased production of LPC by 
p h o s p h o l i p a s e  A 2 or d e c r e a s e d  m e t a b o l i s m  by 
lysophospholipases or the reacylating enzymes could all 
lead to increased LPC concentrations.
l) Ph p sphpl.ip3.se. a^  (ec 3.1.1.4)
Pho s ph oli pa se A 2 (PLA2 ) act i v i t y  leads to the 
hydrolysis of a diacylphospholipid at the C-2 position to 
produce a lysophospholipid and a free fatty acid (FIG 2).
Two types of PLA2 are commonly found, membrane bound 
and soluble forms.
Membrane bound enzymes are integral proteins in the 
plasma, mitochondrial and Golgi membranes, have a neutral 
to alkaline pH optimum and require calcium for activity 
(van den Bosch 1980). Membrane bound PLA2 enzymes were 
thought to depend on c a l m o d u l i n  for their calcium 
dependent activity (Wong and Cheung 1979, Moskowitz, 
Shapiro, Schook and Puszkin 1983, Moskowitz, Andres,
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Silva, Shapiro, Schook and Puszkin 1985) however other 
reports have found no role for calmodulin (Withnall, 
Brown and Diocee 1984, Watanabe, Hashimoto, Teramoto, 
Kume, Naito and Oka 1986) and it is now thought likely 
that the effects of cal m o d u l i n  and its antagonist 
trifluoperazine are due to non specific interactions with 
the membrane phospholipids.
Soluble p h o s pholipases A 2 are thought to be
lysosomal enzymes with no requirement for calcium and an 
acidic pH optimum (van den Bosch 1980) although there has
been a recent report of a plasmenylcholine specific PLA2  
in the cytosolic fraction of the guinea pig heart with an 
alkaline pH optimum and a requirement for calcium (Arthur 
et.al.1986). A calcium independent cytosolic plasmalogen 
specific PLA 2 has also been identified (Wolf and Gross
1985) .
Membrane bound PLA 2 enzymes are thought to be
important in the production of lysophospholipids as they 
are active at physiological pH.
Activation of PLA2 in the isolated cat heart during 
ischaemia has been reported (Shaikh and Downar 1985) 
however as small changes of specific radioactivity of 
labelled phospholipids were quoted with no indication of 
standard errors it is difficult to draw firm conclusions. 
In subcellular fractions from ischaemic portions of the
isolated rabbit heart no change in a s s a y a b l e  P L A 2
activity was seen (Corr and Sobel 1981). Hseuh, Isakson
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and Needleman (1977) showed an increase in prostaglandin 
and fatty acid release during global ischaemia however 
their protocol does not rule out the role of reperfusion 
in this release. Activation of brain PLA 2 in ischaemia 
has been shown but this was only a transient activation 
persisting for a maximum of one minute ischaemia after 
w h i c h  t i m e  the a c t i v i t y  was d e p r e s s e d  (Edgar, 
Strosznajder and Horrocks 1982). Work p o s tulating 
activated P L A 2 during ischa e m i a  has used indirect 
measurements by assaying prostaglandin production (Hsueh 
et.al. 1977) as this was thought to be the rate limiting 
factor in prostaglandin production (Flower 197 8). However 
as arachidonic acid, the precursor of the prostaglandins, 
can also be released by the action of phospholipase C and 
diglyceride lipase (Bell, Kennerly, Stanford and Majerus
1979) and the rate of prostaglandin synthesis in one 
system was shown to be dependent on the rate of 
reacylation of the liberated fatty acid (Korner, 
Hausmann, Gemsa and Resch 1984) care must be taken in 
interpreting indirect measurements of phospholipase 
activity.
The activities of lysoph o s p h o l i p a s e  and the 
reacylating enzyme lysophosphatide acyltransferase are 
both considerably greater than PLA2 activity (Gross and 
Sobel 1981a, Gross and Sobel 1982, Korner et.al. 1984) 
and therefore it has been suggested that changes in these 
a c t i v i t i e s  m a y  be m o r e  i m p o r t a n t  in a f f e c t i n g
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lysophospholipid concentrations than changes in PLA 2  
activity.
One aim in this work was to measure phospholipase A 2  
activity in the isolated rat heart and therefore attempt 
to see if its activity does increase during ischaemia.
2) Lysophospholipase (EC 3.1.1.5)
Lysophospholipase hydrolyses the remaining fatty 
acyl ester to release glycerophosphorylcholine and a free 
fatty acid from LPC (FIG 2).
Lysophospholipases are not calcium dependent, have a 
p H  o p t i m u m  of 6 - 8  a n d  do n o t  h y d r o l y s e  
diacylphospholipids (Gross and Sobel 1983). The effects 
of ischaemic conditions on their activity have been 
studied. Microsomal lysophospholipase is inhibited 81% by 
a reduction in pH to 6.5 from 7.4 (Gross and Sobel 1982), 
and c y t o s o l i c  l y s o p h o s p h o l i p a s e  is i n h i b i t e d  
competitively by palmitoylcarnitine with a Ki of 10-llpM 
(Gross and Sobel 1983). Conditions occuring in the 
ischaemic myocardium are therefore likely to contribute 
to a decrease in lysophospholipase activity.




LPC, with acyl CoA as the acyl group donor, producing a 
diacylphospholipid.
Inhibition of rabbit v e n t r i c u l a r  m i c r o s o m a l  
acyltransferase by glycerophosphorylcholine (GPC) has 
been shown (Gross and Sobel 1981b). In brain microsomes 
acyl CoA will also inhibit acyltransferase, this 
inhibition being overcome by high LPC concentrations 
(Deka, Sun and MacQuarrie 1986) therefore the ratio of 
acyl CoA to LPC in ischaemia could modulate the activity 
of this enzyme. In the hamster heart all reacylation of 
LPC is thought to be carried out by the acyltransferase, 
with no tranacylase being detected (Savard and Choy
1982).
Acyltransferase was not detected in rabbit myocardial 
cytosol (Gross and Sobel 1981a) however as palmitoyl CoA 
was used as the acyl group donor and an acyltransf erase 
specific for polyunsaturated fatty acids has since been 
identified in rabbit cardiac cytosol (Needleman, Wyche, 
Sprecher, Elliott and Evers 1985) this may explain the 
apparent lack of acyltransferase activity.
4) Lysophosphatidylcholine transacylase
Lysophosphatidylcholine transacylase produces PC and 
GPC from two molecules of LPC.
Rabbit myocardial cytosol has been found to possess 
this activity (Gross and Sobel 1981a) and the same enzyme 
protein may also carry out lysophospholipase activity. An
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acyl enzyme intermediate is formed which subsequently 
undergoes nucleophilic attack by either H 2 O or LPC to 
produce ly s o p h o s p h o l i p a s e  or transacylase activity 
respectively. Low concentrations of palmitoylcarnitine 
(20pM) have been shown to inhibit this transacylase 
(Gross and Sobel 1981a, Gross, Drisdel and Sobel 1983). 
Inhibition by reduced pH was also seen, therefore the 
conditions in ischaemia are likely to cause a reduction 
in LPC transacylase activity.
1.7 Membrane phospholipid changes during myocardial 
ischaemia
Although it is a ssumed that lyso p h o s p h o l i p i d 
production is due to membrane phospholipid hydrolysis the 
changes in LPC concentration do not always correlate with 
changes in the membrane phospholipids (Steenbergen and 
Jennings 1984), no significant changes in diacylphospho- 
lipids being seen after short periods of ischaemia when 
significant increases in lysophospholipids are evident 
(Shaikh and Downar 1981, Corr et.al. 1982). However as 
lysophospholipids comprise less than 5% of the total 
phospholipids the decrease in diac y l p h o s p h o l  ipids 
occuring when lysophospholipids increase significantly 
would not be readily detectable.
In a number of models phospholipid concentration has 
been shown to decrease after longer periods of time.
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After 30 minutes of ischaemia a 16% decrease was seen in 
the phospholipid content of dog sarcoplasmic reticulum 
(Yanagishita, Katagiri, Kitsu, Geshi, Konno, Tanno, 
Akiyama, Sekita, Kobayashi and Niitani 1985) and in other 
experiments in dog myocardium a similar decrease was also 
seen after 3 hours of ischaemia (Chien, Han, Sen, Buja 
and Willerson 1984). This phospholipid decrease is 
predominantly in the PC and PE species (Man, Slater, 
Pelletier and Choy 1 983) and may represent the 
involvement of lysosomal enzymes due to tne loss of 
lysosomal integrity (Hoffstein, Weissman and Fox 1976, 
Wildenthal 1978).
1.8 Pii^£phQlipid_metabQlism d u ring reperfusion of the
ischaem ic myocardium
R e p e r f u s i o n  of the m y o c a r d i u m  after prolonged 
ischaemia (>20 minutes) leads to extensive myocardial 
necrosis (Jennings et.al. Iy85) accompanied by severe 
arrhythmias of rapid onset (reviewed by Manning and 
Hearse 1984). There is evidence of sarcolemmal (Jennings 
and Ganote 1974) and cell (Hearse, Humphrey and Chain 
1973) disruption. This cell disruption and irreversible 
damage has been shown to correlate with the phospholipid 
depletion in the sarcolemma and reflects the loss of the 
ability of the membrane to act as a permeability barrier, 
leading to massive calcium influx and cell death (Chien,
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Abrams, Serroni, Martin and Farber 197 8).
Reperfusion of the myocardium may potentiate the 
phospholipid breakdown that occurs in ischaemia by 
washing out the products of this breakdown (Swoboda, 
Fritzsche and Hasselbach 1979, Katz 1982).
During reperfusion oxygen derived free radicals are 
produced (Gauduel and Duvelleroy 1984, McCord 1985). 
These highly reactive species have a very short half 
life. Under physiological conditions the natural cellular 
free radical scavengers such as catalase and superoxide 
dismutase are able to reduce the free radicals and 
prevent damage to the cell. Under ischaemic conditions it 
is thought that there is a decrease in intracellular 
scavengers and these are not able to metabolise the 
radicals formed on subsequent reperfusion.
A major component of cell injury due to free 
radicals is lipid peroxidation. Unsaturated fatty acids 
in membrane phospholipids react with the free radicals to 
produce an alkyl radical and from this a lipid peroxy 
free radical. This produces a disorganisation of membrane 
structure and a disturbance of normal function (Noronha- 
Dutra and Steen 1982). Lipid peroxidative injury can be 
potentiated by amphiphiles (Mak, Kramer and Weglicki
1986) therefore the production of lysophospholipids 
during ischaemia would be expected to enhance reperfusion 
injury due to peroxidation of the sarcolemma.
Enhanced lysophospholipid production by lysosomes
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during free radical generation occurs In vitro (Weglicki, 
Dickens and Mak 1984). Significant increases in LPC plus 
LPE were accompanied by decreases in PC and PE and a 
reduction in lysosomal integrity. It is thought that 
peroxidised phospholipids are better substrates for 
phospholipases (Sevanian, Stein and Mead 1981) and thus 
initial free radical attack on the membranes, which may 
be p o t e n t i a t e d  by LPC, can l e a d  to i n c r e a s e d  
susceptibility to phospholipase and further increases in 
LPC concentration.
Any increase in LPC during ischaemia may therefore 




One o b j e c t i v e  w a s  to d e v e l o p  a m e t h o d  of 
phospholipid extraction, separation and quantification to 
use with small quantities of tissue obtained from the 
isolated rat heart. The isolated rat heart was used due 
to simplicity of the model and because the time course 
and duration of the arrhythmias produced by coronary 
artery ligation are well defined. The arrhythmias could 
then be correlated with any changes in lysophospholipid 
concentration.
The changes in the two lysophospholipids LPC and 
LPE, and their parent phospholipids, PC and PE, were 
measured during ischaemia produced by coronary artery 
ligation.
Changes in the perfusate ionic composition that 
alter the time course of coronary artery ligation induced 
arrhythmias were also examined for their effects on 
lysophospholipid concentrations.
2) Effects of lysophospholipids in vivo
Although work has been done on the effects of lyso­
phospholipids on isolated tissues little work has been
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done on their effects in vivo*
An anaesthetized cat model was used to determine the 
effect of lysophospholipids when infused directly into 
the coronary circulation via the left anterior 
descending coronary artery, and when infused into the 
left ventricular wall. This may show differences between 
the effect of LPC in the vasculature and interstitially. 
The effect of pal mitoylearnitine (PAL) was similarly 
determined. PAL is a long chain acyl carnitine which has 
been shown to accumulate during ischaemia and has a 
similar structure and therefore a similar amphiphilic 
nature to LPC (FIG 3). Effects displayed by LPC due to 
these amphiphilic properties are likely to be also 
displayed by PAL.
A major metabolite of LPC, glycerophosphorylcholine 
(GPC), does not show this amphiphilic structure and 
properties (FIG 3) and the effects of GPC were therefore 
studied as a control.
The effects of LPC and PAL were compared with the 
effects of coronary artery ligation. This may provide 
information on whether accumulation of either LPC or PAL 
could be involved with the development of arrhythmias in 
vivo.
3) Measurement of phospholipase. Ao activity 
Increased phospholipase A 2 activity may contribute
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to the increased LPC concentrations that have been 
reported during ischaemia. Therefore an assay was 
developed and characterised to allow measurement of 
phospholipase A 2 activity in homogenates and subcellular 
fractions of the isolated rat heart.
This allowed m e a s u r e m e n t  of ph o s p h o l i p a s e  A 2  
activity during ischaemia at times when LPC concentration
had been shown to rise, correlations of phospholipase A 2  
activity with the concentration of LPC and the presence 
of arrhythmias could thus be made.
The activity of phospholipase A2 in tissue samples 
from the anaest h e t i z e d  cat was also m e a s u r e d  to 
determine the effect of coronary artery ligation and 
infusion of LPC and PAL on the activity. This was 
compared with the effect of LPC and PAL on phospholipase 
A2 in yitro.
Reperfusion of the ischaemic myocardium has been 
reported to be accompanied by phospholipid degradation 
(Jennings and Ganote 1974) and l y s o p h o s p h o l i p i d  
production (section 1.8). The effect of reperfusion of 
the ischaemic isolated rat heart on phospholipase A 2 
activity was determined to determine any possible role of 
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2 M EASUREMENT OF PHOSPHOLIPIDS AND LYSOPHOSPHOLIPIDS
IN THE ISOLATED RAT HEART
2.1 Heart perfusion by the Langendorff method
Male Wistar rats (Bath University strain) of mass 
250-300g were used throughout.
Hearts were removed, after killing the rat with a 
blow on the head, and placed in ice cold Krebs-Henseleit 







k h 2p o 4 1.2
MgS04 .7H20 1.2
CaCl2 .6H20 1.25
This c o m p o s i t i o n  was used throughout unless 
otherwise stated.
Hearts were perfused retrogradely through the aorta 
by the Langendorff method with Krebs-Henseleit buffer, 
saturated with 95% O 2 / 5% CO 2 to maintain a pH of 7.4, 
at 37°C at a c o n s t a n t  flow rate of l O m l / m i n .  
Contractility was m o n i t o r e d  i s o m e t r i c a l l y  w i t h  a
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D y n a m o m e t e r  VFI transducer and p e r f u s i o n  pressure 
measured with a Washington PT400-5/N259 transducer. 
Perfusion pressure was typically 60-70mmHg. Hearts were 
perfused to waste for 5 minutes to remove blood elements 
before switching to a recirculating system of volume 12ml 
(FIG 4). This allowed continual reoxygenation of the 
recirculating buffer. Equilibration of the heart, as 
judged by steadiness of the contractility and perfusion 
pressure recordingsf was normally achieved after 5 
minutes of recirculation.
For coronary artery ligation experiments a thread 
was passed around the left descending coronary artery 
using a curved needle of 16mm length. The artery could 
then be ligated at the required time, an increase in 
perfusion pre s s u r e  being c onsidered indicative of 
successful ligation. On completion of the experiment the 
heart was removed from the cannula and an area of the 
free left v e n t r i c u l a r  wall, c o r r e s p o n d i n g  to the 
ischaemic area w h e r e  the coronary artery had been 
ligated, excised. In control (sham ligated) hearts a 
tissue sample w as taken from the a n a t o m i c a l l y  
corresponding area.
All samples for phospholipid determination were 
rapidly frozen with liquid nitrogen cooled Wollenberger 
tongs, and stored in liquid nitrogen prior to extraction 
of the phospholipids, in order to minimise post mortem 
changes. Care was taken to minimise the time taken for
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excision of the samples, freezing being accomplished 
within 15-20 seconds of removal of the heart from the 
cannula.
2.2 Extraction of phospholipids
The extraction procedure is based on that of Shaikh 
and Downar (1981) and avoids the i n t r a p reparative  
production of lysophospholipids from plasmalogens which 
can occur if acidic solvents are used (Shaikh and Downar 
1980, Shaikh and Downar 1981). Plasmalogens are glycero- 
phospholipids with an alkenyl group at the C-l acyl 
position, this group being acid labile (Snyder 1969). 
Plasmalogens have been reported to comprise from 18% 
(Gloster and Harris 1969) to 40% (Fleischer, Klouwen and 
Brierley 1961, Mogelson, Wilson and Sobel 1980) of 
myocardial phospholipids and therefore an extraction 
procedure must be used that allows complete phospholipid 
recovery without plasmalogen breakdown. The procedure 
used is a modification of the Folch method of lipid 
extraction (Folch, Lees and Sloane-Stanley 1957) and has 
been shown to achieve almost complete phospholipid 
recovery (Shaikh and Downar 1981).
i) Method of extraction
a) Frozen tissue of mass 200mg was powdered in a 
liquid nitrogen cooled percussion mortar.
b) The powdered tissue was homogenised with a
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Potter homogeniser in 5ml chloroform / methanol (2/1) 
containing 0.005% butylated hydroxytoluene (BHT) as an 
antioxidant.
c) The homogeniser tube was washed with a further 
20ml of solvent and the washings added to the homogenate 
in a 50ml centrifuge tube.
d) After 5 minutes shaking 10ml of 0.9% saline were 
added to produce a biphasic mixture, followed by a 
further 5 minutes shaking.
e) Centrifuged at 2000rpm for 5 minutes in an MSE 
Chilspin at 4°C.
f) Lower layer removed by Pasteur pipette and 
retained.
g) Upper layer extracted a further 3 times with 15 
ml c h l o r o f o r m  / m e t h a n o l  / 0.58% sodium chloride 
(86/14/1). In each case the lower layer was retained and 
pooled in a round bottomed flask.
h) A final extraction of the upper layer was carried 
out with 15ml chloroform / methanol / 1M HC1 (86/14/1), 
the lower layer being neutralised with aqueous ammonia 
prior to addition to the pooled extracts.
i) The combined extracts were taken to near dryness 
under nitrogen at 37°C, transferred to a 10ml tube with 
successive washings of the flask with chloroform / 
methanol / water (75/25/2). This was taken to dryness 
under nitrogen at 37°C and resuspended in 300pl of 
c h l o r o f o r m  / m e t h a n o l  (2/1) for s e p a r a t i o n  of
.1
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phospholipids by high pressure liquid chromatography,
ii) Extraction yields
The recovery of phospholipids through the extraction 
procedure was measured.
20jJl of 0.7mg/ml lysophosphatidylcholine (LPC) 
(27nmol) was added to 25 ml of chloroform / methanol / 
BHT (2/1/0.005%) and taken through the extraction 
procedure before resuspending in 200pl of chloroform / 
methanol (2/1).
IOjjI aliquots were assayed for phosphate (section 
2.4) as were aliquots containing 1.35 nmol LPC (equal to 
100% yield of the extracted lipid).
n=4 Absorbance 660nm (-blankl
1.35nmol LPC 0.1395 +/- 0.011
1.35nmol LPC 0.1272 +/- 0.012
after extraction
Extraction yield = 91%
2.3 separation Qf phosphPlipid.s.
i) Choice of method
The commonest techniques used for the separation of 
phospholipids are thin layer chromatography (TLC) and 
high pressure liquid chromatography (HPLC).
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a) TLC
TLC may require separation of the extract in two 
dimensions with different solvents to achieve sufficient 
resolution of the components (Snyder et.al. 1981). The 
lipids can then be visualised with iodine vapour (Snyder 
et.al. 1981) or an acid molybdate reagent (Dittmer and 
Lester 1964) and assayed for phosphate content (Shaikh 
and Palmer 1976).
b) HPLC
HPLC separation may be achieved with a silica gel 
(Chen and Kou 1982) or a cation exchange column (Gross 
and Sobel 1980). Separation on the silica gel column 
method of Chen and Kou (1982) depends on the presence of 
phosphoric acid in the solvent. Although this improves 
resolution the acidic nature of the solvent may lead to 
plasmalogen degradation. It also necessitates the use of 
an assay system for the p h o s p h o l i p i d s  that w o uld  
distinguish between inorganic and organic phosphate. A 
system without phosphoric acid is therefore preferable.
Using a cation exchange column lipids are retained 
on the column due to the presence of an amino functional 
group in the choline or ethanolamine portion of the lipid 
that is positively charged at neutral pH. This allows 
isocratic elution of the lipids with an organic solvent.
In the majority of HPLC systems the separated 
components are quantified by the absorbance peak area. 
This is not possible with the U.V. detection of phospho­
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lipids as the U.V. absorbance around 200nm is due to the
*
TT—TT transition of long chain unsaturated carbon-carbon 
double bonds present in the C-2 acyl group of most 
phospholipids (Jungalwala, Evans and McCluer 197 6). This 
is dependent on the degree of unsaturation of the sample 
therefore in a tissue sample, where the degree of 
unsaturation is unknown, the absorbance does not directly 
correlate with the quantity of phospholipids and any 
saturated phospholipids would not be detected. Methods of 
q u a n t i f y i n g  the p h o s p holipids by conversion into 
fluorescent dansyl (Chen, Kou and Chen 1981) or biphenyl- 
carbonyl derivatives (Jungalwala, Turel, Evans and 
McCluer 1975) have been reported but as this is only 
a p p l i c a b l e  to p r i m a r y  a m i n o  g r o u p  c o n t a i n i n g  
phospholipids it would preclude the measurement of 
phosphatidylcholine and its lyso-derivative.
c) Method choice
It was decided to use an isocratic cation exchange 
HPLC system for separation of the phospholipids with 
col l e c t i o n  of the eluates and assay for phosphate 
content.
ii) HPLC separation method
A Constametric LDC III chromatographic pump was used 
to pump a mobile phase of acetonitrile / methanol / water 
(55/35/10), degassed with helium before use, through a
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Whatman Partisil 10 SCX 25cm x 4.6mm I.D. column at 
1ml/min.
The eluate was passed to a Spectromonitor III U.V. 
detector for measurement of absorbance at 218nm. The 
relatively high wavelength used in comparison to that 
used by other workers (Gross and Sobel 1980) was used to 
reduce background absorption from the solvents in the 
mobile phase.
The order of elution was phosphatidylethanolamine 
(PE), lysophosphatidylethanolamine (LPE), phosphatidyl­
choline (PC) and lysophosphatidylcholine (LPC), the 
separation being complete in approximately 20 minutes 







Variation in retention times was seen on different 
days, possibly due to temperature changes. Retention 
times were checked daily.
Phospholipids without amino groups are not retained 
on the column and should be eluted with the solvent front 
(Gross and Sobel 1980). This HPLC system is not able to 
s e p a r a t e  PE f r o m  p h o s p h a t i d y 1 s e r i n e  (PS). The 
concentration of PS is low in comparison to that of PE,
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2% PS vs 26% PE (% of total phospholipids) in the human 
heart (Corr and Sobel 1981) , 1.6% PS vs 36% PE in the rat 
myocardial sarcolemma (Tibbits et.al. 1981) and 2^1% PS 
vs 36% PE in rat ventricle mitochondria (Gloster and 
Harris 1970). Thus although the values determined for PE 
are likely to include some PS this is unlikely to be a 
major source of error. It does, of course, preclude the 
measurement of PS with this system.
iii) HPL.C_yields
20pl of 0.7mg/ml LPC (27nmol) was taken through the 
extraction procedure and the yield of the extraction 
procedure determined as previously described (section 2.2
ii) .
20pl of the resuspended extract was injected onto 
the HPLC column and the eluate corresponding to LPC 
collected. This was dried down at 60°C, resuspended in 
200jj1 chloroform / methanol (2/1) and lOOpl assayed for 
phosphate content (section 2.4).
n=4 Absorbance at 660nm (-blank)
1.35nmol LPC 0.1395 +/“ 0.011
1.35nmol LPC 0.1240 +/- 0.0009
extracted + HPLC
Yield through extraction and HPLC = 89%
There was no significant loss during the HPLC separation 
as this yield is the same as that through the extraction
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procedure.
A yield of 90% for extraction and HPLC separation 
was assumed for all further work.
2.4 Quantification of phospholipids
i) Choice of method
An assay of high sensitivity and accuracy was 
required to enable measurement of phosphate in the 0- 
2nmol range. The commonly used methods of Fiske and 
Subbarow (1925) and the modified Bartlett procedure 
(1959) do not allow such sensitivity.
An assay dependent on the formation of a complex 
b e t w e e n  Zn^ + , m o l y b d a t e  and phosp h a t e  at pH 5 was 
investigated (Bencini, Wild and O'Donovan 1983). This 
complex does not need strongly acidic conditions/ uses a 
single reagent with a shelf life of more than a year and 
is measured by absorbance at 350nm. It was found that 
acids suitable for use in the digestion of phospholipids 
such as perchloric, sulphuric and trichloroacetic all 
interfered with the assay such that very high absorbances 
were found with reagent blanks. Thus although this assay 
is suitable for inorganic phosphate it is not suitable 
for organic phosphate.
The assay used was based on that of Hess and Derr 
(1975). This uses the formation of a complex between 
malachite green and phosphomolybdate at low pH to produce
71
a coloured complex when phosphate is present.
ii) Phespha.te assay., roethod 
Reagents
a) 0.045% malachite green hydrochloride (aq). Stored 
at room temperature.
b) 4.2% ammonium molybdate in 4M HC1.
c) 3 volumes of (a) plus 1 volume of (b) mixed and 
stirred for 30 minutes. This was filtered through a 
Whatman no. 1 filter paper prior to addition of l/50th 
volume of 2% Tween 20.
Reagent (c) was made up freshly before each assay 
due to its relative instability, blank values increasing 
with age of the reagent (Hess and Derr 1975 and 
preliminary experiments). All glassware was acid washed 
to prevent contamination with detergent.
300pl of reagent (c) was added to 70pl of sample to 
be assayed, mixed and left at room temperature for 30 
minutes for colour development. The absorbance at 660nm 
was measured in a dual beam spectrophotometer (Cecil CE 
595) against a reagent blank.
iii) Phosphate standard curve
Standard curves were constructed to establish its 
linearity with respect to phosphate concentration.
Inorganic phosphate (KH2P04) was used in varying
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concentrations in a volume of 70pl as a standard (FIG
6).For concentrations 0.5-lnmol r=0.991.
Organic phosphate was obtained by digesting PC 
overnight at 80°C in 30pl 60% perchloric acid, cooling 
the tubes, and adding 40pl of distilled water prior to 
assay as for the inorganic phosphate (FIGS 6 + 7). Care 
was taken to work within the linear portion of the curve 
i.e. above 0.5nmol phosphate. For 0.5-lnmol r=0.9820. For 
phosphate up to 80nmol r=0.996 3.
2.5 Protein assay
Phospholipid content of the heart was measured per 
unit protein.
The protein assay used was that of Read and 
Northcote (1981). It has advantages over the commonly 
used Lowry method (Lowry, Rosebrough, Farr and Randall 
1951) as the reagent is stable at room temperature, 
incubation periods are not necessary and there is less 
interference from other chemicals.
Assay method
lOmg of Brilliant Blue G was dissolved in 5ml of 95% 
ethanol. 10ml of concentrated orthophosphoric acid was 
added and made up to 100ml with distilled water. This was 
filtered twice before use to remove solid particles.
I O O jjI of b o v i n e  s e r u m  a l b u m i n  (B S A ) at 
concentrations of 0-lmg/ml were added to 3ml of Brilliant
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Blue reagent and the absorbance at 595nm read immediately 
against a reagent blank. A standard curve was always 
constructed in parallel to the sample assay although 
little variation in the standards was seen.
2.6 Bxotein content of the isolated rat heart
To enable calculation of phospholipid content per 
unit protein heart samples vere prepared as follows.
Samples of approximately 200mg wet weight were taken 
from liquid nitrogen freeze clamped tissue, chopped 
finely and homogenised in 20ml of distilled water. 
Aliquots of this were assayed for protein content. For 5 
hearts, protein content = 193 +/- 2.2 mg protein / g wet 
weight. This figure was used in all further work.
after 10 minutes coronary artery ligation
Hearts were perfused to waste for 5 minutes, then in 
a recirculating system for 5 minutes prior to either sham 
ligation for 10 minutes (controls) or coronary artery 
ligation (CAL) for 10 minutes.
At the end of the 10 minute period of ligation 
tissue samples were taken from the ischaemic and non- 
ischaemic areas. Samples from corresponding areas were 
taken from the controls. Sample mass was determined 
(approx. 200mg) for calculation of protein content. 
Phospholipids were extracted, separated by HPLC and
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quantified by phosphate assay.
during ischaem i a i n  the isolated rat heart
Hearts were perfused as in section 2.7 prior to 
coronary artery ligation or sham ligation.
Samples were taken from the ischaemic region at 
periods from 0 to 30 minutes following ligation. Sham 
ligated controls at 15 and 30 minutes were carried out. 
Phospholipids were extracted, separated by HPLC and 
assayed by phosphate content.
2.9 Effect of p e rfusate ionic changes on phospholipid
o p position in the isolated rat heart
Hearts were perfused with different composition 
Krebs-Henseleit buffers to determine the effect of ionic 
changes on phospholipid composition.
The standard Krebs-Henseleit used had a calcium 
concentration of 1.25mM and a potassium concentration of 
5.9mM. The following combinations were used, all other 
components of the buffer remaining the same.
a) 1.25mM Ca2+, 5.9mM K+  standard
b) 1.25mM Ca2 + , 2.5mM K+
c) 2.5mM Ca2+, 5.9mM K+
d) 2.5mM Ca2+, 2.5mM K+
Hearts were subjected to 20 minutes coronary artery
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ligation and compared with sham ligated controls at time 
0. Samples were taken from the ischaemic or anatomically 
corresponding area for determination of phospholipid 
composition.
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3 EFFECT OF LYSOPHOSPHOLIPIDS AND RELATED COMPOUNDS
IN THE ANAESTHETIZED CAT
Cats of mass 3-5 kg of either sex were anaesthetized 
with halothane and O 2 / N 2 O (2/1) prior to injection of 
Oi- chloralose (80mg/kg) via the femoral vein. A 
tracheotomy was carried out to allow ventilation with 
room air at a stroke volume of 45cc and rate of 19 
s t r o k e s / m i n  with a Palmer respiration pump. This 
maintained arterial p02 around 100 mmHg, pC02 around 35 
mmHg and pH at 7.3-7.4, values within the physiological 
range. Blood gases were regularly checked using an ABL 
blood gas laboratory. Body temperature was maintained at 
36-38°C with a heated blanket and monitored with an 
intragastric temperature probe. Blood pressure was 
measured in the left carotid artery by a p r e ssure 
transducer linked to a Grass model 7D polygraph. Lead II 
E.C.G. was measured from limb leads.
A left thoracotomy was performed with the removal of 
one rib to allow suspension of the heart in a pericardial 
cradle. This allowed easy access to the left ventricular 
wall and left anterior descending coronary artery.
3.1 lnfu.s.i.oii_.of lysophosphatidylcholine and p a l m itovl- 
caxriitine into the left ventricular wall of the 
anaesthetized cat
Infusions into the left ventricular wall were
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carried out with a Perfusor ED2 infusion pump to allow 
accurate control of the infusion rate. A 27 gauge needle 
connected to the infusion syringe was used to puncture 
the ventricular wall to a depth of 2mm. Initial infusion 
was carried out with Evans Blue dye (0.2mg/ml in 0.9% 
saline) at lml/hr to visualise the area being perfused. 
The infusion rate was maintained at lml/hr with all 
solutions. On changing the infusion solution the needle 
remained In situ thus no variation was introduced by 
repositioning the needle.
The dye infusion was replaced with one of the 
following:
i) Lysophosphatidy lchol ine (LPC) at concentrations 
of 20-2000pM.
LPC was prepared by dissolving in chloroform / 
methanol (2/1) and drying under nitrogen before resuspen- 
ding in 0.9% saline and sonicated for 5 minu t e s  
immediately before use.
ii) Palmitoylcarnitine (PAL) at concentrations of 20- 
lOOOpM prepared in the same manner as LPC. This was kept 
at 30°C to prevent the PAL forming an emulsion,
iii) Noradrenaline at a concentration of lOpM.
This w as used as a further check on the 
positioning of the needle. In the pig noradrenaline has 
been shown to produce reproducible, reversible 
ventricular tachycardia (Podzuweit 1982) and thus if this 
is produced in the cat it demonstrates that the infusion
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is penetrating the tissue.
3.2 Infusion of lysophosphatidylcholine, qlycerophospho- 
xylcholine, and palmitoylcarnitine into the coronary 
artery of the anaesthetized cat.
The cats were prepared surgically as previously. The 
left anterior descending coronary artery was cleared of 
surrounding tissue and a thread passed loosely around it.
Infusions into the coronary artery were carried out 
using a 34 gauge needle (Coopers Instruments) that was 
sufficiently flexible to allow a 90° angle close to its 
tip w ithout o c c l u d i n g  the lumen. This allowed the 
insertion of the needle with the portion within the 
artery being parallel to the artery wall and therefore 
increased the probability of successful infusion.
Initial infusion was again carried out with Evans 
Blue dye (0.2mg/ml in 0.9% saline) to validate the needle 
position. If the needle had been accidently placed with 
the tip in the artery wall , rather than its lumen, or in 
the surrounding tissue, the area would rapidly become 
stained with the dye. No staining occurred if the needle 
was correctly placed.
To calculate the final blood concentrations of the 
infusate a coronary blood flow had to be assumed as there 
were no flow probes of a suff i c i e n t l y  small size 
available to enable direct measurement. A coronary blood
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flow of 4ml/min was assumed. An average coronary blood 
flow of 120ml/min for a 60kg man (Gorlin and Herman 197 8) 
would, if scaled down to a 3kg cat, give a value of 
6ml/min. As the infusions were carried out slightly 
distal to the first branch of the artery the effective 
flow is likely to be less than this. Complete coronary 
artery bypass has been achieved in cats using a flow rate 
of 4 m l / m i n  (Snyder et.al. 1981). As this a l l o w e d  
maintenance of the animal without E.C.G. or haemodynamic 
alterations it is unlikely to be a gross underestimate of 
coronary flow.
Infusions were carried out as follows:
i) L y s o p h o s p h a t i d y 1 c h o 1 ine at f i n a l  b l o o d  
concentrations of 20jjM-500pM.
ii) Palmitoylcarnitine at final blood concentrations 
of 10pM-7 5pM.
iii) Glycerophosphorylcholine at a final blood 
concentration of 400pM.
All infusions were carried out for 1 hour unless 
death occurred earlier.
Glycerophosphorylcholine was obtained as its cadmium 
chloride complex and the free glycerophosphorylcholine 
had to be prepared from this. An excess of solid silver 
carbonate was added to a saline solution of the complex. 
On shaking, the chloride precipitates as silver chloride 
and the cadmium as cadmium carbonate. Filtering produces
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a solution of free glycerophosphorylcholine.
During infusions blood pressure and lead II E.C.G. 
were monitored. In i) and ii) tissue samples were taken 
at the completion of the experiment for the determination 
of phospholipase A 2 activity (section 5.0). Samples were 
taken from the left and right ventricular walls. In the 
case of hearts that had LPC or PAL infused into the 
coronary artery the left ventricular wall would be 
expected to receive the highest concentrations of the 
infused LPC or PAL, and the right ventricular wall the 
lowest. These areas correspond anatomically to the 
ischaemic and non-ischaemic regions of hearts that had 
undergone coronary artery ligation. Samples were taken 
from the same position in the wall in each experiment to 
minimise variation due to location.
3.3 Effect of coronary artery ligation on the production
of arrhythmias and on temperature in the left 
ventricular wall of the anaesthetized cat
Cats were prepared surgically as previously. The 
left anterior descending coronary artery was ligated and 
the p r o d u c t i o n  of a r r h y t h m i a s  monitored. In some 
experiments the temperatures in the ischaemic and non- 
ischaemic zones were measured using electric thermometer 
probes (Light laboratories). The positioning of the 
probes was checked at the end of the experiment by
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injecting Evans Blue dye i.v. The ischaemic area remained 
unstained.
Tissue samples were taken from ischaemic and non 
ischaemic regions for determination of phospholipase A 2  
activity.
This enabled comparison of the effects of coronary 
artery ligation on the production and time course of 
arrhythmias, and on the tempe r a t u r e  of the left 
ventricular wall with the effects of LPC, PAL and GPC 
(when infused into the coronary circulation) on the same 
parameters.
3.4 Effect of p almitoylcarnitine and.streptokinase 
infusion into the coronary artery of. the 
anaesthetized cat on the left ventricular wall 
tempe rature
Cats were prepared surgically as previously and the 
left anterior descending coronary artery cleared of 
surrounding tissue. Monitoring of the temperature of the 
left ventricular wall was carried out throughout.
PAL was infused at a final blood concentration of 
20pM (assuming a blood flow of 4ml/min). Streptokinase 
(170U/min) was then infused to see if reversal of the 
effects of PAL on ventricular wall temperature could be 
obtained.
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3.5 Effect of lysophospha:idylcholine infusion into the 
coronary artery.. of_ the anaesthetized cat on the left 
ventricular wall temperature
Cats were prepared surgically as previously.
Infusion of LPC into the left descending coronary 
artery, at a final blood cnncentration of 300jjM, was 
carried out (assuming a coronary flow of 4ml/min) with 
simultaneous measurement of the left ventricular wall 
temperature. This enabled conparison with the effects of 
PAL.
3.6 Effect of lysophosphatidylcholine and palm itoylcarn- 
itine on rat and rabbit platelet aggregation
The effect of LPC and PAL on rat and rabbit platelet 
aggregation was determined to see if this bore any 
correlation with their effects when infused into the 
coronary artery of the anaesthetized cat.
i) Preparation of platelet rich plasma
Rat blood (obtained by cardiac puncture) or 
rabbit blood (obtained by venepuncture) was immediately 
added to 3.2% sodium citrate (1 volume sodium citrate to 
9 volumes blood) to prevent clotting. This was 
centrifuged at lOOOrpm for 10 minutes to sediment the 
erythrocytes, producing a supernatant of platelet rich 
plasma (PRP). This was kept at room temperature and used
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immediately.
ii) Measurement of platelet aggregation
200pl of PRP was pipetted into a small plastic 
tube and placed in an aggregometer, heated to 37°C, with 
stirring. After equilibration of 4-5 minutes additions of 
LPC or PAL were made in a small volume (less than lOpl) 
with a Hamilton syringe. LPC and PAL were dried down 
under nitrogen from chloro f o r m  / methanol (2/1) 
solutions, resuspended in distilled water and sonicated 
in a Soniclear bath immediately prior to use.
Aggregation in response to 50pg ADP (in 5p 1) was 
used to test for platelet viability.
4 MEASUREMENT OF PHOSPHOLIPASE Ao ACTIVITY IN .THE
ISOLATED RAT HEART
4.1 Assay choice
Phospholipase A 2 activity can be measured, like most 
enzymes, by assaying for substrate disappearance or 
product formation. However due to the low catalytic 
turnover of cellular phospholipases these enzymes are 
best assayed using a radiolabelled substrate. This allows 
the accurate detection of a small amount of substrate, 
and from thence, product. It also allows differentiation 
between the two fatty acids of the phospholipid and thus 
phospholipase A^ and A 2 can be measured separately by
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selective labelling.
P hospholipase A 2 activity was m e a s u r e d  using 
phosphatidylethanolamine labelled with C^^-oleic acid in 
the 2-acyl position. PE was used as phospholipase A 2  
appears to be more specific for this phospholipid 
(Weglicki, Waite, Sisson and Shohet 1971, Richards, 
Irvine and Dawson 1979, Wurl and Kunze 1985). This may be 
due to a different physical presentation of the phospho­
lipid as it forms hexagonal arrays rather than the 
bilayers the majority of phospholipids form (Waite 1985), 
however this substrate preference has also been shown 
with endogenous substrates (Bjtfrnstad ly66).
4.2 Preparation of l-acyl-2(l-C^-oleQYll.ql:zggCQ=3..- 
B hQsphQrylethanolamin.e
Based on the method of Blackwell, Duncombe, Flower, 
Parsons and Vane (19/7).
i) Preparation of rat liver microsomes
Method of Warner and Lands (1961)
a) Tissue was rinsed in saline, homogenised in 3 
volumes of 0.25M sucrose with a Potter homogeniser and 
centrifuged in a bench centrifuge at 2000g for 15 minutes 
to pellet nuclei and unbroken cells.
b) Pellet was resuspended in the same volume of 
0.25M sucrose and recentrifuged at 2000g for 15 minutes.
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The supernatant was combined with that of a).
c) The combined supernatant was centrifuged at 
13,000g for 20 minutes at 4°C in an MSE 6$ centrifuge to 
pellet the mitochondria and lysosomes.
d) The supernatant from c) was centrifuged at 
78,OOOg in an MSE Superspeed 65 centrifuge to pellet the 
microsomes.
e) The pellet (microsomes) was resuspended in a 
v o lume of 0.25M sucrose equivalent to that of the 
original tissue volume (assuming lg wet weight = 1ml).
Microsomes can be kept frozen for long periods of 
time without loss of activity (Warner and Lands 1961) but 
were prepared and frozen 24 hours before use.
ii) Synthesis., of lr.acyl-211_--C^4--oleoyl)glycero-3- 
phosphorylethanolamine
a) 250pCi of 1-C^4 oleic acid (57m C i /mmol), 2mg 
carrier oleic acid and 20mg L-a-lysophosphatidylethanol- 
amine were pooled in a conical flask and the organic 
solvents removed under nitrogen.
b) 150ml of 0.1M phosphate buffer, pH 7.5, was added 
and sonicated to disperse the lipids.
c) The following reagents were added:
200pmol ATP (pH 6.5 in water)
200pnol MgCl2
2pmol Coenzyme A (sodium salt adjusted to pH
86
6.5 with sodium bicarbonate)
3ml of the suspension of rat liver microsomes 
in 0.25M sucrose
d) This was incubated at 37°C with shaking for 3 
hours. At 30 and 120 minutes further equal amounts of 
ATPf MgCl 2 , CoA and microsomes were added.
e) After 3 hours the reaction was terminated with 
225ml or c h l o r o f o r m  / methanol (2/1), shaken in a 
separating funnel and the lower layer decanted off.
f) The lower layer was dried under nitrogen and 
resuspended in a small vo l u m e  of c h l o r o f o r m  for 
subsequent separation of the labelled PE from oleic acid.
iii) Separation of l-acyl-2(l-C^ rQlgflyllglycero-l^
Phosphorylethanolam ine. £rom_C^- oleic acid
a) 2g of Florisil (Sigma activated m a g n e s i u m  
silicate TLC grade) was suspended in chloroform and 
poured into a plastic column (volume 5ml) at 4°C.
b) The labelled mixture was applied to the column 
and the radioactivity of 5ml fractions, eluted from the 
column by chloroform , monitored by liquid scintillation 
counting (LKB 1215 R a c kbeta with 5ml O ptiphase 
scintillant). When the radioactivity in the eluted 
fractions approached zero the solvent was changed to 
methanol. The radioactivity of 5ml fractions eluted with 
methanol were likewise monitored (FIG 8).
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Chloroform will elute unreacted oleic acid, methanol 
will elute the labelled PE. This was validated using TLC 
separation of unlabelled oleic acid and PE following 
their elution from a column and visualisation with iodine 
vapour.
c) The fractions eluted with methanol were pooled, 
dried down under nitrogen, and resuspended in 150ml of 
chloroform / methanol (2/1). 20pl samples were separated 
by TLC (in a solvent of chloroform / methanol / acetic 
acid (90/5/5)) with concomitant running of standards.
The following results were obtained:
PPM
PE 38388 +/- 655
oleic acid 1187 +/- 88
The solution of labelled phospholipid in chloroform 




a) 20jj1 chloroform / methanol (2/1) solution 
containing l-acyl-2(1-C*^oleoyl) glycero-3-phospho ry 1- 
e t h a n o l a m i n e  (2jjM l a b e l l e d  PE and t o t a l  l i p i d  
concentration 146 jjM in the assay) was dried down under
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nitrogen in a 1ml Eppendorf tube. The substrate was at 
saturating substrate concentration (Prelil“inary experiments)
b) The lipid was resuspended in 50pl of 150mM Tris- 
/maleate pH 7 and sonicated for 30 seconds to disperse 
the lipid.
c) 50pl of 15mM CaCl 2 was added (final calcium 
concentration = 5mM)
d) 50pl of sample (heart homogenate, mitochondria or 
sarcolemma) for d e t e r m i n a t i o n  of phospholipase A 2  
activity added. Unless stated otherwise the tissue sample 
was prepared in 150mM Tri/maleate pH 7 to produce a final 
buffer concentration of lOOmM. Blanks without protein 
were carried out with every assay to correct for non 
enzymic degradation of the substrate.
e) Incubation at 37°C for 45 minutes.
f) Reaction stopped by addition of 188pl chloroform, 
375pl methanol, vortexed, and a further 188pl chloroform 
and 188pl water added. This was vortexed and centrifuged 
for 4 minutes in an Eppendorf 5412 centrifuge.
g) The top layer and protein interface were removed 
with a Pasteur pipette and the lower layer dried under 
nitrogen.
h) Lower layer resuspended in 50pl chloroform/ 
methanol (2/1).
i) 20pl was applied to TLC plates (5x20cm) of silica 
gel Type G particle size 10-40pm spread to 250pm 
thickness. The plates were run in a solvent of chloroform
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/ methanol / acetic acid (90/5/5) for 30 minutes, dried 
in air and the lipids visualised by exposure to iodine 
vapour.
j) The portions corresponding to the oleic acid- as 
evidenced by the concurrent running of a standard- were 
scraped off and counted by liquid scintillation counting.
Blanks with no protein were taken through the 
incubation procedure, extraction and TLC separation, and 
any radioactivity in the oleic acid portion subtracted 
from the experimental values. Protein content of the 
tissue samples was d e t e r m i n e d  to calculate the 
phospholipase activity per mg protein per hour.
ii) Thin layer chromatography of reaction products
The solvent system used enabled separation of the 
oleic acid, which ran near the solvent front, from the 
labelled PE, which remained at the origin. The lyso 
derivative of PE also remains at the origin therefore 
should the substrate be acted upon by a phospholipase 
the radioactive product, lyso-PE, would not be measured. 
Likewise, the products of phospholipase C activity would 
not be measured as diolein,a diacylglycerol, was shown to 
migrate with the solvent front. Phosphatidic acid, a 
phosphorylated metabolite of diacylglycerol, can be 








iii) Y i e l d s .  0ieic acid through the extraction
procedure
a) IOjjI of C 1* oleic acid was added to 150jj1 lOOmM 
Tris/maleate pH 7.5
b) lOpl of oleic acid was added to lOCtyil lOOmM
Tris/maleate pH 7.5 and 50pl heart homogenate. Final 
concentration of Tris/maleate = lOOmM.
These solutions were put through the lipid 
extraction procedure. After centrifugation to separate 
the two phases the lower, chloroform phase was counted by 
liquid s c i n t i l l a t i o n  counting. In an additional 
experiment samples of the same composition as b) were 
extracted, dried down under nitrogen, resuspended in 
chloroform / methanol (2/1) and counted [c)J.
Yields
Counts in lOpl oleic acid solution = 42912 d.p.m.
n=3
a) 77.3 +/- 2.8 %
b) 82.8 +/- 2.26 %
c) 76.4 +/- 3.9 %
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The yields b e t w e e n  the three groups w e r e  not 
significantly different. There is therefore no loss of 
oleic acid due to the presence of protein in the assay or 
due to the final drying down and resuspension of the 
extract.
For all samples:- yield = 78.8%. This yield was 
assumed for all further experiments.
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4.4 £lia £££ t  ol_phosphQlipase in the
homogenate of the isolated rat heart
i) Protein dependence
Male Wistar rats (250-300g) Bath University strain 
were used throughout.
A rat heart was perfused retrogradely through the 
aorta by the Langendorff method for 5 minutes with 0.9% 
saline to remove blood elements. The heart was then 
homogenised with an Ultra Turrax homogeniser in 6ml of 
150mM Tris/maleate pH 7. Phospholipase A 2 activity was 
determined with 3-5 volumes of homogenate from 0-50pl, 
the volume being made up to 50pl with the buffer. Boiled 
controls were carried out to demonstrate the enzymic 
nature of the assay.
ii) Calcium dependence
The activity of phospholipase A2 was determined with 
concentrations of calcium from 0 to 5 mM.
50^il aliquots of heart h o m o g e n a t e s  in 1 5 0 m M  
Tris/maleate pH 7 were incubated with 50jil of buffer and 
varying volumes of 15mM CaCl2 from 0 to 50pl, the volume 
being made up with distilled water. Comparison was made 




To determine the degree of linearity of the reaction 
with time 50pl aliquots of heart h o m o g e n a t e  were 
incubated for 15, 30 and 45 minutes before stopping the 
reaction. To correct for spontaneous, non-enzymic, 
release of C ^ - o l e i c  acid controls with no homogenate 
present were incubated for 15 and 60 minutes. Spontaneous 
breakdown of the labelled substrate was assumed to be 
linear with time and thus control values for the other 
times could be calculated. These control values enabled 
calculation of C ^ - o l e i c  acid release at the various 
times due to enzymic activity only.
iv) Loss of activity.jpxl-freezing
All samples, unless stated otherwise, were assayed 
freshly.
Samples of tissue from the jji vivo cat work had to 
be stored for up to 3 months before assay and therefore 
the effect of freezing on phospholipase A 2 had to be 
determined.
a) Samples previously assayed freshly that had been 
kept frozen at -20°C were reassayed to determine any 
change in phospholipase A 2 activity. These had been 
frozen for approximately 5 months.
b) A time course of activity loss was carried out. 
Hearts were homogenised in 150mM Tris/maleate pH 7 and 
separated into 5 portions, one of which was assayed
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freshly. The others were frozen and assayed on subsequent 
days to calculate the change in activity over 12 days.
4.5 Effect of coronary artery ligation on phospholipase 
^ a c t i v i t y  in the ischaemic and non-ischaemic areas 
of- the isolated rat heart
Hearts were perfused as in section 2.7. Hearts were 
r e m o v e d  at 5 or 20 m i n u t e s  p o s t  l i g a t i o n  and 
phospholipase A 2 activity determined in a homogenate of 
the ischaemic and non-ischaemic areas. Heart tissue was 
homogenised in approximately 1ml buffer per 150mg wet 
weight. Regions corresponding anatomically to these were 
taken from the sham ligated hearts.
A pH profile of activity was determined, the tissue 
being homogenised in 0.9% saline on ice and 50pl aliquots 
immediately added to 50pl 15mM CaCl 2 an(  ^50pl of one of 
the following:
pja Buffer
4 0.3M Sodium acetate





The final buffer concentration in the assay was 
lOOmM and the pH that of the buffer used,i.e. dilution of
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the buffer did not affect the resulting pH.
4.6 Mitochondrial phospholipase
i) Ereparation of mitochondria
a) Isolation o f mitochondria
Heart tissue was placed in 250mM sucrose / lOmM 
TrisHCl pH 7.6 and chopped finely (lg wet weight tissue 
to 5 ml buffer). This was homogenised with the Potter 
homogeniser (2 passes of the pestle at mark 3) and 
centrifuged at 2000rpm for 5 minutes (MSE Chilspin) at 
4°C to pellet the nuclei and whole cells. The supernatant 
was centrifuged at full speed in an Eppendorf 5412 
centrifuge at 4°C for 8 minutes.
The pellet was resuspended in 250mM sucrose / lOmM 
TrisHCl pH 7.6 (approx. 1ml).
b) Mitochondrial integrity
Mitochondrial integrity was measured by measuring 
the respiratory control index (RCI).
The following were pipetted into the chamber of a 
Clark oxygen electrode:
Volume(ml) OQUQn , (mM) Final Cone.(mM)
sucrose 1.5 667 200
Tris/HCl
KC1











j before addition of mitochondrial suspension.
Oxygen was bubbled through to saturate the solution^
After equilibration of the contents in the closed chamber 
lOOpl of 85mM sodium succinate was added through the 
injection port (final concentration = l*7mM) and oxygen 
consumption recorded with time (state 4 respiration).
50pl of 3 3 m M  ADP (pH 6 .6 ) was added. Oxygen 
consumption of intact mitochondria increases on addition 
of ADP (state 3 respiration) and enables calculation of 
the respiratory control index.
state 3 respiration rate 
RCI = _________________________________
state 4 respiration rate
Mitochondria prepared as above typically had an RCI 
of 2.5-3.7. As a reasonable degree of coupling exists the 
majority of the mitochondria are likely to be intact.
ii) MitPChdndrial Ph0 sphdlipes.e-.A2 : pH dependency
Mitochondria were prepared from a heart sham ligated 
for 5 minutes. The pH dependency of the phospholipase A 2  
w a s  d e t e r m i n e d  by i n c u b a t i n g  50pl a l i q u o t s  of 
mitochondrial suspensions with 50pl of 15mM CaCl 2 and 
50pl of a 300mM buffer (pH 4-9). The pH 7.6 lOmM Tris/HCl 
buffer of the mitochondrial suspension did not affect the 
final pH of the assay.
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iii) Mitochondrial phospholipase Ao: calcium dependency
The activity of phospholipase A 2 was determined with 
concentrations of caLcium from 0 to lOmM. 50pl aliquots 
of mitochondrial suspension from a heart sham ligated for 
5 minutes were incubated with 50pl of 300mM Tris/maleate 
pH 7 and varying volumes of 30mM CaCl 2 from 0 to 50pl, 
the volume being made up with distilled water. Comparison 
was made with aliquots incubated with lOmM EDTA (disodium 
salt) replacing the calcium.
4.7 Effect of coronary artery ligation on the activity of 
mitochondrial phospholipase Ao, in the ischaemic and 
non-ischaemic regions of the isolated rat heart
Hearts were perfused as in section 2.7. Mitochondria 
were prepared from the ischaemic and non-ischaemic areas 
20 minutes following coronary artery ligation.A pH 
profile of activity was determined with 50pl aliquots of 
the mitochondrial suspension being incubated with 50pl of 
15mM CaCl2 and 50pl of a 30QmM buffer (pH 4-9) .
4.8 Sarcolemmal phospholipase A2
i) Preparation of sarcolemma
a) Isolation of sarcolemma
A crude sarcolemmal preparation was made by the 
method of Pang and Weglicki (1977).
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Ventricular tissue was excised and weighed before 
[ for two passes of the perstle
homogenising^with a Potter homogeniser in 10 volumes of 
0.6M KC1 / 250mM sucrose / lOmM imidazole pH 7. This was 
further homogenised vith an Ultra Turrax homogeniser for 
5 seconds. After centrifugation at 1600g for 20 minutes 
the pellet was washed twice with the same buffer, the 
supernatant being discarded in each case. The pellet was 
resuspended in 250mM sucrose / lOmM imidazole pH 7, 
centrifuged as before and resuspended in this buffer to 
remove the excess KC1.
b) Estimation of sarcolemmal enrichment
To estimate the degree of purification of 
sarcolemma achieved the content of sialic acid was 
measured as by Takahashi and Kako (1984) using N-acetyl 
neuraminic acid as a standard.
Sialic acid assay 
Based on that of Warren (1959 and 1959a).
Reagents
1) 0.2M sodium periodate in 9M H 2 SO4
2)10% sodium arsenite in 0.5M sodium sulphate / 
0.1M H2 S0 4
3) 0.6% thiobarbituric acid in 0.5M sodium sulphate 





i) 0 to 0.05pmoles of N-acetylneuraminic acid standard in 
a volume of 0 .2 ml was added to 0 .1 ml of reagent 1 ).
ii) This was shaken and left to stand at room temperature 
for 2 0  minutes.
iii) 1 ml of reagent 2 ) was added and shaken until the 
yellow colour disappeared.
iv) 3ml of reagent 3) was added and shaken. The tubes 
were loosely capped and heated in a boiling water bath 
for 15 minutes before cooling in cold w a ter for 5 
minutes.
v) 1 ml of the solution was added to 1 ml of cyclohexanone, 
shaken thoroughly and centrifuged at 2000rpm for 5 
minutes.
vi) The upper layer was pipetted off and the absorbance 
at 549nm read against a reagent blank (FIG 9).
Tissue s a m p l e s  (heart h o m o g e n a t e  or isolated 
sarcolemma) were heated at 80°C for 1 hour in 0.1M H2 SO 4  
(3 volumes sample to 1 volume acid) to release the tissue 
sialic acid without degradation. This allows their 
subsequent assay.
2 -deoxyribose in tissue samples has an absorption 
maximum at 532nm and thus contributes to the absorbance 
measured at 549nm. This absorbance must be accounted for 
to allow measurement of the absorbance at 549nm due to 
sialic acid only.
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Calculation of 2-deoxyribose contribution to absorbance 
at 5i9nm
For standards of N-acetylneuraminic acid:
Ab 549 / Ab 532 = 2 .47 +/“ 0.104
whilst for tissue samples assayed concurrently:
Ab 549 / Ab 532 = 0.996 +/- 0.06
This demonstrates absorbance at 532nm by 2-deoxyribose in 
the tissue samples. From Warren (1959) it can be seen 
that for N-acetylneuraminic acid and 2-deoxyribose this 
ratio is 2.26 and 0.3387 respectively.
If Ab 549 due to N-acetylneuraminic acid = x
and Ab 549 due to 2-deoxyribose = y
Ab 549 total = x + y, Ab 532 total = x/2.26 + y/0.3387 
then 0.442x + 2.952y = Ab 532 total.
From the tissue samples assayed-
Ab 549 total / Ab 532 total = 0.996 
thus 0.442x + 2.952y = Ab 549 / 0.996
0.440x + 2.94y = Ab 549 total
0.440x + 2.94y = x + y
x = 3.464y
From this the contribution of 2-deoxyribose and sialic 
acids to the absorbance at 549nm can be calculated and 
therefore the sialic acid concentration of the samples.
Using this method the degree of enrichment of 4 
preparations of s a r c o l e m m a  fr o m  the respective 
homogenates was calculated. The ratio of sialic acid in
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the sarcolemma with that in the homogenate = 3.6 +/- 0.7 9 
n=4. Sarcolemma = 160.9 +/- 26.3 nmol/mg protein and 
homogenate = 48.5 +/- 8.7 nmol/mg protein.
C al c u l a t i o n s  of the degree of p u r i f i c a t i o n  of 
sarcolemma were carried out using hearts that had not 
undergone coronary artery ligation and yields in 
ischaemic tissue were assumed to be similar. This was 
assumed because of reports of increased sialic acid 
contents of ischaemic tissue (Takahasi and Kako 1984) 
w h i c h  w o u l d  l e a d  to e r r o n e o u s  c a l c u l a t i o n s  of 
purification if this occurred in the isolated rat heart.
The purification factor of 3.6 achieved compared 
with a ratio of 3.11 for crude sarcolemma using Na+ / K+ 
ATPase as a marker enzyme (Pang and Weglicki 1977) and 
3.19, also for crude sarcolemma (Franson, Pang, Towle and 
Weglicki 1978). Much higher degrees of purification have 
been reported, from 7 fold (Pang and Weglicki 1977), 12 
fold (Takahashi and Kako 1983), to 34 fold (Tibbits 
et.al. 1981). These preparations involved the use of 
sucrose density gradients for further purification of the 
crude sarcolemma. The crude sarcolemma were thought to be 
sufficient for the purposes of these experiments.
ii) Calcium dependence of sarcolemmal phospholipase Ao
Sarcolemmal preparations were made from hearts 
perfused for 10 minutes with Krebs-Henseleit by the 
Langendorff method.
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50pl aliquots were assayed at calcium concentrations 
from 0 to 5mM using varying volumes of 15mM CaCl 2 an<  ^
incubating with 50pl 300mM Tris/maleate pH 7. Comparison 
was made with aliquots incubated with lOmM EDTA (disodium 
salt) replacing the calcium.
4.9 Effect of coronary artery ligation on phospholipase 
An activity in the sarcolemma of the ischaemic and 
non-ischaemic areas of the isolated rat heart
Hearts were perfused as in section 2.7. Sarcolemma 
were prepared from the ischaemic and non-ischaemic 
regions 2 0  minutes following coronary artery ligation, 
and resuspended in 1ml 250mM sucrose / lOmM imidazole pH 
7. A pH profile of phospholipase A 2 activity from pH 4-9 
was constructed with 50pl aliquots being incubated with 
50pl of 15mM CaCl 2 and 50pl of a 300mM buffer pH 4-9.
4.10 Effect of lysophosphatidylcholine and palmitoyl-
carnitine on phospholipase A^ activity— in
homogenates of the isolated rat heart
The effects of LPC and PAL on phospholipase A 2  
activity were determined.
Hearts perfused with Krebs-Henseleit buffer to 
remove blood e l e m e n t s  were h o m o g e n i s e d  in 1 5 0 m M  
Tris/maleate pH 7. 50pl aliquots were assayed with
varying concentrations of LPC or PAL, 50pl of 15mM CaCl2 ' 
and 50pl 150mM Tris/maleate pH 7. The LPC and PAL were
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initially in solution in chloroform / methanol (2 / 1 ) and 
were dried down under nitrogen in the assay tube with the 
radiolabelled substrate prior to resu s p e n s i o n  and 
sonication. Concentrations of LPC up to 400jjM and of PAL 
up to IOOOjjM were used.
4.11 Effect, of mepacrine on. Piiosphol i p a s e activity in
homogenates of the isolated rat heart
Homogenates of rat hearts prepared as in 4.10 were 
assayed for phospholipase A 2 activity with 50pl of l5mM 
CaCl 2 and 50pl of 150mM Tris/maleate pH 7 added to 50pl 
aliquots of the homogenate. Mepacrine, at a maximum 
volume of 30pl was added to give a final concentration of
0-50jjM. Controls with 30pl distilled water added were run 
to control for volume addition.
carnitine and mepacrine on ADP induced platelet 
agg regation
The effect of LPC, PAL and mepacrine on ADP induced 
platelet aggregation was determined to see if this 
correlates w i t h  their effect on p h o s p h o l i p a s e  A 2  
activity.
Platelet rich plasma was prepared from rabbit blood. 
2 0 0 jjl aliquots were placed in plastic tubes in a platelet 
aggregometer at 37°C with stirring. After 4-5 minutes 
equilibration LPC, PAL or mepacrine were added in the
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required concentration in a maximum volume of 1 0 pl, 
followed 3.5 minutes later by 50pg ADP (in 5]j1) .
The following concentrations were used to determine 





5 PHOSPHOLIPASE An ACTIVITY. lit HEART TISSUE SAMPLES FROM
THE ANAESTHETIZED CAT
Samples were taken from the left and right 
ventricular walls of hearts treated as follows (sections
3.2 and 3.3).
i) Infused with LPC at final blood concentrations of 20- 
500jjM via the left anterior descending coronary artery.
ii) Infused with PAL at final blood concentrations of 10- 
75pM via the left anterior descending coronary artery.
iii) Subjected to coronary artery ligation
In all cases s a m p l e s  were taken 1 hour after 
coronary artery ligation or initiation of infusion unless 
death occured prior to this, in which case samples were 
taken as rapidly as possible after death. A n i m a l s  
remaining alive after 1 hour were killed with saturated
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KC1 i.v. and tissue samples then taken.
Samp l e s  were stored at -20°C until assay. All 
phospholipase A 2 assays were carried out at pH 7 in the 
presence of lOOmM Tris/maleate and 5mM CaCl 2 «
106
6 EFFECT OF REPERFUSION OF THE ISCHAEMIC ISOLATED RAT 
HEART ON PHOSPHOLIPASE Ao ACTIVITY
Hearts were perfused with Krebs-Henseleit buffer for 
5 minutes to waste and 5 minutes in a recirculating 
system before ligation of the left coronary artery.
Ligation was achieved by passing both ends of the 
thread around the artery through a narrow bore 
polyethylene tube. This could be pulled against tne heart 
to occlude the artery and allowed subsequent reperfusion 
by releasing the tubing from the heart.
6.1 Effect of 10 minutes occlusion and 1 minute
JLep.erfusi_OD on phospholipase Ao— activity— in— the. 
isQlated..rat.. heart
Hearts were perfused as above (section 6 ) and the 
coronary artery occluded for 1 0  minutes prior co 1 minute 
reperfusion. Tissue samples were taken from the ischaemic 
and n o n - i s c h a e m i c  regions for d e t e r m i n a t i o n  of 
phospholipase A 2 activity in tissue homogenates at pH 7 
with lOOmM Tris/maleate, 5mM CaCl2 •
6.2 Effect of a lower.Ki concentration Krebs-Henseleit 
buffer on phospholipase A2  activity in the— isolated
rat, heart following 10 minutes occlusion and 1 minute
reperfusion
As no reperfusion arrhythmias were seen in section
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6 . 1  the composition of the buffer was changed to one with 
a lower K+ concentration, 3.2mM as opposed to 5.9mM in 
the standard Krebs-Henseleit. This makes the hearts more 
susceptible to reperfusion arrhythmias and thus the 
possible effect on the phospholipase A 2 activity can be 
determined.
Hearts underwent 10 minutes coronary artery ligation 
and 1 minute reperfusion prior to excision of tissue 
samples to determine phospholipase A 2 activity in the 
ischaemic and non-ischaemic areas.
6.3 Effect of the 2,2mM K— Krebs-Henseleit on
phospholipase Ao_activity in the isolated rat heart 
dyjing ischaeroia
Controls were carried out for the 3.2mM K+ buffer to 
ensure that any change in phospholipase A 2 activity in 
section 6 . 2  was due to reperfusion and would not occur 
after 1 0  minutes ischaemia.
Hearts were perfused as in section 6 . Samples of the 
ischaemic and non-ischaemic areas were taken after 1 0  
minutes coronary artery ligation for determination ot 
phospholipase A 2 activity. Sham ligated controls were 
also carried out.
6 .4 Measurem ent of the effects of eluted perfusate from 
reperfused hearts on phospholipase Ao activity
As reperfusion caused a change in phospholipase A 2
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activity it is possible that something in the eluted 
perfusate is capable of eliciting this effect.
i) Effect of perfusate on phospholipase An activity
Hearts were perfused in the recirculating system 
with the 3.2mM K+ Krebs-Henseleit and the coronary artery 
ligated for 1 0  minutes prior to 1 minute reperfusion. 
Samples of perfusate from the heart were collected just 
before and after reperfusion, kept on ice and used within 
1 hour. 30jj1 of the perfusate was added to the assay of 
phospholipase A 2 in a homogenate of a sham ligated heart.
ii) Effect of lipid extract of reperfusion perfusate on
phosphQlipflse. activity
a) Extraction method
A lipid extract of the perfusate collected from a 
reperfused heart was made as follows:-
6 x 300pl samples of perfusate added to 6 x 750pl 
c h l o r o f o r m  / m e t h a n o l  / BHT (2/1/0.005%), shaken, 
centrifuged at full speed in an Eppendorf centrifuge for 
5 minutes at 4°C and the lower layer retained. 3 further 
extractions of the upper layer were carried out with 
450pl chloroform / methanol / 0.58% NaCl (86/14/1), the 
lower layers being retained and pooled. A final 
extraction was carried out with 450pl chloroform / 
methanol / 1M HC1 (86/14/1) and the lower layer 
neutralised with aqueous ammonia before addition to the 
pooled extracts. These were dried under nitrogen and
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resuspended in 1800pl chloroform / methanol (2/1). The 
concentration of any lipids in the lipid extract was 
therefore the same as in the perfusate.
Volumes of the extract from 30 to 90 pi were dried 
down under nitrogen with the labelled substrate for a 
subsequent phospholipase A 2 assay of a whole heart 
homogenate from a heart sham ligated for 1 0  minutes.
b) TLC of the lipid extract
Aliquots of lipid extract were spotted onto silica 
gel TLC plates of 250pm thickness and run in a system of 
chloroform / acetone / methanol / acetic acid / water 
(6 / 8 / 2 / 2 / 1 ) which allows separation of free fatty acids, 
PE, PC, LPC and LPE (Sobel, Corr, Robison, Goldstein, 
Witkowski and Klein 1978). After drying in air the lipids 
were visualised with iodine vapour. Standards of oleic 
acid and L-a- lysophosphatidylcholine were also run.
6.5 Effect of a free radical scavenger on phospholipase
An activity during reper£usio_n_ of the isolated__
heart
Changes in ph o s p h o l i p a s e  A 2 activity during 
reperfusion may be due to the production of free radicals 
which cause lipid peroxidation and membrane damage (FIG
10). The effect of reduced glutathione, a cellular 
antioxidant, on the changes in phospholipase A 2 during 
reperfusion was determined.
ImM reduced glutathione was included in the 3.2mM K+
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Krebs-Henseleit buffer. The hearts were ligated for 10 
m i n u t e s  a nd r e p e r f u s e d  for 1 m i n u t e  p r i o r  to 
d e t e r m i n a t i o n  of the p h o s p holipase A 2 activity in 
homogenates of the ischaemic and non-ischaemic areas.
6 . 6  Effect o_£ a constant pressure head system on
phospholipase An activity d u ring repgj-fusipn cf the 
isolated rat heart
All experiments have been done under constant flow 
(lOml/min). Thus on occlusion of the coronary artery 
perfusion of the non-ischaemic area would rise and then 
fall again on reperfusion. It is possible that changes in 
phospholipase A 2 activity are secondary to these flow 
changes. A constant head system was used to produce 
ischaemia and reperfusion where there should be no flow 
changes in the non-ischaemic area.
Hearts were perfused at a constant pressure head of 
100cm water. During 10 minutes coronary artery occlusion 
coronary flow was 6.5 +/- 3.7% of that before occlusion 
(reduced from a mean of 10.9 ml/min to 6.89 ml/min n = 4). 
After 1 minute reperfusion phospholipase A 2 activity was 
assayed in the ischaemic and non-ischaemic areas.
6.7 Effect of flow rate changes on phospholipase Ao
activity in the isolated rat heart
During coronary artery occlusion the non-ischaemic 
area is relatively overperfused. Assuming the decrease in
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coronary flow seen on occlusion in a constant pressure 
system is typical, an increase of flow from lOml/min to 
15ml/min in a constant flow system would simulate, in a 
whole heart, the degree of overperfusion seen in the non- 
ischaemic area during coronary artery occlusion.
The effect of flow changes was d e t e r m i n e d  as 
follows:
a) Hearts perfused for 10 minutes at 15ml/min
b) Hearts perfused for 10 minutes at 15ml/min and 1 
minute at lOml/min.
These simulate the flow changes in the non-ischaemic area 
in a) ischaemia and b) ischaemia + reperfusion
Glooal ischaemia was used to simulate, in a whole 
heart, the flow changes that occur in the ischaemic area
of a heart with the coronary artery occluded as follows:
a) no flow for 1 0  minutes
b) no flow for 10 minutes and 1 min at lOml/min.
These simulate the flow changes in the ischaemic area in
a) ischaemia and b) ischaemia + reperfusion.
Phospholipase A 2 activity was then assayed in homogenates 
of the tissue.
6 . 8  Effect of vasodilators on phospholipase A^ activity
in the isolated rat heart on high flow rate
perfusion
Changes in phospholipase A 2 activity which were seen 
on increasing flow may be due to the increased perfusion
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pressure. The effect of two vasodilators, which should 
reduce the pressure in the vessels by causing dilatation, 
on phospholipase A 2 activity was determined.
i) Effect. oiL adenosine
a) 1 0 “ adenosine in a recirculating system
Hearts were perfused with 3.2mM K+ Krebs-Henseleit
containing 10“^M adenosine for 10 minutes at 15ml/min in 
a recirculating system. The tissue was then homogenised 
and assayed for phospholipase A 2 activity.
b) 10”5M and 10“^M adenosine in a non-recirculating 
system
Adenosine is stable in Krebs-Henseleit (preliminary 
experiments) but has a short half life in blood (Klabunde 
1983) and is rapidly taken up and metabolised by tissue 
(Jacob and Berne 1960, review Berne 1980). Therefore in 
the recirculating system, where the buffer containing 
adenosine has been passing through the tissue for 5 
minutes before elevation of the flow rate to 15ml/min, it 
is likely that all the adenosine has been metabolised by 
then. A non-recirculating system was used for comparison 
so that all the Krebs-Henseleit passing through the heart 
contains adenosine that has not been metabolised.
Hearts were perfused with 3.2mM K+ Krebs-Henseleit 
c o n t a i n i n g  1 0 ” ^M or 1 0 “ ^M a d e n o s i n e  in a n o n ­
recirculating system at 15ml/min for 10 minutes. The 
tissue was then homogenised and assayed for phospholipase
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activity.
ii) Effect of sodium nitroprusside
Hearts were perfused with 3.2mM K+ Krebs-Henseleit 
containing 10” ^M sodium nitroprusside at 15ml/min in a 
recirculating system. The tissue was then homogenised and 
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RESULTS
7 MEA.SUREMENT_.OF PHOSPHOLIPIDS AND LYSOPHOSPHOLIPIDS U 2
THE ISOLATED RAT HEART
7.1 Phospholipid composition of the isolated rat heart
after 1 0  minutes coronary artery ligation
I n i t i a l l y  it w a s  d e c i d e d  to m e a s u r e  the 
concentrations of lysophospholipids after a fixed period 
of ischaemia ( 1 0  minutes), to look at any changes in both 
the ischaemic and non-ischaemic regions.
Phospholipid composition was determined in the 
ischaemic and non-ischaemic areas of hearts subjected to 
1 0  minutes coronary artery ligation or sham ligation for 
1 0  minutes.
No difference was seen in composition between the 
ischaemic and non-ischaemic areas in each heart. However 
changes were seen between control and coronary artery 
ligated hearts (FIG 11). The means of the values for the 
ischaemic and non-ischaemic areas were obtained for 
c o m p a r i s o n  of the pho s p h o l i p i d  c o m p o s i t i o n s  under 
ischaemic and control conditions (FIG 12). There was no 
significant change in PE or PC concentrations after 10 
minutes coronary artery ligation in comparison to sham 
ligated controls (FIG 12).
In contrast, LPE and LPC both showed a significant 
increase in concentration following 1 0  minutes coronary
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artery ligation, from 1.54 +/- 0.22 to 4.70 +/- 0.40 
n m o l / m g  protein and 1.25 +/- 0.29 to 5.74 +/- 0.63 
nmol/mg protein respectively. Ten minutes coronary artery 
l i g a t i o n  t h e r e f o r e  p r o d u c e s  an i n c r e a s e  in 
lysophospholipid concentration in the isolated rat heart 
although this increase was not confined to the ischaemic 
area.
7.2 Time course of changes in phospholipid composition
during ischaemia in the isolated rat, heart
Although increases in LPC and LPE concentrations 
have been seen in a n umber of p r e p a r a t i o n s  during 
i s c h a e m i a  and these have been i m p l i c a t e d  in the 
development of arrhythmias (see section 1.5 (3)) it is 
possible that this increase is produced either as a 
consequence of, or in parallel to, arrhythmias as opposed 
to being a causative factor in their production. Thus a 
time course of phospholipid concentration following 
coronary artery ligation was carried out to see if 
changes occurred before the onset of arrhythmias.
Phospholipid composition was determined in ischaemic 
tissue after periods of coronary artery ligation from 0  
to 30 minutes. Sham ligated controls were also carried 
out.
No change was seen in PE or PC concentrations during 
the 30 minutes after coronary artery ligation (FIG 13) 
although there was a trend towards a slow oscillation of
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the concentrations. Ten minutes ligation did produce a 
significant increase in PE concentration in comparison to 
time 0 but PE concentrations at other times were not 
significantly different from time 0. At 15 minutes 
control PE and PC concentrations were 25.69 +/- 2.0 and 
24.49 +/- 1.45 nmol/mg protein respectively whilst at 30 
minutes PE and PC concentration were 31.2 +/- 2.7 and 
25.95 +/- 2.33 nmol/mg protein respectively.
T h e r e  a p p e a r e d  to be an i n c r e a s e  in LPE 
concentration at approximately 2 0  minutes post ligation 
but this was not statistically significant (FIG 14). The 
controls sh o w e d  no difference from the time 0 LPE 
concentration , being 2.03 +/- 0.27, 1.65 +/- 0.144 and 
2.09 +/- 0.3 nmol/mg protein at time 0, 15 and 30 minutes 
respectively.
LPC concentration had increased significantly by 5 
minutes post ligation and remained elevated until 25 
minutes post ligation, when the concentration fell to 
control levels (1.65 +/- 0.31 as opposed to 1.51 +/- 0.14 
nmol/mg protein at time 0) (FIG 14). At 30 minutes 
however the LPC concentration had again increased to a 
value significantly greater than time 0. In contrast 
control hearts showed no difference from time 0 in LPC 
concentration, being 1.99 +/- 0.21 and 2.09 +/- 0.52 
nmol/mg protein at 15 and 30 minutes respectively.
In this model a r r h y t h m i a s  we r e  not p r e c i s e l y  
quantified but were seen as changes in the developed
126
tension and perfusion pressure traces and they typically 
commenced at 1 1  to 1 2  minutes post ligation, thus there 
was a significant increase in LPC concentration before 
the onset of arrhythmias. Arrhythmias ceased at 23 to 25 
m i n u t e s  post ligation and this coincided with the 
decrease in LPC concentrations to control levels at 25 
minutes. The further increase in LPC at 30 minutes did 
not relate to the production of more arrhythmias at this 
time.
If the values for LPE and LPC are summed (FIG 15) 
there can be seen to be a significant increase in lyso- 
phospholipid concentration with time after coronary 
artery ligation until 25 minutes when the concentration 
approaches that of controls.
7.3 Effect of perfusate ionic changes on phospholipid
composition in the isolated rat heart
The ionic composition of the perfusate affects the 
severity and time of onset of arrhythmias produced by 
coronary artery ligation and therefore it was decided to 
see if this relates to any changes in phospholipid 
concentration.
The effect of changes in the perfusate K+ and Ca^ + 
concentrations on phospholipid composition in control 
hearts and hearts subjected to 2 0  minutes coronary artery 
ligation was determined (as 2 0  minutes was shown in the 
time course study to produce maximal changes in LPC and
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LPE) .
No change was seen in PC or PE concentration in 
control hearts with any of the buffers in comparison to 
the standard buffer (FIG 16). Similarly 20 minutes 
coronary artery ligation did not produce any change in 
the PC or PE concentration with any of the four buffers 
(FIG 17) .
LPE concentration did not change in controls with 
any of the buffers and no change was seen after 2 0  
minutes coronary artery ligation (FIG 18).
Thus in control and coronary artery ligated hearts 
there were no significant differences in PE, PC, or LPE 
concentrations when the ionic composition of the Krebs- 
Henseleit buffer was changed oy increasing the calcium 
and/or decreasing the potassium concentrations.
In contrast, in non-ligated control hearts changes 
in perfusate ionic composition caused changes in the 
c o n c e ntration of LPC (FIG 19). An increase in C a ^ + 
concentration from 1.25mM to 2.5mM caused, at a constant 
potassium concentration of either 5.9mM or 2.5mM, an 
increase in tne concentration of LPC. Although a decrease 
in K+ concentration at constant calcium concentration 
appeared to produce an increase in LPC concentration this 
was not significant (FIG 19) .These increases in LPC in 
control hearts were similar to those seen after 2 0  
minutes coronary artery ligation in the standard Krebs- 
Henseleit buffer (FIG 20) implying that a maximal LPC
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c o n c e n t r a t i o n  might have been reached by either 
increasing perfusate Ca^+ concentration or by coronary 
artery ligation. Twenty minutes coronary artery ligation 
produced slight increases in LPC concentration with all 
the buffers. These were not significant , except with the 
standard Krebs-Henseleit (FIG 20).
Increasing c £ + c o n c e ntration thus produces an 
increase in total lysophospholipid concentrations (FIG 
21) in control hearts. The concentration of LPC plus LPE 
after 2 0  minutes coronary artery ligation was not 
significantly different between the varying buffers.o^** jit
CQ at ft'
Therefore changes in Ca^+ and K+ concentration of 
the perfusing buffer w h ich make the isolated rat 
(Woodward, Hassan and Mohamed 1983) or rabbit heart 
(Karki 1958) more susceptible to ischaemically induced 
a r r h y t h m i a s  l e a d  to i n c r e a s e d  b a s a l  l e v e l s  of 
lysophospholipids, in particular LPC, although they do 
not change tne concentration seen after 2 0  minutes 
coronary artery ligation. These changes in ionic 
composition do not produce any further increase in 




M EASUREMENTS OF PHOSPHOLIPIDS AND LYSQPHOSPHQLIPIDS IN
THE ISOLATED RAT HEART
Phospholipid composition of the isolated rat heart after 
IQ„minut.es .coronary, .a rtery ligation
An increase in lysophospholipid concentration in the 
i s c h a e m i c  area of the isolated rat heart was seen 
following coronary artery ligation for 10 minutes. This 
increase was also seen in the non-ischaemic area (FIG 
11). This result was surprising as no change would be 
expected in the non-ischaemic area. However such a change 
was also seen by Shaikh and Downar (1981) in the in vivo 
pig heart following 40 minutes ischaemia, with an 
increase from 40.3 +/- 1.3 to 51.0 +/- 2.6 nmol/ g wet 
weight in the non-ischaemic area compared to 55.2 +/- 2.6 
nmol/ g wet weight in the ischaemic area. Increases in 
LPC concentration in the non-ischaemic area may be due to 
collateral flow, washout from the ischaemic to the non- 
ischaemic area occuring. Collateral flow in the rat has 
been estimated to be 18% (Kannengiesser, Lubbe and Opie 
1975) although other workers have concluded it is much 
smaller (Schaper 1984). Collateral flow in the pig is 
also thought to be small (1 to 10%) (Bloor and White 
1982) therefore collateral flow is unlikely to account 
for LPC concentrations increasing in the non-ischaemic
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area to levels approaching those in the ischaemic area. 
However, washout of lactate from tne ischaemic area has 
been d e m o n s t r a t e d  in a similar prepa r a t i o n  of the 
isolated rat heart (Daugherty, Frayn, Redfern and 
Woodward 1986) and as a recirculating system was used in 
this study it is possible that washout of LPC to the 
perfusate followed Dy recirculation to the non-ischaemic 
area could occur and contribute to the raised LPC 
concentrations in this area.
In the r e m a i n i n g  w o r k  c o n c e n t r a t i o n s  of 
lysophospholipids following coronary artery ligation 
were studied in the ischaemic area in comparison to sham 
ligated controls.
SUMMARY: Coronary artery ligation produces increases in 
lysophospholipids in both tne ischaemic and non-ischaemic 
regions of the isolated rat heart, although the increase 
in the latter may be an artefact of using a recirculating 
perfusion system.
Time course of changes in phospholipid composition during 
ischaemia in the isolated rat heart
Over a time course of 30 minutes following coronary 
artery ligation there was a significant increase in LPC 
concentration. The control concentration of LPC, prior to 
ligation, was 1.51 +/- 0.14 nmol/mg protein, similar to 
that seen in the dog (LPC = 1.0 +/- 0.21 nmol/mg protein, 
Man and Slater et.al. 19 83) and the cat myocardium (LPC =
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2.8 +/- 0.23 nmol/mg protein, Corr and Snyder et.al. 
1982) but greater than that in the pig (LPC = 40.3 +/-
1.3 nmol/g wet weight, i.e. approx. 0.2nmol/mg protein, 
Shaikh and Downar 1981). This may reflect methodological 
differences or a l t e r natively be due to species 
difference.
The control concentration of LPE found in the 
isolated rat heart (2.03 +/- 0.27 nmol/mg protein ) was 
similar to that reported in the cat (2 . 1  +/- 0 . 1 2  nmol/mg 
protein, Corr and Snyder et.al.1982) and the dog 
myocardium (0.51 +/“ 0.07 nmol/mg protein, Man and Slater 
et.al. 1983).
LPC concentration was increased within 5 minutes 
following coronary artery ligation and thus as the 
concentration had increased before the onset of 
arrhythmias, w h i c h  c o m m e n c e d  at 1 1  to 1 2  m i n u t e s  
f o llowing ligation, it is unlikely that increased 
lysophospholipid concentrations are a result of the 
arrhythmias. This is supported by the failure of 
e lectrically induced ventr i c u l a r  f i b r i l l a t i o n  in 
a n aesthetizea cats to increase l y s o p h o s p h o l i p i d  
concentrations (Corr, S harma and Sobel 1983). As 
lysophospholipid concentrations increase prior to the 
development of arrhythmias it does not exclude the 
possibility that they may have a causative role in their 
development. LPC concentrations continued to increase 
until 25 minutes following coronary artery ligation, at 
which time the concentration was not significantly
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different from time 0. This coincides with the cessation 
of arrhythmias and may represent the loss of cellular 
integrity and washout of lipids from the ischaemic 
region. A similar decrease in the LPC concentration of 
rat heart mitochondrial phospholipids has been reported 
following 25 minutes global ischaemia (Victor, van der 
Merwe, Benade, LaCock and Lochner 1985). In this study an 
increase in LPC occurred from 0 to 15 minutes which was 
followed by a fall below control values at 25 minutes. 
The same pattern was seen by these w o r k e r s  in the 
concentration of LPE.
Following the decrease in LPC at 25 minutes there 
was a further increase at 30 minutes. As this was little 
different from the concentration at 2 0  minutes it may 
represent a maximal concentration similar to that seen in 
the pig myocardium (Shaikh and Downar 1981) following 8  
minutes coronary artery ligation with the establishment 
of an equilibrium between production and metabolism. This 
further increase at 30 minutes post ligation did not 
correlate with any further production of arrhythmias. 
This may be caused by the lack of excitability of the 
cells following prolonged ischaemia and thus any effects 
of LPC on ion movement would be of no importance.
In contrast to LPC, LPE showed little change in 
concentration over the time course of 30 minutes although 
there was a trend to increased LPE concentrations from 15 
to 20 minutes prior to a decrease to control levels by 25
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minutes ligation. With the exception of the controls 
there was a large degree of variability between different 
hearts which led to large standard errors. This probably 
reflects the i n h o m o g e n e i t i e s  in response b e t w e e n  
different hearts to the same ischaemic insult and may 
also reflect differences in collateral flow which could 
allow both washout of l y s o p h o s pholipids and cause 
variation in the size of tne ischaemic area. It is 
unlikely to be due to variations in basal levels between 
different hearts or methodological errors as control 
hearts showed markedly less variation.
Control LPC and LPE values from 0 to 30 minutes 
showed no significant change in comparison to time 0  
therefore the increase in lysophospholipids seen is not a 
progressive increase in phospholipid breakdown due to the 
perfusion system used.
The sum of LPC and LPE increased following coronary 
artery ligation (FIG 15). By 15 minutes post ligation a 
50% increase had occurred which is of the same order as 
that seen in the cat myocardium where an increase of 53% 
occurred following 1 0  minutes coronary artery ligation 
(Corr and Snyder et.al. 1982), and in the pig myocardium 
where there was an increase of 46% following 12 minutes 
coronary artery ligation (Shaikh and Downar 1981).
No significant changes were seen in PC concentration 
fo l l o w i n g  ligation. This is despite a significant 
increase in LPC which is probably formed by deacylation
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of PC. The lack of an observed decrease in PC could be 
due to the high concentrations of the phospholipid in 
comparison to its lyso- derivative, as only a small 
amount of PC degradation could lead to a significant 
increase in LPC. There was likewise no decrease in PE 
c o n c e ntration over the time course studied. These 
findings are in agreement with those of Shaikh and Downar 
(1981), Corr and Snyder e t . a l . (1982), Chien et.al. 
(1984), and Steenbergen and Jennings (1984), all of whom 
found no change in total phospholipid or PE and PC 
concentrations following ischaemia lasting up to 1 hour. 
Longer periods of ischaemia have resulted in decreases in 
phospholipids in the latter two reports and these changes 
have been suggested to be due to the release of lysosomal 
e n z y m e s  ( W i l d e n t h a l  1978) or t i s s u e  o e d e m a  as 
concentrations are often quoted per gram wet weight (Man 
and Slater et.al. 1983, Steenbergen and Jennings 1984).
There did appear to be an oscillation in PC and PE 
concentration over the 30 minute time course which may 
represent phospholipid turnover in tne cell membrane. 
This type of oscillatory trend has been shown with other 
compounds previously thought to be constant in the cell 
such as adenine nucleotides (Mowbray, Bates and Perrett 
1981) .
SUMMARY: L y s o p h o s p h o l i p i d  c o n c e n t r a t i o n s  increase 
significantly before the onset of arrhythmias indicating 
that they could have a role to play in their development
135
and it is unlikely that their levels increase as a 
consequence of the arrhythmias. The concentration of 
lysophospholipids appeared to reach a maximum, possibly 
due to the establishment of an equilibrium between their 
production and metabolism.
E ffect of perfusate ionic changes on phospholipid
composition in the isolated rat heart
Changes in the ionic composition of the perfusate 
caused changes in the lysophospholipid concentrations in 
sham ligated controls. Although no change in LPE 
concentration was seen between the various buffers 
a significant increase in LPC concentration was seen 
w h e n  the calcium concentration of the buffer was 
increased from 1.25mM to 2.5mM at a constant potassium 
concentration. N o rmal ionised blood calcium is 
approximately ImM (Poole-Wilson, Harding, Bourdillon and 
Tones 1984) and in isolated heart myocytes this 
extracellular calcium concentration has been shown to 
produce an intracellular calcium concentration of 0.2jjM 
(Klein, Snowdowne and Borle 1982). Increases in external 
calcium co n c e n t r a t i o n  have been s h own to cause an 
increase in intracellular free calcium in the sheep 
papilliary muscle (Sheu and Fozzard 1982), rabbit heart 
(Bridge and Bassingthwaite 1982), and ferret ventricular 
muscle (Allen, Eisner, and Orchard 1984) and in isolated
136
smooth muscle cells where an increase in external calcium 
concentration from 1.25mM to 2.5mM produced an increase 
in cytoplasmic calcium concentration from approximately 
0.125pM to 0.15pM ( Williams, Fogarty, Tsien and Fay 
1985). Increased intracellular calcium may cause 
increased phospholipid breakdown as membrane bound 
phospholipases are calcium dependent (review van den 
Bosch 1980), alternatively there may be a decreased 
reacylation of LPC as calcium has been shown to inhibit 
some of the enzymes involved with this process (Arthur 
and Choy 1986). The increases in cytosolic free calcium 
seen on raising the external calcium concentration in 
isolated ventricular cells were proportional to the 
change in external calcium (Snowdowne, Ertel and Borle 
1985) as were changes in total cell calcium (Cheung, Leaf 
and Bonventre 1984) however in the latter case free 
calcium was not measured and there is no good correlation 
between free and total intracellular calcium content 
(review Cheung, Bonventre, Malis and Leaf 1986).
The increase in cellular free calcium is not likely 
to be large enough to produce effects on phospholipid 
metabolism if tne calcium concentration is assumed to be 
homogenous in the cell (although local concentrations 
near the sarcolemma may be initially greater) as the Km 
for the e n z y m e s  are in the m i l l i m o l a r  range, 
substantially greater than the internal free calcium 
concentration. Subcellular regions of locally elevated 
intracellular calcium rather than homogenously elevated
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calcium transients have been demonstrated in isolated 
rat heart cells (Berlin, Cannell, Goldman, Lederer, 
M arban and Wier 1985) and in s m o o t h  muscle cells 
(Williams et.al. 1985) using digital imaging of Fura-2 
fluorescence and thus an elevated local concentration of 
calcium is possible.
LPC concentrations also appeared to increase when 
the calcium concentration was kept constant but the 
potassium concentration of the perfusate was decreased 
from 5.9mM to 2.5mM although this was not statistically 
significant. A reduction in extracellular potassium is 
likely to cause some inhibition of the Na+ / K+ ATPase, a 
rise in intracellular sodium and therefore of calcium by 
Na+ / Ca^+ exchange as shown by Hoerter, Miceli, Renlund, 
Jacobus, G e r s t e n b l i t h  and Laxatta (1986) in the 
Langendorff perfused rat heart.
Thus increases in external calcium concentration and 
decreases in external potassium concentration may be 
acting by the same mechanism to increase intracellular 
free calcium.
Following coronary artery ligation for 20 minutes 
with increased Ca^+ or decreased K+ concentrations there 
were slight increases in LPC which were not statistically 
significant, possibly due to the large numbers needed to 
achieve significance because of the variability m  LPC 
concentrations seen.
When the concentrations of LPC and LPE were summed
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there can be seen to be an increase in lysophospholipids 
in c o n t r o l  h e a r t s  w h e n  the p e r f u s a t e  c a l c i u m  
concentration is increased or the potassium concentration 
is decreased (FIG 21). Thus changes in the perfusate 
ionic composition that cause an increase in the severity 
and incidence of ischaemically induced arrhythmias 
(Woodward et.al. 1983) or electri c a l l y  induced 
a r r h y t h m i a s  (Karki 1958) c a u s e  i n c r e a s e s  in 
lysophospholipid concentration in the isolated rat heart 
independent of coronary artery ligation.
With both the time course of lysophosphol ipid 
concentration changes during ischaemia and the perfusate 
ionic changes, the changes in LPC were more marked than 
those in LPE. This could reflect either;
a) increased specificity of the deacylating enzyme 
for PC
b) increased specificity of the reacylating enzymes 
for LPE
c) functional compartmentation of PC and PE
a) PE has been shown to be a better substrate for 
phospholipase A 2 when added exogenously (Weglicki et.al. 
1971, Wurl and Kunze 1985). However in cases where 
phospholipid concentration has been shown to decrease 
during i s chaemia both PC and PE have been equally 
affected (Man and Slater et.al. 1983, Steenbergen and 
Jennings 1984, Finkelstein, Gilfor and Farber 1985). 
However these decreases were following long periods of
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ischaemia when lysosomal lipases may be of importance. 
This w o u l d  suggest that there is unlikely to be a 
selective degradation of PC, as opposed to PE, during 
ischaemia although in one report PC depletion was been 
shown to surpass that of PE in canine sarcoplasmic 
reticulum following 30 minutes ischaemia (Yanagishita, 
Katagiri, Mochizuki, Umezu, Kitsu, Geshi, Konno, Tanno, 
Akiyama, Sekita and Niitani 1986).
b) The deacylation-reacylation reactions for PC and PE 
are suggested to change in ischaemia (Shaikh and Downar 
1985) with differences between PC and PE occuring. It is 
also known that plasmalogen catabolism, which would lead 
to the produc t i o n  of lysophospholipids, occurs by 
different pathways for PC and PE ( Arthur et.al. 1986) 
with plasmenylcholine being catabolised by phospholipase 
A 2 and plasmenylethanolamine by plasmalogenase. This may 
result in differential breakdown and reacylation.
Although from this evidence it appears unlikely that 
PC b r e a k d o w n  w o u l d  surpass that of PE functional 
compartmentalisation of PC with phospholipase A 2  may 
still exist. Evidence for this is difficult to interpret 
but it is known that the distribution of phospholipids 
within the lipid bilayer is not homogenous (Op den Kamp, 
Roelofsen and van Deenan 1985) and there is an 
asymmetrical distribution of phospholipids on the inner 
and outer bilayer (Rothman and Lenard 1977). Purified 
enzymes and enzymes supplied with exogenous substrates
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may show different substrate specificity to enzymes 
acting on substrates in the same membranes.
SUMMARY: LPC concentrations are increased in control 
hearts by changes in perfusate ionic composition that 
increase the severity of i s c h a e m i c a l l y  induced 
arrhythmias. This may be secondary to an increase in 
intracellular free calcium concentration which activates 
phospholipase A 2 and/or inhibits reacylation of LPC 
although evidence suggests that the increase in 
intracellular calcium would not be large enough if 
distributed homogenously. Greater changes in LPC than in 
LPE may reflect differences in metabolism of PC and PE 
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PHOSPHOLIPID CONCENTRATIONS IN THE ISOLATED RAT HEART AFTER 
10 MINUTES CORONARY ARTERY LIGATION. MEAN +/- SEM. n=3-5.
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FIG 12. PHOSPHOLIPID CONCENTRATIONS IN THE ISOLATED RAT HEART
FOLLOWING 10 MINUTES CORONARY ARTERY LIGATION. MEAN +/- SEM.
PE = PHOSPHATIDYLEHANOLAMINE LPE = LY S OP HOS PHATIDYLETHANOLAMINE 
PC = PHOSPHATIDYLCHOLINE LPC = LYSOPHOSPHATIDYLCHOLINE. n = 5.
S = SHAM LIGATED. CAL = CORONARY ARTERY LIGATED.
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FIG 15. SUM OF LPE AND LPC CONCENTRATIONS WITH TIME FOLLOWING 
CORONARY ARTERY LIGATION.
□  LPE + LPC CORONARY ARTERY LIGATED.
O  LPE + LPC SHAM LIGATED CONTROLS.











FIG 16. PHOSPHOLIPID CONCENTRATION IN SHAM LIGATED CONTROLS
SUBJECTED TO DIFFERENT COMPOSITION BUFFERS. MEAN +/- SEM.
□ 1. 2mM Ca2+, 5. 9mM K+ n = 12
u 1. 2mM Ca2+, 2. 5mM K+ n = 4
□ 2. 5mM Ca2+, 5. 9mM K+ n = 4
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FIG 17 PHOSPHOLIPID CONCENTRATIONS FOLLOWING 20 MINS. CORONARY 
ARTERY LIGATION WITH DIFFERENT COMPOSITION BUFFERS. 



























A=1 2mM Ca^ ,5-9mMK 
B=1-2mM C a £  2 5rrM K 
C = 2 -5 m M C a £  59mMK  
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FIG 18. CHANGES IN LPE CONCENTRATION FOLLOWING 20 MINUTES 
CORONARY ARTERY LIGATION WITH DIFFERENT IONIC 
COMPOSITION BUFFERS.
MEAN +/- SEM. A n = 12. B-D n = 4
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A B C D
FIG 19. CHANGES IN LPC CONCENTRATION IN CONTROLS WITH DIFFERENT 
IONIC COMPOSITION BUFFERS. MEAN +/- SEM.
A: n = 12. B-D:n = 4.













A B C D
FIG 20. LPC CONCENTRATIONS FOLLOWING 20 MINUTES CORONARY
ARTERY LIGATION WITH DIFFERENT IONIC COMPOSITION
BUFFERS. A = 1.2mM Ca2+, 5.9mM K+ .
B = 1.2mM Ca2+, 2.5mM K+ .
C = 2.5mM Ca2+, 5.9mM K+.
D = 2.5mM Ca2 + , 2.5mM K+.
MEAN +/- SEM. A: n = 12. B-D: n = 4.
□  SHAM LIGATED. E3 20 MINUTES LIGATED.
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FIG 21. SUM OF LPE AND LPC CONCENTRATIONS FOLLOWING CORONARY
ARTERY LIGATION (20 MINS.) WITH DIFFERENT IONIC
COMPOSITION BUFFERS. MEAN +/-SEM.
A = 1.2mM Ca , 5.9mM K+ .
B = 1.2mM Ca^ + , 2.5mM K+ .
C = 2.5mM Ca , 5.9mM K+ .
D = 2.5mM Ca^+ , 2.5mM K+.
A : n = 12. B-D : n = 4. p $0.02 vs B sham. 
★ ^ P ^ 0 . 0 2  vs B 20 min LIGATED.
□  SHAM LIGATED. □  CORONARY ARTERY LIGATED.
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RESULTS
8 EFFECT OF LYSOPHOSPHOLIPIDS AND RELATED COMPOUNDS IN
THE ANAESTHETIZED CAT
Although LPC has been shown to produce arrhythmias 
in isolated hearts (section 1,5 (4)) there are no reports 
of its effects in vivo. Two modes of administration to 
the heart were investigated, direct infusion into the 
ventricular wall and into the coronary circulation.
Palmitoylcarnitine, an amphiphile with similar 
detergent properties to LPC, and glycerophosphory1- 
choline, a m e t a b o l i t e  of LPC, were also used for 
comparison.
8.1 infusion of lysophosphflt idylcholine and palmitoylr.
carnitine into the left ventricular wall ol the
anaesthetized-gat
i) Lysophosphatidylcholine, infused at lml/hr into the 
left ventricular wall in concentrations of 20-2000pM, 
produced no significant change in the heart rate or blood 
pressure of the anaesthetized cat (FIG 22). No change in 
the lead II E.C.G. was seen.
ii) Palmitoylcarnitine, infused at lml/hr into the left 
ventricular wall in concentrations of 20-lOOOpM, also 
produced no significant changes in heart rate or blood 
pressure of the anaesthetized cat (FIG 23). No change in 
lead II E.C.G. was seen.
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iii) Noradrenaline, which has been shown by Podzuweit 
(1982) to cause arrhythmias when infused into the left 
ventricular wall of the pig in yiYOr did cause 
arrhythmias when infused at lml/hr at a concentration of 
lOpM into the in vivo cat heart, producing ventricular 
tachycardia within 1 minute of the start of the infusion. 
This was reversible, the heart returning to normal rhythm 
approximately 6 minutes after the noradrenaline infusion 
was replaced with one of Evans Blue dye (0.2mg/ml 0.9% 
saline), and reproducible, with ventricular tachycardia 
recommencing 1 minute following a second noradrenaline 
infusion. Heart rate was therefore increased on 
noradrenaline infusion but the blood pressure did not 
change (FIG 24), presumably due to reflex compensatory 
mechanisms . Heart rate returned to basal levels when the 
noradrenaline infusion was replaced with dye in saline.
Thus, unlike lOpM noradrenaline, LPC and PAL did not 
produce arrhythmias when infused directly into the left 
ventricular wall.
carnitine and glycerophosphorylcholine into_
left anterior descending csi-finary artery of the
anaesthetized cat
i) Lysophosphatidylgholirie
Infusion of LPC at final blood concentrations of 20
154
to lOOpM via the left anterior descending coronary artery 
caused no change in blood pressure, heart rate or lead II 
E • C • G • •
300pM LPC was capable of producing a small number of 
arrhythmias with peak incidence at 14 to 17 minutes after 
the start of the infusion.
500pM LPC produced severe arrhythmias commencing 
within 5 to 10 minutes after the start of the infusion. 
In 2 out of 3 cats this led to ventricular fibrillation 
and death at 22-26 minutes. Some increase in T-wave 
amplitude was seen prior to the onset of arrhythmias. A 
typical course of arrhythmia development is shown in FIG 
25.
In the case where the cat survived the 500pM LPC 
infusion with, few arrhythmias being produced, the 
coronary artery was ligated 35 minutes after the 
beginning of the LPC infusion. This produced ventricular 
fibrillation and death within 3 minutes, something that 
was not seen in any of the e x p e r i m e n t s  where only 
coronary artery ligation was performed (section 8.3). LPC 
may be producing membrane damage which makes the heart 
more susceptible to fibrillation on subsequent coronary 
artery ligation. The possibility exists that endothelial 
d a m a g e  m a y  be n e c e s s a r y  for the p r o d u c t i o n  of 
arrhythmias by other potential arrhythmogens.
ii) Ealmitoylcarnitine
155
Infusion of PAL at final blood concentrations of 10- 
2 0 pM produced no arrhythmias or changes in blood pressure 
and heart rate. Changes in the lead II E.C.G. did however 
take place/ and were not reversible when the PAL infusion 
was replaced with one of dye in saline (FIG 26) .
PAL, at concentrations of 30-40pM did produce a 
small number of arrhythmias and a short duration of 
ventricular tachycardia/ with changes in the E.C.G. 
similar to those in FIG 26.
50-75pM PAL produced severe arrhythmias with onset 
at 6 - 1 0  minutes after the start of the infusion leading 
to ventricular fibrillation and death in 2 out of 3 cases 
at 18 to 21 minutes. A typical course of arrhythmia 
de v e l o p m e n t  is s h own in FIG 27. ST elevation was 
pronounced before the onset of arrhythmias.
Thus like LPC f PAL was capable of producing 
arrhythmias when infused directly into the coronary 
ci rculation.
iii) Glycerophosphorylcholine
Infusion of GPC at a final blood concentration of 
400pM, a concentration sufficient to cause arrhythmias 
with LPC and P A L , produced no arrhythmias or changes in 
heart rate and blood pressure.
Initial experiments had shown a large immediate 
increase in heart rate and blood pressure on infusion of 
GPC but this was found to be due to cadmium remaining in
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the GPC solution (see method of GPC preparation section 
3,2) as these changes could be mimicked by a solution of 
cadmium chloride. Cadmium chloride, at final blood 
concentrations of 200-300pM gave increased heart rate (+ 
20 bpm) and blood pressure ( + 20mm Hg) with 400pM CdCl2  
producing arrhythmias, and in one case ventricular 
fibrillation and death.
8.3 Effect of coronary artery ligation on the production
of arrhythmias and on temperature in the Lett
ventricular wall of the anaesthetized cat
In order to compare the effects of LPC, PAL and GPC 
on arrhythmogenesis with arrhythmias produced by coronary 
artery ligation some experiments were carried out whereby 
the coronary artery was ligated and a r r h y t h m i a s  
monitored. In some of these the temperature in tne left 
and right ventricular walls was monitored to see if this 
could be used as a marker of ischaemia.
Coronary artery ligation produced arrhythmias in all 
6 animals. In 3 this led to ventricular fibrillation and 
death (mean number of extrasystoles = 554 +/- 262) with 
fibrillation occuring at 26.6 +/- 6.7 minutes post
ligation. The r e m a i n i n g  a n i m a l s  recovered from 
arrhythmias (mean number of extrasystoles = 415 +/- 8 8 ) 
and survived to one hour post ligation by which time the 
heart had returned to normal rhythm. Those cats 
developing ventricular fibrillation after coronary artery
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ligation did so at a similar time to those given LPC or 
PAL infusion. This was also the time of highest ectopic 
activity in cats that survived one hour of coronary 
artery ligation. Lead II E.C.G. changes were seen after 
coronary artery ligation (FIG 28) as were changes in 
blood pressure and heart rate (FIG 29).
After coronary artery ligation the temperature in 
the left ventricular wall decreased while that in the 
non-ischaemic area remained the same (FIG 30). A reduced 
temperature was therefore taken to be an indicator of 
ischaemia. On occasions where no fall in temperature was 
observed, or where an initial fall was followed by an 
increase back to the initial value, it was found that 
there was no defined ischaemic area as judged by i.v. dye 
i n t u s i o n .  In t h e s e  c a s e s  t h e r e  w a s  p r o b a b l y  a 
considerable amount of collateral flow.
8.4 Effect Qf-...palmifQylgarni-tine and streptokinase
infusion into the coronary actery on the
temperature in the left ventricular wall of the 
anaesthetized cat
As infusion of palmitoylcarnitine into the coronary 
artery produced ST elevation experiments were carried out 
to see if this was indicative of ischaemia by monitoring 
left ventricular wall temperature and examining the 
ability ot streptokinase to reverse any of these changes.
Infusion of 20jjM palmitoylcarnitine (final blood
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concentration), which did not produce arrhythmias, 
produced ST elevation and a decrease in temperature in 
the left ventricular wall. This temperature fall was not 
reversed when the p a l m i t o y 1 carnitine infusion was 
replaced with one of dye in saline but was reversed by an 
infusion of streptokinase (170U/min) (FIG 31).
Paimitoylcarnitine thus appeared to cause ischaemia, 
as evidenced by the fall in temperature in the left 
ve n t r i c u l a r  wall. It is unlikely to be caused by 
vasoconstriction as it was not reversed by dye in saline 
but w a s  r e v e r s e d  by s t r e p t o k i n a s e  i n f u s i o n .  
Paimitoylcarnitine therefore appears to be producing 
ischaemia by some effect on haemostasis in the coronary 
arteries.
8.5 Effect of lysophosphatidylcholine infusion into the 
coronary.-a rteiy o f the__anaesthetized cat on the left 
ventricular wall temperature
As paimitoylcarnitine appeared to produce ischaemia 
the effect of LPC on left ventricular wall temperature 
was monitored to check whether it produced the same 
effects as PAL.
Infusion of lysophosphatidylcholine at a final blood 
c o n c e n t r a t i o n  of 300pM produced no change in the 
t e m p e r a t u r e  in the left ventr i c u l a r  wall. Correct 
positioning of the probes was validated by the decrease 
in temperature seen on coronary artery ligation and by
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dye infusion i.v. to visualise the ischaemic area.
8 . 6  Effect Ql lysophosphatidylcholine and palmitoyl-
carnitine on_rat and rabbit platelet aggregation
PAL appeared to produce ischaemia when infused into 
the coronary artery ot the anaesthetized cat. This may be 
mediated by effects on platelet aggregation therefore the 
effects of both PAL and LPC on this were studied.
Neither PAL nor LPC stimulated platelet aggregation. 
No difference was seen between rat and rabbit platelets 
in their response. The effect of intracoronary PAL in 
producing ischaemia in the cat which was reversible oy 
streptokinase is therefore unlikely to be due to a direct 
effect on platelets. This does not exclude the 
possibility of platelet behaviour being modified in whole 
blood in ullLQ. as opposed to platelet rich plasma 
(Harrison, Pollock, Steiner and Weisblatt 1985), or an 
indirect effect with other components of the blood.
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8 DISCUSSION
EFFECT OF LYSOPHOSPHOLIPIDS AND RELATED COMPOUNDS IN THE
ANAESTHETIZED CAT
Infusion of lysophosphatidylcholine and paimitoyl­
carnitine into the left ventricular wall of the 
anaesthetized cat
No effects ot LPC were seen when it was infused 
directly into the left ventricular wall at concentrations 
up to 2mM. This surpasses c o n c entrations found in 
ischaemic tissue during arrhythmias of 1.65mM (Corr and 
Snyder et.al. Iy82) and 1.2mM (calculated from results in 
section 7.2 at 20 minutes of ischaemia, LPC + LPE = 6.22 
x 10“ ^ mol/mg protein, assuming 193 mg protein / g wet 
weight and 1ml = 1 g wet weight then LPC + LPE = 1.2mM) 
and those shown to produce electrophysiological changes 
in tissue when added exogenously (Nakaya and Ozaki et.al. 
1984, Sawicki and Arnsdorf 1985).
Although albumin binding of LPC would be expected to 
occur this would also occur with LPC generated during 
ischaemia and therefore the same proportion of free LPC 
should exist. It is possible that endogenously produced 
LPC will only be slowly washed out of the membranes and 
therefore the effective concentration in the membrane is 
relatively high as the interstitial fluid has a lower 
albumin concentration than blood (Halsmann, Stam and
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Lamers 1985). Protein concentration in the interstitial 
fluid has been estimated to be 0.2mM as opposed to ImM in 
plasma although a ratio of albumin concentration of 0.85 
in the l y m p h  in c o m p a r i s o n  to the p l a s m a  has been 
measured (Laine and Granger 1985). There is thought to be 
free m o v e m e n t  of LPC b e t w e e n  the vascular and 
extracellular space and labelled LPC that has been 
previously taken up by the perfused rat heart can be 
eluted by perfusion with a protein containing medium 
(Stein and Stein 1965) therefore infused LPC may be 
eluted rapidly by the blood and diluted to an ineffective 
concentration before incorporation into the cellular 
membranes is able to occur.
PAL, wnich has similar detergent-like properties to 
LPC because of structural similarities, also produced no 
effects when infused into the left ventricular wall. This 
may again d e m o n s t r a t e  the rapid dil u t i o n  of the 
ampniphile, precluding its incorporation into the cell 
membrane. PAL accumulates in the sarcolemma during 
ischaemia and may bind selectively to membrane proteins 
rather than distribute within the lipid bilayer (Knabb, 
Saffitz, Corr and Sobel 1986). Its e f f e c t s  during 
endogenous generation in ischaemia may differ from those 
when added exogenously and may result from effects on 
cellular metabolic processes in the former case, being an 
intermediate in fatty acid oxidation, rather than non­
specific detergent effects in the latter.
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Noradrenaline was shown to produce reversible, 
reproducible ventricular tachycardia, in common with the 
results of Podzuweit (1982) in the pig. Albumin binding 
of noradrenaline does not occur and thus noradrenaline 
is unlikely to be removed as avidly from the interstitial 
space as LPC or PAL. It is possible that LPC or PAL need 
to incorporate into a larger area of tissue to produce 
electrophysiological effects than does noradrenaline due 
to the latters specific receptor mediated effects as 
opposed to the possibly non-specific depression of 
membrane conductance produced by LPC or PAL (Clarkson and 
Ten Eick 1983). The effect of noradrenaline is only 
temporary. When the infusion is stopped uptake of 
noradrenaline into cells occurs thus its concentration is 
rapidly reduced. Diffusion away from the nerve terminal 
will also occur.
SUMMARY: LPC and PAL do not produce any effects when 
infused into the left ventricular wall, possibly due to 
binding to albumin and washout from the interstitial 
space. It is also possible that they need to affect a 
large area of tissue for any electrophysiological effects 
to be seen.
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■Lnfuslgfl Ql.. lysQphPSphfltidylcJiPline into the coronary
circulation
Unlike infusions into the ventr i c u l a r  wall, 
intracoronary LPC did produce concentration dependent 
arrhythmias.
At low final blood concentrations of LPC (20-100pM) 
no arrhythmias were seen, however at a final blood 
concentration of 500pM (assuming a blood flow of 4ml/min) 
severe arrhythmias were seen leading to ventricular 
fibrillation and death. This concentration is higher than 
that producing arrhythmias when perfused through isolated 
hearts i.e. 50 - IOOjiM in the isolated hamster heart (Man 
and Choy 1982, Man, Wong and Choy 1983), 20pM (Man and 
Lederman 1985) and lOOpM (Bergmann et.al. Iy81) in the 
isolated rabbit heart. However all these values were for 
albumin free LPC. As the free concentration of LPC 
appears to be tne important factor in initiating both 
arrhythmias (Man and Choy 1982) and electrophysiological 
changes (Corr and Snyder et.al. 1981) rather than the 
total concentration, the binding of LPC by the blood 
proteins is likely to be of importance. Blood albumin 
concentration is approximately 500 - 600pM (Lehninger 
1975) and as LPC binding is thought to saturate at a 
ratio of 1.4 : 1 (Klopfenstein 1969) the binding capacity 
of albumin is likely to have reached saturation on 
infusion of SOOjjM LPC because the endogenous venous
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plasma LPC concentration has been shown to average 370 
+/” 20 pM in the anaesthetized cat (Snyder et.al. 1981) 
and thus the albumin binding capacity will already be 
partly saturated before any LPC is infused.
LPC can be taken up by the isolated rat heart while 
complexed to albumin (Stein and Stein 1965), this uptake 
being dependent on the LPC/albumin ratio and was high at 
an LPC/albumin ratio of less than 1. LPC uptake has also 
been shown in the in vivo dog heart (Riemersma and 
Michorowski 1983).
At an infused LPC concentration of 500pM, albumin 
binding of LPC is therefore likely to be saturated. If a 
basal c o n c e n t r a t i o n  of LPC of 370pM, an a l b u m i n  
concentration of 500pM and a saturation binding of 1.4 
LPC : 1 albumin are assumed, a final free LPC
concentration of approximately 170pM would result on 
infusion of 500pM (final blood concentration) LPC. This 
is in the same range as the free LPC concentration 
p rod u c i n g  a r r h y t h m i a s  in isolated hearts. At this 
concentration there is likely to be considerable uptake 
of LPC which is not confined to the vascular tissue and 
if this is not reacylated (as only 15% of LPC taken up 
was seen to be by Stein and Stein (1965)) incorporation 
into the cellular membranes will occur. This may lead to 
changes in ion conductances, membrane enzyme activities 
and characteristics which can lead to the production of 
arrhythmias.
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It has been suggested that lysophospholipids in 
ischaemia have a vascular or endothelial origin with 
their release into the coronary circulation (Stam and 
Hulsmann 1981), thus intracoronary infusion of LPC may 
mimic this release and the subsequent arrhythmias may be 
due to its incorporation into the membranes of both 
vascular cells and myocytes. If this is the mechanism by 
w h i c h  LPC g e n e r a t e d  during i s c h a e m i a  exerts its 
arrhythmogenic effects lower concentrations are likely to 
be effective in ischaemic, as opposed to normoxic, tissue 
as the reduced pH seen in ischaemia potentiates the 
electrophysiological effects of LPC without increasing 
its incorporation (Gross et.al. 1982) and a reduced pH 
reduces albumin binding (Kurien and Olivier 1970).
Although LPC incorporation into the sarcolemmal and 
mitochondrial membranes is probably the ultimate cause of 
membrane dysfunction and arrhythmogenic effects both 
endogenously generated lysophospholipids and lysophospho- 
l i p i d s  g e n e r a t e d  at one site a nd s u b s e q u e n t l y  
incorporated into other cells may play a role.
Prior to the development of arrhythmias during 
infusion of 500pM LPC there were no gross changes in the 
lead II E.C.G. and no ST elevation (a characteristic of 
ischaemia) was seen. An increase in T-wave amplitude was 
seen prior to the development of arrhythmias. This is in 
agreement with the findings of Bergmann et.al. (1981) in 
the isolated rabbit heart where little change was seen in
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the epicardial electrogram apart from some conduction 
delay (not seen in the anaesthetized cat) and changes in 
T-wave amplitude and morphology. The increase in T-wave 
has also been shown in anaesthetized cats following 
coronary artery occlusion, in c o n j u n c t i o n  with ST 
elevation (Spath, Lane and Lefer 197 4).
The time course of the LPC induced arrhythmias was 
similar to that of coronary artery ligation induced 
arrhythmias in the anaesthetized cat. This may be due to 
initial rapid incorporation of LPC inducing the same 
electrophysiological changes seen in ischaemia which, 
once induced, lead to the production of arrhythmias and 
thus once LPC production (in ischaemia) and incorporation 
(in LPC infusion) have passed a certain level the same 
mechanisms lead to the development ot arrhythmias. 
Further infusion of LPC may not lead to greater effects 
as an all or none response may be operating with a 
certain membrane concentration of LPC being needed to 
elicit effects.
G l y c e r o p h o s p h o r y l c h o l i n e  did not produce any 
arrhythmias, at a final blood concentration of 400pM. It 
is thus unlikely that LPC is exerting its effects by 
breakdown into GPC. The latter is not amphiphilic and 
does not have detergent like actions thus lending support 
to the hypothesis that the effects of LPC are due to 
these properties. This is in agreement with the lack of 
e f f e c t  of G P C  a n d  f r e e  f a t t y  a c i d s  on
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electrophysiological characteristics of canine Purkinje 
fibres (Corr et.al. 1979).
SUMMARY: LPC, infused into the coronary artery, is
therefore capable of producing a r r h y t h m i a s  in the 
anaesthetized cat. These arrhythmias follow the same time 
course as coronary artery ligation induced arrhythmias 
and may be ultimately caused by electrophysiological 
changes produced by in c o r p o r a t i o n  of LPC into the 
sarcolemma. It is also possible that LPC is causing 
damage to the vascular tissue, in particular to the 
endothelial cells, releasing potential arrhythmogens and 
by reducing their ability to act as a permeability 
barrier this could allow other potential arrhythmogens 
to enter the tissue from the circulation.
Infusion of paimitoylcarnitine into the coronary 
circulation
Like LPC, PAL produced arrhythmias when given 
intracoronary, but at lower concentrations than did LPC.
Low concentrations of PAL that did not produce 
arrhythmias did produce cnanges in the lead II E.C.G. 
indicative of ischaemia, i.e. ST elevation. This ST 
e l evation i n c r e a s e d  as the PAL c o n c e n t r a t i o n  was 
increased and was not reversed by replacing the PAL 
infusion with one of dye in saline therefore it is 
unlikely to be due to vasoconstriction.
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In cases where PAL produced arrhythmias the final 
blood c o n c e ntration of PAL was 50 - 75 pM. This 
concentration is approximately a tenth of that of LPC 
needed to produce the same arrhythmogenic effects, 
therefore if non-specific detergent effects of LPC are 
important in producing arrhythmias some other mechanism 
must also apply for PAL. It is possible that binding of 
PAL by serum albumin does not have as high an affinity or 
capacity and thus the same free concentration of this 
a m p h i p h i l e  m a y  be a c h i e v e d  at d i f f e r e n t  t o t a l  
concentrations. It seems unlikely that this would account 
for a 1 0  fold difference.
PAL has similar amphiphilic properties to LPC 
therefore its incorporation into tne tissue is likeiy to 
occur and this could mimic production and accumulation of 
PAL during ischaemia. Preferential accumulation into the 
rat m y o c y t e  s a r c o l e m m a  during h y p o x i a  has been 
demonstrated (Knabb et.al. 1986). Such accumulation was 
thought to cause electrophysiological changes similar to 
those induced by LPC. D i f ferences in the m e m b r a n e  
dynamics of sarcolemma were seen when LPC or PAL were 
incorporated into isolated canine s a r c o l e m m a  thus 
although LPC and PAL are both amphiphiles there are 
differences between their effects on membranes (Fink and 
Gross 1984).
Infusion of PAL at final blood c o n c e n t r a t i o n s  
producing ST elevation also produced a decrease in
169
temperature of the left ventricular wall. This is a 
further indication of the development of ischaemia within 
the tissue as this fall in temperature could also be 
produced by coronary artery ligation. The drop in 
temperature produced by PAL could be reversed by infusion 
of streptokinase (17 0U/min).
Streptokinase, a single chain polyp e p t i d e  of 
molecular weight 48,000, has thrombolytic effects and has 
been used clinically for the treatment of thrombosis 
(Kennedy, Ritchie, Davis, Stadius, Maynard and Fritz 
1985, Olson, Butman, Piters, Gardin, Lejons, Jones, 
Chilazu, Kumar and C o l o m b o  1986). It acts on the 
plasminogen-plasmin system by binding to plasminogen, 
producing an active site in the latter which can activate 
a further molecule of plasminogen to plasmin (Sarnama, 
Szwarcer, Conard and Horellou 1985). P l a s m i n  is a 
proteolytic enzyme that converts fibrin polymer to 
soluble components and therefore streptokinase acts on a 
preformed clot to break down the fibrin polymer. There is 
not a close correlation between administered dose and the 
response due to the mechanism of action, high doses 
binding all the free plasminogen and leaving none free to 
be activated by proteolytic cleavage (Johnson and 
MacCarty 1959).
The ability of streptokinase to reverse the drop in 
temperature seen on PAL infusion suggests that PAL causes 
the production of intracoronary occlusion. As a drop in
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t e m p e r a t u r e  and ST e l e v a t i o n  w e r e  not seen on LPC 
infusion this represents an important difference between 
the action of the two amphiphiles, with PAL apparently 
causing this formation whilst LPC did not. The time 
course of the PAL induced arrhythmias was again similar 
to those produced by coronary artery ligation and by 
500pM LPC infusion, thus this may be a result of the 
ischaemia produced by PAL leading to the same mechanism 
of arrhythmia production as occurs following coronary 
artery ligation.
PAL could produce a reduction in coronary flow by 
various mechanisms. As no effect of LPC or PAL was seen 
on rat or rabbit platelet aggregation it is unlikely that 
PAL was acting directly on platelets to cause aggregation 
although it is still possible that a species difference 
may be present between rat, rabbit and cat platelets. It 
has been shown that platelet aggregation is associated 
with the level of haematocrit (Harrison, Pollock, Steiner 
and Weisblatt 1985). This was thought to be due to the 
increased number of platelet collisions or increased ADP 
release from damaged erythrocytes at high haematocrit. 
Therefore in v ivo platelet aggregation may occur due to 
release of ADP from damaged erythrocytes. PAL may cause 
h a e m o l y s i s  as lysis of e r y t h r o c y t e s  at a m p h i p h i l e  
c o n c e n t r a t i o n s  e x c e e d i n g  t h e  c r i t i c a l  m i c e l l e  
concentration has been shown (Bergmann et.al. 1981). It 
would be expected that LPC would also produce these
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effects unless binding to albumin or uptake into the 
heart is more extensive, leading to a reduced effective 
LPC concentration.
PAL could also be interacting with the vascular 
endothelium and causing release of a pro-aggregatory 
substance. There may also be a vasoconstrictor component 
potentiating the effects of any thrombi, as PAL has been 
shown to contract aortic rings in a c o n c e ntration 
dependent manner, although this was not dependent on the 
presence of endothelium, and can also antagonise the 
effects of endothelium dependent relaxant factor (Bigaud 
and Spedding 1986).
SUMMARY: PAL, when infused into the coronary circulation, 
produces arrhythmias which have a similar time course to 
those initiated by intracoronary LPC and by coronary 
artery ligation. The effect of PAL differs from that of 
LPC in that the former is effective at one tenth the 
concentration of LPC and appears to produce ischaemia. 
The effect of PAL in producing ischaemia may be due to an 
effect on the coronary vasculature with release of a pro- 
aggregatory substance coupled with vasoconstriction, but 
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FIG 23. CHANGES IN BLOOD PRESSURE AND HEART RATE OF THE
ANAESTHETIZED CAT ON INFUSION OF PAL INTO THE LEFT
VENTRICULAR WALL. MEAN OF 2.
X 20uM, 0 50uM, <  lOOuM, \ 200uM, /  500uM, • lOOOuM,
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FIG 24. CHANGES IN BLOOD PRESSURE AND HEART RATE OF THE
ANAESTHETIZED CAT ON INFUSION OF lO^lM NORADRENALINE 
INTO THE LEFT VENTRICULAR WALL, n = 5. MEAN +/- SEM.
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FIG 25. THE PRODUCTION OF ARRHYTHMIAS BY INFUSION OF 500pM LPC 
(FINAL BLOOD CONCENTRATION) INTO THE CORONARY ARTERY OF 
THE ANAESTHETIZED CAT. VT = VENTRICULAR TACHYCARDIA/




FIG 26. LEAD II E.C.G. ON INFUSION OF INTRACORONARY PALMITOYL- 
CARNITINE IN THE ANAESTHETIZED CAT.
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FIG 27. THE PRODUCTION OF ARRHYTHMIAS BY THE INFUSION OF
50jaM PAL ( FINAL BLOOD CONCENTRATION) INTO THE CORONARY 
ARTERY OF THE ANAESTHETIZED CAT. VT = VENTRICULAR 




FIG 28. E.C.G. CHANGES SEEN ON LIGATION OF THE LEFT DESCENDING 
CORONARY ARTERY OF THE ANAESTHETIZED CAT.
A = CONTROL, B = 2 MINUTES POST LIGATION,
C = 10 MINUTES POST LIGATION.
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FIG 29. CHANGES IN BLOOD PRESSURE AND HEART RATE FOLLOWING
CORONARY ARTERY LIGATION IN THE ANAESTHETIZED CAT. 
MEAN +/- SEM. 0-15 min n = 6. 20 min n = 5,
25-35 min n = 4, 40-60 min n = 3.
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FIG 30. CHANGES IN TEMPERATURE IN THE ISCHAEMIC AND NON-ISCHAEMIC 
AREAS FOLLOWING CORONARY ARTERY LIGATION IN THE 
ANAESTHETIZED CAT. CAL = CORONARY ARTERY LIGATION.
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FIG 31. EFFECT OF 20pM PALMITGYLCARNITINE AND STREPTOKINASE 
INFUSION (170 U/min) ON THE TEMPERATURE OF THE LEFT
VENTRICULAR WALL OF THE ANAESTHETIZED CAT.
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RESULTS
9 M EASUREMENT OF PHOSPHOLIPASE An ACTIVITY IN . THE
ISOLATED RAT HEART
As LPC concentration increased during ischaemia it 
was decided to assay phospholipase A 2 activity to see if 
an increase in its activity could account for the rise in 
LPC.
9.1 Characterisation____ o l  phgsphQlipase &2__ in the
homogenate of the isolated rat heart
i) Protein dependence
In the phospholipase A 2 assay the quantity of C h ­
oleic acid released was proportional to the amount of 
protein added to the assay. No release of C ^ - o l e i c  acid 
was seen with varying volumes of protein homogenate that 
had been boiled to inactivate the enzymes (FIG 32). Thus 
the rate of product release is proportional to enzyme 
concentration.
ii) Calcium dependence
The release of C ^ - o l e i c  acid was dependent on 
calcium. Increasing tne calcium concentration increased 
the reaction rate to a maximum at 3-5 mM ta^+ (FIG 33). A
calcium concentration of 5 mM was therefore chosen for
future assays of phospholipase A 2 as it would prevent 
Ca^+ from being rate limiting. Some activity was seen in 
the presence of lOmM EDTA which may be due to binding of
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calcium to the enzyme that EDTA could not displace or a 
calcium independent reaction. Using the direct linear 
plot for kinetic analysis a Km of 0.6mM for calcium was 
obtained.
iii) Time dependence
The release of C^-oleic acid due to enzymic release 
from the labelled PE was linear with time until at least 
45 minutes (FIG 3 4 ) , therefore a 45 minute incubation 
period was chosen for all future experiments as it 
provided a compromise between rapidity of the assay and 
accuracy by maximisation of the quantity of C ^ - o l e i c  
acid released.
iv) Loss of phospholipase A^ activity on freezing
a) Samples previously assayed freshly that were 
reassayed after being stored at -20°C for up to 5 months 
were found to have retained 57.9 +/- 3.4% of their 
original activity (n = 9). Samples having original
activity ranging from 2.39 to 11.47 x 10“^^mol/mg protein 
/hr were chosen and the activity loss appeared to be a 
constant percentage of the initial activity rather than a 
decrease to a common basal activity.
b) The loss of activity on freezing appeared to be 
due to an initial loss on freezing, the activity 
thereafter remaining constant (FIG 35), in common with 
the findings of Corr, Ahumada and Sooel (1982).
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In tissue samples that had to be stored before assay 
it was concluded that some loss of activity would have 
occurred on the initial freezing. This loss of activity 
is likely to be of the same percentage in all samples 
and therefore allows comparison of samples. As the loss 
of activity seems to be due to an initial loss on 
freezing samples frozen for different periods of time can 
be compared.
9.2 Effect of coronary artery ligation on phospholipase
& 2  activity in Uie ischaemic and non-ischaemic
regions of the isolated rat heart
Sham ligated control hearts showed no difference in 
PLA 2 activity between the regions corresponding to the 
ischaemic and non-ischaemic areas in hearts subjected to 
coronary artery ligation.
Following 5 minutes coronary artery ligation there 
was no difference in the activity of PLA 2 between the 
ischaemic and non-ischaemic areas (FIG 36). The pH 
optimum was in the neutral to alkaline region, pH 7-8.
Twenty minutes following coronary artery ligation 
there was a significant depression of PLA 2 activity in 
the ischaemic region in comparison to the non-ischaemic 
region (FIG 37).
It would appear that as the length of ischaemia 
increases inhibition of PLA2 occurs, being significant at 
2 0  minutes post ligation when the concentrations of lyso-
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phospholipids (FIG 14 + 15) and the arrhythmias are at 
their peak.
9.3 Mitochondrial phospholipase An
i) pH dependence
Mitochondrial PLA 2 showed a broad pH profile with 
maximal activity at pH 6 - 8  (FIG 38). The pH profile was 
similar to that seen in the whole heart homogenate (FIG 
36) .
ii) Calcium dependency
The activity of mitochondrial PLA2 increased as the 
calcium concentration was increased, to a maximal 
a c t i v i t y  at 5 - 7 . 5 m M  C a ^ + (FIG 39), a c a l c i u m  
concentration of 5mM being chosen for further experiments 
to prevent calcium being rate limiting.
Effect of coronary artery liaation on the activity
of mitochondrial DhosDholioase __Ao in the




F o l l o w i n g  20 m i n u t e s  coronary a r tery 1 igation
mitochondria isolated from the ischaemic region exhibited 
a depressed PLA 2 activity in comparison to those isolated 
from the non-ischaemic area (FIG 40). This is similar to 
the change in PLA 2 activity seen in the homogenate of the 
isolated rat heart following 2 0  minutes coronary artery
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ligation (FIG 37).
9.5 Sarcolemmal phospholipase Ao 
i) Calcium dependency
Sarcolemmal PLA 2  activity increased with calcium 
concentration up to a plateau at 3 to 5 mM Ca^+ (FIG 41). 
A concentration of 5mM Ca^+ was therefore chosen for 
further experiments to produce maximal activity. This is 
in common with the homogenate and mitochondria which were 
found to have similar calcium dependencies (FIGS 33 + 
39) .
The sarcolemmal PLA 2 showed some activity in the 
presence of lOmM EDTA. This may be due to high affinity 
binding of calcium by the sarcolemma and/or the formation 
of vesicles retaining calcium which is not accessible to 
the EDTA, or a calcium independent enzyme.
9.6 Effect of coronary artery ligation on phospholipase
 activity in the sarcolemm a of the ischaemic and
non-ischaem ic regions of the isolated rat heart
Sarcolemma isolated from hearts after 20 minutes 
coronary artery ligation had a PLA2 PH dependency similar 
to that seen with the homogenate, having a pH optimum of 
7-8.
Although there was no significant difference between 
sarcolemma from the ischaemic and non-ischaemic regions 
there was a tendency towards a decrease in activity in
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the ischaemic region (FIG 42).
9.7 Effect of lysophosphatidylcholine and palmitoyl-
carnitine_____on.... phospholipase Ao activity in
homogenates .oflfJie isolated rat heart
As inhibition of PLA 2 in the ischaemic region of the 
isolated rat heart had been shown following 2 0  minutes 
ischaemia, a time when the LPC concentration was maximal, 
the effect of LPC on PLA 2 activity was studied. The 
effect of PAL was also studied as this is an amphiphile 
with similar properties to LPC and has also been shown to 
accumulate during ischaemia (Idell-Wenger et.al. 1*78).
LPC produced a stimulation of PLA 2 activity at low 
concentrations ( ^ 50pM) and an inhibition at higher 
concentrations ( ^lOOpM) (FIG 43).
A similar profile of action on PLA 2 was seen with 
PAL (FIG 43) with a stimulatory action at ^ 50jjM and an 
inhibitory action at ^200pM.
9.8 Effect of mepacrine on phospholipase A^ activity in 
homogenates of the isolated rat heart
Mepacrine, a known inhibitor of PLA 2 (Thakkar, 
Sperelakis, Pang and Franson 1983), inhibited PLA 2  
activity in homogenates of the isolated rat heart at 
concentrations of lOpM and above (FIG 44). No stimulatory 
phase was seen, in contrast to the actions of LPC and 
PAL.
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9.9 Effect q±  ly&gphgsphatidylchplin^r palmitoyl-
garnitine and mepacrine on ADP induced platelet
aggregation
LPC and PAL had similar effects on ADP induced 
platelet aggregation, producing an inhibition at 
concentrations of lOOpM and greater (FIG 45). Mepacrine 
had a greater inhibitory effect than LPC or PAL on ADP 
induced platelet aggregation. This paralleled the order 
of potency of these agents on the inhibition of PLA 2  
activity (FIGt> 43 + 44).
10 PHOSPHOLIPASE Aq ACTIVITY IN HEART TISSUE SAMPLES
FROM THE ANAESTHETIZED CAT
i) Hearts infused with LPC a t final blood
concentrations of 20-500pM via the coronary artery
At final blood concentrations of LPC up to lOOpM, 
where no arrhythmias occurred, there was no difference 
b e t w e e n  the P L A 2 activity in the left and right 
ventricular walls (FIG 46).
Greater LPC concentrations, (300-500pM) which 
produced a r r h y t h m i a s  and in some cases death from 
ventricular fibrillation, caused a reduction in PLA 2  
activity in the left ventricular wall (FIG 46 + 47). The 
left ventricular wall would be expected to receive the 
highest c o n c e n t r a t i o n s  of LPC and therefore this
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inhibition of PLA 2 may be due to direct inhibition by LPC 
(as shown in FIG 43) .
ii) Hearts infused Mi.th..-palmitoylcarnitine at final
blood concentrations of 30-75pM via the coronary
artery
In hearts infused with PAL at concentrations that 
produced arrhythmias, and with the higher concentrations 
death, the PLA 2  activity in the left ventricular wall 
tended to be depressed (FIG 48 + 49) however this was not 
significant.
PAL may therefore be causing direct inhibition of 
PLA 2 (FIG 43) rather than causing changes in the heart 
which indirectly lead to PLA2 inhibition.
iii) Hearts with the left anterior descending coronary
artery. ligated
There was no significant difference between the PLA2  
activity in the ischaemic and non-ischaemic areas of 
hearts with coronary artery ligation, the activity being
1.50 +/- 0.28 and 1.34 +/- 0.22 x 10 ” 1 1  mol/mg/hr in the
ischaemic and non-ischaemic regions respectively (n = 7). 
This is in contrast to the isolated rat heart. There 
appeared to be no c o r r e l a t i o n  b e t w e e n  severity of 
coronary artery ligation induced arrhythmias and PLA 2  
activity in the ischaemic and non-ischaemic regions.
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11 EFFECT.OF REPERFUSION OF THE ISCHAEMIC ISOLATED RAT 
HEART ON. PHOSPHOLIPASE Ao ACTIVITY
11.1 Effect of 10 minutes coronary artery occlusion and
I m inute reperfusion on phospholipase A2— activity
in the isolated rat heart
After 1 minute reperfusion following 10 minutes 
coronary artery occlusion the PLA 2 activity in the non- 
ischaemic area was significantly greater than in the 
ischaemic area, being 7.67 +/- 0.39 and 3.56 +/- 0.40 x 
1 0 - 1 1  m o l / m g / h r  respectively (FIG 50). In these 
experiments a K+ concentration of 5.9mM was used in the 
Krebs-Henseleit buffer and no reperfusion arrhythmias 
were seen. In all the subsequent e x p e r i m e n t s  on 
reperfusion the K+ concentration was reduced to 3.2mM as 
this makes the hearts more susceptible to reperfusion 
arrhythmias.
11.2 Effect of 10 minutes coronary artery occlusion and
I minute reperfusion on phospholipase Ao— activity
In the isolated, rat_heart_perfused with 3.2mM__K±-
Krebs-Henseleit buffer
U s i n g  K r e b s - H e n s e l e i t  c o n t a i n i n g  3 . 2 m M  K + 
arrhythmias were seen in all the hearts on reperfusion, 
in contrast to the 5.9mM K+ Krebs-Henseleit where no 
reperfusion arrhythmias were seen.
P L A 2 activity in the n o n - i s c h a e m i c  area was
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significantly elevated in comparison to that in the 
ischaemic area (FIG 50), being 9.79 +/- 1.56 and 4.17 +/- 
0.70 x 10“ H  m o l / m g / h r  respectively. Ten m i n u t e s  
ischaemia only with this composition buffer produced PLA2  
activities of 1.86 +/- 0.07 and 2.21 +/- 0.48 x 1 0 " ^  
mol/mg/hr in the ischaemic and non-ischaemic areas 
respectively (see section 11.3). Thus reperfusion causes 
an increase in PLA2 activity in the non-ischaemic region, 
regardless of whether arrhythmias occur.
11.3 £fLf£C.t of 10 minutes coronary artery ligation on
phospholipase A^ activity in the isolated rat heart
perfused with Krebs-Henseleit buffer containing
3.2mM K—
As the composition of the Krebs-Henseleit buffer was 
changed for the reperfusion experiments the relevant 
ischaemic and sham ligated controls were carried out.
The course of ischaemically induced arrhythmias was 
also changed in the hearts perfused with 3.2mM K+ Krebs- 
Henseleit. At a p o t a s s i u m  c o n c e n t r a t i o n  of 5.9 m M  
arrhythmias typically commence following 1 2  minutes 
coronary artery ligation and therefore in the occlusion / 
reperfusion experiments no ischaemic arrhythmias were 
seen because the occlusion period was only 1 0  minutes. 
With 3.2mM potassium Krebs-Henseleit arrhythmias commence 
at approximately 8 minutes following coronary artery 
ligation and therefore ischaemic arrhythmias are seen in
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these experiments.
Following 10 minutes coronary artery occlusion with 
the 3.2mM K+ K r e b s - Henseleit buffer there was no 
significant difference between the PLA2 activity ot the 
ischaemic (1.86 +/“ 0.07 x 10”^  mol/mg/hr) and the non- 
ischaemic (2.21 +/- 0.4b x 10“H  mol/mg/hr) areas (FIG 
50) .
Sham ligated controls showed no difference between 
the PLA 2 activity in the areas corresponding to the 
ischaemic and non-ischaemic areas (FIG 50). Although 
there was no significant difference in PLA 2 activity 
between the non-ischaemic areas of sham ligated and 1 0  
minute CAL hearts (3.49 +/“ 0.55 vs 2.21 +/~ 0.48 x lO ” ^ 1  
mol/mg/hr) the 10 m i n u t e  CAL i s chaemic area had a 
significantly lower PLA2 activity (1.86 +/- 0.07 x 10“^  
mol/mg/hr) compared with the sham ligated heart (4.57 +/- 
0.52 x 10”H  mol/mg/hr), p^O.Ol. This is in agreement 
with the depression in PLA 2 activity seen in ischaemia 
(FIG 37) although this latter depression was after 20 
minutes coronary artery ligation as opposed to 1 0  minutes.
11.4 Effects of effluent perfusate from  reperfnse£
hearts on phospholipase Ao activity
As activation of PLA 2 in the non-ischaemic region, 
and to a lesser extent in the ischaemic region, occurred 
on reperfusion it is possible that the heart is producing 
something capable of activating PLA2 . Thus the effect of
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the perfusate eluting from the reperfused heart on PLA 2  
activity was examined.
i) Effects of perfusate on phospholipase A^ activity
The addition of 30pl of perfusate eluted from a 
heart reperfused after 1 0  minutes coronary artery 
occlusion to the homogenate of a control heart produced 
an increase in PLA 2 activity from 1.50 +/- 0.1b to 1.98 
+/- 0.20 x 10“H m o l / m g / h r  (FIG 51). Perfusate from the 
same heart before reperfusion had no effect on PLA 2  
activity (FIG 51). Freshly made Krebs-Henseleit buffer 
had no effect on P L A 2 activity. The effect of the 
perfusate was stable to its freezing.
ii) Effect of lipid extract of perfusate fjLQID a
reperfused heart on phospholipase Ao activity
A lipid extract of the perfusate was made to 
investigate whether lipids were mediating the effects of 
the perfusate on PLA2 activity.
a) The lipid extract of the perfusate from a reperfused 
heart was tested for its effect on PLA 2 activity in the 
h o m o g e n a t e  of a control heart. As the extract was 
resuspended in the same volume as the original perfusate 
the volumes added contained the same concentration of 
lipid as the perfusate.
At low concentrations (below 50pl) a stimulation of 
PLA 2 activity was seen, a stimulation being obtained on
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addition of 30pl extract, confirming the results with the 
perfusate. At higher concentrations of extract (greater 
than 50pl) an inhibition of PLA 2 activity was seen (FIG 
52). This type of effect is similar to that seen with LPC 
and PAL (FIG 43) ther e f o r e  the lipid extract was 
separated by TLC to try to identify the lipids.
b) The lipid extract, when separated by TLC, appeared to 
be composed almost entirely of free fatty acids which 
comigrated with the oleic acid standard. A small quantity 
of lipid material remained near the origin which may be 
LPC or LPE as lysophospholipids remained in this area. As 
other lipids also remain near the origin these could not 
be positively identified.
11.5 Effect of a free radical scavenger on phospholipase
&2_ activity during reperfusion
It is possible that free radicals have a role in 
changes occuring during reperfusion (see section 1 .8 ) and 
thus a free radical scavenger was tested for its ability 
to mod u l a t e  the changes in P L A 2 a c t ivity seen on 
reperfusion.
The presence of ImM reduced glutathione in the 
perfusate reduced tne PLA2  activity seen on reperfusion 
following 10 minutes coronary artery ligation. This is in 
c o m p a r i s o n  to ithe identical e x p e r i m e n t  without 
glutathione (FIG !53) , with PLA 2 activity being 9.79 +/-
1.56 and 4.62 +/“ 0.41 x 1 0 " 1 1  mol/mg/hr without and with
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glutathione respectively.
The activity in the non-ischaemic area (4.62 +/- 
0.41 x 10“H  mol/mg/hr) is still significantly greater 
than in the ischaemic area (2.63 +/- 0.27 x 10 " 1 1  
mol/mg/hr, p 0 .0 2 ) and significantly greater than in 
the non-ischaemic area after 1 0  minutes ischaemia (2 . 2 1  
+/“ 0.48 x 10 - 1 1  mol/mg/hr).
1 1 . 6  £f.£ect q£  a constant pressure head system on
phospholipase Ao activity during reperfusion of the 
isolated rat heart
During coronary artery occlusion there would be 
expected to be an increase in flow in the non-ischaemic 
region using a constant flow system. As these flow 
changes may cause changes in PLA2 activity independently 
of ischaemia and reperfusion a constant pressure head 
system was used to reduce any flow changes.
PLA2 activity after 1  minute reperfusion following 
1 0  minutes occlusion was the same in the ischaemic and 
non-ischaemic regions (3.76 +/- 0.42 vs 3.9 +/- 1.32 x 
10 - 1 1  mol/mg/hr) (FIG 54). This represented a significant 
decrease in activity in the non-ischaemic region between 
the constant flow (9.79 +/- 1.56 x 10”^  mol/mg/hr) and 
the constant pressure systems ( 3.9 +/- 1.32 x 1 0 ~ H  
mol/mg/hr) (FIG 54) .
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11.7 Effect of flow rate changes on phospholipase A^
activity in the isolated rat heart
As ischaemia and reperfusion in a constant flow 
system produced diffe r e n c e s  in P L A 2 a c t ivity from 
ischaemia and reperfusion in a constant pressure head 
system the effect of flow changes on PLA 2 activity were 
investigated.
a) Hearts perfused at 15ml/min for 10 minutes had a 
higher PLA 2 activity (8.41 +/- 1.33 x 10“^  mol/mg/hr) 
than hearts subsequently perfused at lOml/min for 1 
minute (5.2 +/- 1.16 x 10 ” 1 1  mol/mg/hr) although this 
difference was not significant (FIG 55). These two 
regimes simulate the flow changes seen in the non- 
ischaemic region of the CAL, and CAL plus reperfused 
hearts respectively.
b) Hearts made globally ischaemic for 10 minutes had 
a significantly higher P L A 2 activity than hearts 
subsequently perfused at lOml/min for 1 minute (5.50 +/- 
0.69 vs 2.83 +/- 0.25 x 1 0 - 1 1  mol/mg/hr) (FIG 55). 
Although the hearts were perfused in a heated water 
jacket the temperature of the heart decreased during 
global ischaemia. This may cause changes in PLA2 activity 
w h i c h  are unrelated to the flow changes but are a 
function of the decreased temperature. The temperature in 
the ischaemic area of the coronary artery ligated heart 
would be expected to fall but not to the same extent as
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during global ischaemia.
Therefore changes in the flow rate of the whole 
heart are able to produce changes in PLA 2 activity 
i n d e p e n d e n t l y  of any e f f e c t s  of i s c h a e m i a  and 
reperfusion, increased flow producing increased PLA 2  
activity.
11.8 Effect of vasodilators on phQ£Pholipas£-.Ao activity 
in the isolated rat heart
As increased flow produced an increase in PLA 2  
activity it is possible that increased shear and stress 
forces in the vasculature lead to damage and raised PLA2  
activity. Thus the effects of two vasodilators were 
investigated to see if a reduction in stress affected 
PLA2 activity.
a) Effect Of adenosine on phospholipase activity
during high flow
A concentration of lCT^M adenosine was chosen as it 
has been r e p o r t e d  to cause m a x i m a l  v a s o d i l a t i o n  
(Schrader, Haddy amd Gerlach 1977) and during preliminary 
experiments a maximal effect was seen on the perfusion 
pressure reduction in an isolated rat heart with this 
concentration of adenosine contained in Krebs-Henseleit 
buffer.
Significant differences were seen between the effect 
of adenosine in ir eci rculating and non-recirculating
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systems.
A 10 minute perfusion with 10“ ^M adenosine in a 
recirculating system produced no effect on the elevated 
PLA 2 activity seen on perfusing a heart at 15ml/min 
instead of lOml/min (9.85 +/- 1.29 x 10“^  mol/mg/hr with 
adenosine in comparison to 8.41 +/- 1.33 x l O " H  mol/mg/hr 
without adenosine). As it is possible that adenosine is 
metabolised by the tissue in the 5 minute perfusion prior 
to elevation of flow rate from 10 to 15 ml/min the same 
experiment was carried out with a non-recirculating 
system where this metabolism should not occur.
In a non-recir c u l a t i n g  sy s t e m  1 0 " 5M adenosine 
produced a significant decrease in PLA2 activity (3.7 +/- 
0.55 x 10- H  m o l / m g / h r  from 8.41 +/- 1.33 x 10” H  
mol/mg/hr) while 10“^M adenosine had an intermediate 
effect (FIG 56) .
As there is a significant decrease between the 
effect of 1 0 “ ^M adenosine on P L A 2 a c t ivity in a 
recirculating and a n o n - r e c i r c u l a t i n g  system the 
assumption that metabolism of the adenosine by the tissue 
occurs is probably correct.
b) Effect of sodium nitroprusside on phospholipase hg
activity during_Mgh flow
In p r e l i m i n a r y  e x p e r i m e n t s  1 0 “ ^M s o d i u m  
nitroprusside was shown to produce maximal vasodilation 
in the whole rat heart in a recirculating system.
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Hearts perfused at a flow rate of 15ml/min (high 
flow rate) for 1 0  minutes with 1 0 ”^M sodium nitroprusside 
containing Krebs-Henseleit buffer exhibited a lower PLA2  
activity (4.12 +/- 0.16 x 1 0 ” 1 1  mol/mg/hr) than those 
perfused without sodium nitroprusside (8.14 +/- 1.33 x 
1 0 " ^  mol/mg/hr) (FIG 57) .
Thus both v a s o d i l a t o r s  adenosine and sodium 
nitroprusside are capable of antagonising the effect of a 
high flow rate on PLA 2 activity in the whole heart. 
Therefore the increase in PLA2 activity at high flow rate 
may be due to stress forces within the vasculature.
9 DISCUSSION
PHOSPHOLIPASE A n ACTIVITY IN THE ISOLATED RAT HEART
.Characterisation of phospholipase A^ activity in the 
homogenate of the isolated rat heart
The release of C ^ - o l e i c  acid from PE labelled with 
the oleic acid in the 2 -acyl position was shown to be 
proportional to the protein concentration and to be 
totally attributable to enzymic activity when compared to 
controls run in parallel with no protein present (FIG 
32), This release of C ^ - o l e i c  acid was calcium 
dependent, reaching a maximum at 3-5mM Ca^+ (FIG 33) ,and 
was linear with time until at least 45 minutes (FIG 34). 
T h i s  c a l c i u m  d e p e n d e n c y  is s i m i l a r  to th a t  of 
phospholipase A 2 activity in rat aorta smooth muscle 
(Thakkar et.al. 1983), rat and human lymphocytes (Etienne 
and Polonovski 1984), rat platelets (Withnall et.al.
1984), and s u b c e l l u l a r  fractions of the rat heart 
(Nalbone and Hostetler 1985). In common with the work of 
Nalbone and H o s t e t l e r  (1985) EDTA did not produce 
complete inhibition of the activity, suggesting the 
presence of a calcium independent enzyme. A plasmalogen 
specific calcium independent PLA 2 has been reported in 
c a n i n e  m y o c a r d i u m  w h i c h  has low a c t i v i t y  for 
diacylphospholipids (Wolf and Gross 1985) therefore this 
could account for the activity seen in the presence of 
EDTA. The Km for calcium was calculated to be 0.6mM by
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the direct linear plot method, a value similar to that 
reported for platelet PLA 2 (Watanabe et.al.1986).
The maximal activity seen was approximately 2.5 x 
10”^  mol/mg/hr. This is 100 times lower than many of the 
reported values in the literature (Weglicki et.al. 1971, 
Franson et.al. 1978, Corr, A h u m a d a  and Sobel 1982, 
Nalbone and Hostetler 1985). This may be due to the 
different modes of substrate preparation. In most cases 
labelled substrate of known specific activity is diluted 
with an identical unlabelled substrate. However, when 
labelled substrate is prepared using rat liver 
microsomes, as in this thesis, the labelled lipid will 
also be diluted with other phospholipids present in these 
microsomal membranes as they will all be extracted and 
isolated together with the labelled substrate. It was not 
thought valid to m e a s u r e  tne total p h o s p h o l i p i d  
concentration in the substrate aliquots and assume that 
this is the effective substrate concentration as under 
most conditions PC and PE form entirely different types 
of aggregates (Waite 1985) and PE is a better substrate 
for PLA 2 than PC (Weglicki et.al. 1971, Wurl and Kunze
1985). However as PLA 2 is capable of acting on other 
phospholipids apart from PE the total concentration of 
the latter is also not an accurate reflection of the 
substrate concentration. The activity was thus calculated 
for the labelled substrate only. In each assay labelled 
PE of 40,000 dpm was used. At a specific activity of
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57mCi/mmol of C^^-oleic acid this is equivalent to 2.1pM 
of labelled PE.
The rat liver microsomes used in the preparation of 
the labelled substrate had a protein concentration of 
lOmg/ml. As 11ml of microsomes were used , lipid to 
protein content is approximat ely/*2 pmol/mg protein in 
lipid bilayers (Philipson, Bers and Nishimoto 1980) and 
1 2 0 ml of substrate solution was prepared there would be 
1.32 x lO”  ^ moles in 120ml of substrate. Thus in 20pl 
there would be 2.20 x 10"® mols of lipid. This in the 
assay would give an unlabelled lipid concentration of 
1 46pM. Therefore if PLA2 acts equally on all the phospho­
lipids the activity is 73 times greater than quoted, i.e 
approximately 2nmol/mg/hr. This is in the range of 
activities quoted by other workers. The proportion of 
hydrolysed labelled substrate did not exceed 4%, in 
common with the results of Ballou and Cheung (1985) with 
platelet PLA 2 and thus it is likely that unlabelled and 
labelled substrates are degraded equally. The PLA 2  
a c t i v i t y  , as m e a s u r e d  against e x o g e n o u s l y  added 
substrate, does not necessarily reflect that towards 
endogenous substrates in the in vivo situation where 
enzyme and substrate are in the same membrane. Kinetic 
parameters for mitochondrial PLA2 against endogenous and 
exogenous substrates have been shown to differ (De 
Winter, Korpancova and van den B o s c h  1984). The 
saturating substrate concentration used in this thesis
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a l l o w e d  assessment of activity towards exogenous 
substrate. Although it would be possible to determine 
kinetic constants for the exogenous substrate there is 
little meaning in such values as solution kinetics do not 
apply when the substrate is above its critical micelle 
concentration (Waite 1985).
SUMMARY: PLA2 activity in the rat heart homogenate was
shown to be proportional to protein concentration, time 
and calcium dependent with a Km of approximately 0.6mM 
Ca2+.
Effect of coronary artery ligation on phospholipase
activity
PLA 2 in the homogenate of the isolated rat heart 
showed a pH optimum of 7-8 in both ischaemic and non- 
ischaemic regions. This alkaline pH optimum is consistent 
with that found for membrane bound PLA 2  (van den Bosch 
1980, Etienne and Polonovski 1984). Some activity was 
seen at acidic pH 4-5. This may be due to the activity of 
a lysosomal soluble PLA 2 which is active at this pH, 
however the majority of phospholipase activity at pH 4 
has been reported to be of the A^ type rather than A 2  
(Nalbone and Hostetler 1985) therefore this may explain 
why very little activity was seen at acidic pH.
Following 5 minutes coronary artery ligation there 
was no difference between PLA2 activity in the ischaemic
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and non-ischaemic areas of the isolated rat heart (FIG 
36). H o w e v e r  following 20 minu t e s  coronary artery 
ligation the activity in the ischaemic region was reduced 
(FIG 37). Thus at a time when the lysophospholipid 
concentration and severity of arrhythmias are at their 
peak the activity of PLA 2 is actually inhibited. This 
does not support the hypothesis that PLA 2 activity 
increases during ischaemia and is responsible for the 
increased lysophosphol ipid concentrations. Although the
enzyme is calcium dependent any regulation of PLA 2 by 
calcium will not be seen in this assay as it is carried 
out at a calcium co n c e n t r a t i o n  producing m a x i m a l  
activity. It is possible that an initial increase in 
intracellular free calcium could cause PLA 2 activation 
before the inhibition of PLA 2 at 20 minutes ischaemia 
h o w e v e r  e v i d e n c e  for i n c r e a s e d  fr e e  c a l c i u m  
concentrations during the early phase of ischaemia is 
lacking. In rabbit septal preparations cytosolic calcium 
is reported to be less than lOOpM during ischaemia and in 
the Langendorff perfused rabbit heart a free calcium 
c o n c e n t r a t i o n  of only 40jjM w o u l d  be obtained if 
intracellular calcium was h o m o g e n o u s l y  distr i b u t e d  
(Poole-Wilson et.al. 1984). S i m i l a r l y  it has been 
suggested that free calcium during ischaemia does not 
exceed 25pM (Jennings et.al. 1985). These values are 
considerably lower than the quoted Km for calcium, 
casting doubt on the ability of calcium to exert a
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regulatory role during ischaemia.
Inhibition of PLA 2 following periods of ischaemia 
greater than five minutes has been reported in the gerbil 
brain (Edgar et.al. 1982) and was attrib u t e d  to 
inhibition by free fatty acids. When the effect of LPC, a 
product of PLA2 action, on PLA2 activity was studied (FIG 
43) it was seen that after an initial stimulation at low 
concentrations, an inhibition of activity was seen at 
concentrations of LPC above lOOpM. This profile of 
activity was similar to that of another amphiphile, 
oleoyl CoA, on N a + / K + ATPase (Weglicki, Kramer, 
Franson, Pang and Owens 1985). The LPC concentration in 
the rat heart following 2 0  minutes coronary artery 
ligation was previously calculated to be 1.2mM. As a 
dilution of the tissue of 18 occurs in the assay ( 6  in 
homogenisation and a further 3 in the assay itself) the 
LPC concentration in the PLA2 assay of the ischaemic area 
following 2 0  minutes coronary artery ligation is likely 
to be approx. 70pM. This does not appear sufficient to 
cause inhibition of PLA2 however this calculation assumes 
homogenous distribution of LPC within the tissue. As LPC 
r e a d i l y  i n c o r p o r a t e s  i n t o  m e m b r a n e s  the l o c a l 
concentration of LPC near the PLA 2 in the membrane is 
likely to be m u c h  higher. During i s c h a e m i a  LPC is 
produced by PLA2 action and is therefore already situated 
within the membrane bilayer in close proximity to the 
enzyme. It is thus possible that inhibition will occur.
206
PAL was also shown to have a similar inhibitory 
action on PLA 2  (FIG 43) and concentrations of PAL reach 
millimolar levels during ischaemia (Idell-Wenger et.al. 
1978, Shug, Thomsen, Folts, Bittar, Klein, Koke and Huth 
197 8 ). PAL has been shown to accumulate primarily in the 
sarcolemma during hypoxia (Knabb et.al. 1986) although 
other workers found accumulation was largely in the 
cytosol during ischaemia (Idell-Wenger et.al. 1978) and 
this could also contribute to inhibition of PLA 2 during 
ischaemia.
Synergy has been reported in the inhibitory action 
of PAL and other amphi p h i l e s  , such that two non- 
inhibitory concentrations would produce an effect when 
added together , on the activity of myocyte sarcolemmal 
Na+/K+ ATPase (Weglicki et.al. 1985) and therefore it is 
possible that this may occur in the heart with LPC and 
PAL.
SUMMARY: PLA 2 activity in the rat heart homogenate was 
shown to be the same in the ischaemic and non-ischaemic 
regions following 5 minutes coronary artery ligation 
however at 2 0  minutes post ligation the activity in the 
is c h a e m i c  region was reduced. This may be due to 
inhibition by LPC and PAL, both of which were shown to 
inhibit PLA2 when added exogenously.
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Mitochondrial phospholipase
Mitochondrial PLA 2 activity showed a broad pH 
optimum at neutral pH and calcium dependency (FIGS 38 
+ 39). M a x i m a l  a c t i v i t y  was s e e n  at a c a l c i u m  
concentration of 3-5mM. Some activity was seen in the 
presence of lOmM EDTA. This could be due to the presence 
of a calcium independent enzyme or calcium binding to the 
mitochondria. It has been reported that washing of 
mitochondria in sucrose/EDTA does not remove all the 
calcium from the mitochondria (Bjtfrnstad 1966).
Following 20 minutes coronary artery ligation, at a 
time when the activity of PLA 2 in a nomogenate of the 
ischaemic region of the isolated rat heart is depressed, 
there also appeared to be a reduced mitochondrial PLA 2  
activity in the i s c h a e m i c  region (FIG 40). This 
inhibition may be due to LPC or PAL accumulation within 
the membranes. Isolation of mitochondria from ischaemic 
tissue may result in the selective isolation of the least 
damaged organelles as it has been shown that isolation of 
canine cardiac sarcoplasmic reticulum is selective during 
ischaemia, in this case for the more damaged organelles 
(Rapundalo, Briggs and Feher 1986). Slight mitochondrial 
damage has been seen following 15-20 minutes ischaemia 
(Schaper 1979) thus it is possible that the functionally 
more n o rmal m i t o c h o n d r i a  have been isolated . Two 
different mitochondrial populations also appear to exist, 
depending on the mode of p r e p a r a t i o n  (Nalbone and
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Hostetler 1985) and therefore these may be affected 
differently by ischaemia.
SajTcolemmal phospholipase An
The calcium dependency of sarcolemmal PLA 2 was 
similar to that of the mitochondria and the whole heart 
homogenate with maximal activity at 3-5mM calcium (FIG 
41). With this preparation there was still substantial 
activity in the presence of lOmM EDTA. Again this may 
represent a calcium independent activity. As the 
sarcolemma will be present as vesicles it is possible 
that these will retain calc i u m  from the initial 
homogenisation and this would not be accessible to EDTA. 
Sarcolemmal phospholipids such as PS and PI are also 
known to have an important role in calcium binding 
(Philipson et.al. 1980, Langer 1985) as have the 
g ly c o c a l y x  sialic acids (Langer, Frank, Nudd and 
Seraydarian 1976, Nathan and Bhattachayya 1981) and this 
bound calcium may be retained through the isolation 
procedure.
The pH profile of sarcolemmal PLA2 , in common with 
that of the homogenate and mitochondria, showed a pH 
optimum at pH 7-8 (FIG 42). There appeared to be no 
difference in the PLA2 activity in the sarcolemma between 
the ischaemic and non-ischaemic areas following 2 0  
minutes coronary artery ligation (FIG 42). This could 
indicate that the PLA 2 activity is unchanged during
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ischaemia , the change seen in the homogenate being due 
to that in the mitochondria, or it may be a result of 
removal of inhibitory moieties during the isolation 
procedure of the sarcolemma.
SUMMARY: Mitochondrial and sarcolemmal PLA2 both showed 
pH and calcium dependencies similar to that of the 
homogenate. During ischaemia depression of activity in 
the ischaemic region was seen in the mitochondria but not 
in the sarcolemma which may be due to differences in the 
enzyme or washout of inhibitory substances during the 
isolation of the sarcolemma.
Effect of lysophosphatidylcholine, palmitoylcaxnitine and 
mepacrine on phospholipase Ao- flCti-Vitv
LPC and PAL both showed a similar profile ot 
effect on PLA 2 activity, an initial stimulation at low 
concentrations followed by an inhibition at greater 
concentrations (FIG 43). As already discussed this could 
be a causative factor in the inhibition of PLA 2 during 
ischaemia.
Stimulation seen at low amphiphile concentrations 
could be due to unmasking of latent PLA 2 activity that 
was not previously accessible to the substrate. Changes 
in membrane dynamics and fluidity produced by amphiphiles 
(Fink and Gross 1984) may allow accessibility of PLA 2  
that is shielded from the substrate. Tne inhibition of
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PLA2 by LPC may be Dy product inhibition as suggested by 
Lawrence (197 5) but as the same effect is produced by PAL 
it is more likely to be a non-specific inhibition. It has 
previously been suggested that 2 -acyl lysophospholipids 
are weak inhibitors of PLA 2 (Wolf and Gross 1984) and 
drugs with diverse a m p h i p h i l i c  structures such as 
chlorpromazine and imipramine have also been reported to 
inhibit PLA2 (Hostetler and Matzuzuawa 1981). The latter 
compounds have been shown to have a bipnasic profile of 
action on isolated PLA 2  (Kunze, Nahas, Traynor and Wurl 
1976), however the effect was dependent on substrate 
p r e s e n t a t i o n  and en z y m e  source. These types of 
in t e raction did not appear to be due to substrate 
competition.
Me p a c r i n e  also inhibited P L A 2 activity of the 
isolated rat heart, however no stimulatory phase was seen 
at low concentrations unlike LPC and PAL (FIG 44). The 
m e c h a n i s m  of its inhibition is thus likely to be 
different from that of LPC and PAL. Inhibition by 
mepacrine was seen at lower concentrations than reported 
elsewhere (Flower and Blackwell 1976, Thakkar et. al. 
1983, Glaser and Jacobs 1986) however as these reports 
refer to different systems it is difficult to draw a true 
c o m p a r i s o n  as m e p a c r i n e  is thought to act non- 
specifically by binding to membrane phospholipid (Dise, 
Burch and Goodman 1982).
The effect of added LPC on rat heart PLA 2 (FIG 4j)
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was qualitatively similar to that seen on the calcium / 
ATPase of rabbit skeletal muscle sarcoplasmic reticulum 
(Martonosi, Donley and Haipin 1968, Martonosi, Donley, 
Purcell and Haipin 1971). In the latter case increased 
Ca^+ / ATPase activity was seen at LPC concentrations 
less than 150pM w h i l s t  inh i b i t i o n  was seen at 
concentrations greater than this. However when the same 
m e m b r a n e s  were treated with P L A 2 to increase the 
production of LPC and fatty acids e n d o g e n o u s l y  no 
stimulatory phase was seen on addition of exogenous LPC. 
It is therefore possible that in vivo stimulation of PLA2  
by low concentrations of LPC will not be seen.
As both PLA 2 and phospholipase C are thought to be 
involved in the aggregatory response of platelets to ADP 
(Bills, Smith and Silver 1976, Bell et.al. 1979, Simon, 
Chap and Douste-Blazy 1986) the effect of LPC, PAL and 
mepac r i n e  on ADP induced p l a t e l e t  a g g r e g a t i o n  was 
investigated. Both LPC and PAL had an inhibitory effect 
on aggregation at concentrations greater than 50pM, an 
effect similar to their action on PLA 2 « Mepacrine had a 
much stronger inhibitory effect than LPC and PAL which 
may reflect inhibition of PLC by mepacrine in addition to 
PLA2 , mepacrine and similar compounds having been shown 
to inhibit macrophage PLC (Wightman, Dahlgren, Hall, 
Davies and Bonney 1981) and human platelet Pi-specific 
PLC (Hofmann, Prescott and Majerus 1982). It is not known 
whether LPC or PAL inhibit PLC and thus if this is the
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case the stronger inhibitory effect of mepacrine on ADP 
induced platelet aggregation may be due to another cause. 
The majority of the PLC activities studied have been 
reported to be of cytosolic origin (Waite 19b5, Wolf and 
Gross 1985). The interactions of LPC and PAL with PLA 2  
and PLC may differ as the former is membrane bound and 
the a m p h i p h i l e s  may act by intercalation into the 
membrane. The correlation between platelet aggregation 
and release (by P L A 2 or PLC) and m e t a b o l i s m  of 
arachidonic acid is not absolute as a-tocopherol has been 
shown to be anti-aggregatory but had no effect on the 
c o n c entrations of a r a c h i d o n i c  acid m e t a b o l i t e s  in 
platelets (Srivastava 1986) although other workers have 
found an inhibitory effect of a-tocopherol on platelet 
PLA2 (Douglas, Chan and Choy 1986).
SUMMARY: LPC and PAL are capable of inhibiting PLA 2 * 
therefore increased concentrations of these two compounds 
during ischaemia may explain the inhibition of PLA2 * LPC 
and PAL both inhibit ADP induced platelet aggregation as 
d oes m e p a c r i n e ,  p o s s i b l y  due to i n h i b i t i o n  of 
phospholipases. Therefore the production of ischaemia by 
PAL in the anaesthetized cat is unlikely to be due to a 
direct effect on platelet aggregation or the potentiation 
of aggregation induced by another factor.
213
10 PHOSPHOLIPASE A. ACTIVITY IN HEART TISSUE SAMPLES FROM
THE ANAESTHETIZED CAT
In hearts infused wi t h  c o n c e n t r a t i o n s  of LPC 
sufficient to produce arrhythmias PLA 2 activity was 
depressed in the tissue perfused by the left anterior 
descending coronary artery (FIGS 46 + 47). This implies 
that during ischaemia, when LPC concentrations are 
elevated s u f f i c i e n t l y  to cause arrhythmias, this 
concentration may be sufficient to cause suppression of 
PLA2 activity. It is therefore unlikely that there would 
be a m a i n t a i n e d  increase in P L A 2 a c t ivity during 
ischaemia.
There does not appear to be as great an effect on 
P L A 2 a c tivity in tissue from hearts infused w i t h  
arrhythmogenic concentrations of PAL (FIGS 48 + 49). This 
is perhaps to be expected as lower concentrations of PAL 
than LPC produced arrhythmias thus it is likely that 
there is less PAL present within tne cells.
Unlike the isolated rat heart there was no 
difference in PLA 2 activity in the ischaemic and non- 
ischaemic areas of the cat heart following coronary 
artery ligation. During ischaemia other factors are also 
t h o u g h t  to be i n v o l v e d  w i t h  the p r o d u c t i o n  of 
arrhythmias. The reduced pH in ischaemia increases the 
suscepti b i l i t y  of Purkinje fibres to LPC induced 
electrophysiological changes (Corr and Snyder et.al.
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1981), thus arrhythmias may be produced in the ischaemic 
heart at lower LPC concentrations than in the normoxic 
heart by LPC infusion. However these factors should also 
apply in the isolated rat heart unless collateral flow is 
substantially greater in the cat, allowing washout of LPC 
from the ischaemic area. Considerable collateral flow was 
seen in the cat heart in some experiments as coronary 
artery ligation occasionally did not produce either a 
well defined ischaemic area, as visualised by dye (i.v.), 
or a fall in temperature in the ischaemic area. These 
were a separate set of experiments. The presence of blood 
in the in vivo cat heart is also likely to facilitate 
washout of LPC due to binding to albumin.
The PLA 2 activities measured in the cat heart were 
considerably lower than in the isolated rat heart. This 
is in agreement with differences seen between in vivo 
and in vitro rabbit hearts (review Corr, Ahumada and 
Sobel 1981). Some loss of activity occurred due to 
storage at -20°C for prolonged periods of time (section 
9.1 iv) and it is also possible that there are inhibitory 
factors in the blood trapped within the tissue (Miwa, 
Ichihashi, Motojima, Onodera-Kubota, Matsumoto 1985). 
Species differ e n c e  can also not be excluded. Thus 
although it is valid to compare results between the 
different cat heart samples comparison with the rat heart 
has little meaning.
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SUMMARY: LPC, at concentrations causing arrhythmias when 
infused into the left descending coronary artery of the 
anaesthetized cat, caused a depression of PLA 2 activity 
in the left ventricular wall. PAL, at arrhythmogenic 
concentrations , produced a smaller non significant 
depression of PLA2 activity, possibly due to the smaller 
concentrations of PAL needed to produce arrhythmias. 
Ischaemia did not produce inhibition of PLA2 * This may be 
due to the large degree of collateral flow in the cat 
heart allowing washout of the LPC and PAL produced during 
ischaemia. Activities were lower than in the isolated rat 
heart, probably due to loss of activity during freezing 
and the effects of the presence of blood in the in vivo 
cat heart.
11 EFFECT OF REPERFUSION OF THE ISCHAEMIC ISOLATED RAT 
HEART ON PHOSPHOLIPASE Ao ACTW ill
Effect of reperfusion and free radical scavengers on 
ghgspholipase activity
On reperfusion of the isolated rat heart following 
1 0  minutes coronary artery occlusion PLA2  activity was 
significantly greater in the non-ischaemic region than in 
the i s c h a e m i c  region (FIG 50). This occ u r r e d  with 
perfusates containing either 3.2mM or 5.9mM K+ , the 
f o r m e r  p r e d i s p o s i n g  the h e a r t s  to r e p e r f u s i o n  
arrhythmias, none occuring with 5.9mM K+. The difference
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in activity between the ischaemic and non-ischaemic 
regions appeared to be due to an increase in activity in 
the non-ischaemic area rather than a decrease in activity 
in the ischaemic region (as seen during ischaemia).
PLA 2 activity m  the ischaemic region of hearts 
ligated for 1 0  minutes was reduced in comparison with 
that in sham ligated hearts, again c o n f i r m i n g  a 
depression of PLA 2 activity during ischaemia (FIG 50). 
Although there appeared to be a slightly elevated PLA 2  
activity in the ischaemic region during reperfusion this 
was not significant.
During reperfusion of the ischaemic tissue it is 
possible that something capable of activating PLA 2 is 
produced or some inhibitory substance already present is 
washed out leading to activation in the non-ischaemic 
region. When the effect of perfusate from ischaemic and 
reperfused hearts on control PLA2 activity was determined 
there appeared to be something present only in the latter 
that could increase P L A 2 a c t i v i t y  (FIG 51). The 
concentration dependent effect of this perfusate was 
qualitatively similar to that of LPC and PAL on PLA2 * As 
shown by TLC this may be due to fatty acids or LPC in the 
perfusate and thus the change seen in PLA 2  activity may 
be due to washout from the ischaemic area. However, if 
this is the case it w o u l d  have been e x p e c t e d  that 
activity would also have been elevated in the ischaemic 
area unless it is a function of concentration.
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Alternatively changes in the ischaemic area during 
reperfusion lead to the production of something able to 
activate PLA 2 in the non-ischaemic region. Reduced 
glutathione, a scavenger of hydrogen peroxide (FIG 10), 
produced a reduction in the PLA 2  activity in the non- 
ischaemic region following reperfusion although the 
activity was still greater than that in the ischaemic 
region (FIG 53). This may indicate that free radical 
m e c h a n i s m s  do have a role m  the increase in P L A 2  
activity seen on reperfusion however glutathione also 
acts as a vasodilator, in common with other free radical 
scavengers (Lucas, Gardner, Flaherty, Bulkley, Elmer and 
Gott 1980) and this may have a separate effect on PLA 2  
activity.
During reperfusion there is rapid, severe damage to 
the myocardial cells (Hearse et.al. 1973, Hearse, 
Humphrey, Naylor, Slade and Border 197 5). A major cause 
of this reper f u s i o n  injury is thought to be the 
production of free radicals (FIG 10), as demonstrated by 
the protective effects of free radical scavengers such as 
reduced glutathione, catalase, superoxide dismutase and 
mannitol (Lucas et. al. 1980, Shlafer, Kane and Kirsch 
1982, Stewart, Blackwell, Crute, Loughlin, Greenfield and 
Hess 1983). Free radical f o r m a t i o n  is thought to 
contribute to myocardial membrane damage by initiating a 
chain reaction of lipid peroxidation (Svingen, Buege, 
O'Neal and Aust 1979, review Meerson, Kagan, Kozlov,
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Belkina and Arkipenko 1982). During the propagation 
reactions a number of products are formed (Bernheim, 
Bernheim and Wilbur 1948), one of which (malondialdehyde) 
is often assayed to provide a m e a s u r e  of lipid 
peroxidation (Bird and Draper 1984).
As free radicals lead to the degradation of membrane 
polyunsaturated fatty acids the membrane structure is 
disorganised and can lead to disturbance of its function 
due to changes in the lipid environment of membrane bound 
enzymes and formation of new permeability channels 
(Goldstein and Weissman 1977) .
It is thus possible that lipid peroxidation products 
could wash out of the ischaemic region on reperfusion and 
cause perturbation of the membrane structure in the non- 
ischaemic region and lead to activation of PLA 2 * is 
unlikely to be a direct effect of tree radicals as they 
have a very short half life and will react before 
reaching the non-ischaemic region. Lipid amphiphiles such 
as LPC and PAL, that would wash out of the ischaemic 
region upon reperfusion, have been shown to potentiate 
free radical induced lipid p e r o x i d a t i v e  injury to 
sarcolemmal membranes (Mak et.al. 1986) although other 
workers reported an inhibition of lipid peroxidation In 
vitro by LPC (Kihlstrom and Saiminen 1985) and thus LPC 
and PAL may alter the effects of free radicals.
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Effect Ql flew changes and vasodilators on
phospholipase activity
As the standard perfusion uses a constant flow 
( l O m l / m i n ) , i s c h a e m i a  produced by coronary artery 
ligation would be expected to lead to an increase in flow 
in the non-ischaemic region which would then decrease on 
reperfusion. It is possible that the changes in flow may 
contribute to the changes in PLA 2 * Using a constant 
pressure head system no such changes in flow would be 
expected to occur and therefore the effects of flow 
changes could be investigated separately from those of 
reperfusion. With a constant pressure system there was no 
increase in PLA2 activity upon reperfusion and therefore 
it is possible that changes in flow are contributing to 
changes in PLA2 activity under the constant flow system 
(FIG 54) .
To examine further the effects of flow rate changes 
on PLA 2 its activity was determined in whole hearts 
subjected to flow changes simulating those of ischaemia 
and reperfusion in both the ischaemic and non-ischaemic 
regions. Increasing flow (FIG 55 A + C) increased PLA 2  
activity. The activity seen on increased flow (FIG 55 C) 
is much greater than that seen in the non-ischaemic 
region of a heart subjected to coronary artery ligation 
(FIG 40). This may reflect the lack, in the former, of 
inhibition by recirculation of substances such as LPC, 
that have washed out of the ischaemic area.
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Activity in FIG 55 (A), where increased flow was 
followed by a return to normal flow, simulating the 
changes seen in the n o n - i s c h a e m i c  region of the 
r e p e rfused heart, w a s  less than that seen in the 
reperfused heart. This may be due to a contributory role 
of free radical damage which would apply on reperfusion.
The previously ischaemic region of the reperfused 
heart showed no significant difference in PLA2 activity 
from FIG 55 (B) i.e. from its simulated flow change in 
the whole heart. However there was a greater activity 
when the flow change of ischaemia, i.e. zero flow, was 
simulated than in the ischaemic area of a coronary artery 
ligated heart (5.495 +/- 0.69 vs 1.863 +/- 0.066 x 10“H  
mol/mg/hr). This may be a function of different metabolic 
changes occuring in the globally, rather than regionally, 
ischaemic heart especially as the temperature of the 
former was significantly reduced , and thus enzyme 
activity leading to the production of possibly inhibitory 
moieties will be depressed.
Flow changes may cause endothelial damage. 
Functional and morphological abnormalities of the brain 
vasculature (both endothelial and vasculature smooth 
muscle) have been seen following an elevation of blood 
pressure (Kontos, Wei, Dietrich, Navari, Povlishock, 
Ghatak, Ellis and Patterson 1981). It has been suggested 
that this causes phospholipase activation in the vessel 
wall (Ellis, Wright, Wei and Kontos 1981, Wei, Lamb and
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Kontos 1982) although the mechanism of activation is 
unknown. The products of arachidonic acid metabolism 
appeared to mediate the vascular injury seen.
The effects of vasodilators on the increased PLA 2  
activity induced by increased flow was studied to 
determine whether reduced vascular resistance may limit 
any damage and thus reduce PLA2 activity. A concentration 
of adenosine that produces maximal vasodilation (10“^M) 
in a non-recirculating system reduced the PLA2 activity 
seen on increasing flow to 15ml/min (FIG 56), as did 10“ 
^M sodium nitroprusside (FIG 57). It is thus possible 
that vasodilators reduce the shear stress caused by high 
flow rates and reduce vascular d a m a g e  and P L A 2  
activation.
It cannot be excluded that the vasodilators are 
acting by another mechanism. Sodium nitroprus side is 
thought to act by increasing cGMP content (Gruetter, 
Gruetter, Lyon, Kadowitz and Ignarro 1981) and adenosine 
may act by interfering with calcium utilisation (review 
Berne 1980). It could therefore be other effects of these 
cGMP and calcium systems on P L A 2  rather than the 
resultant vasodilation that leads to changes in PLA 2  
activity.
SUMMARY: Reperfusion causes slight increases in PLA 2
activity in the ischaemic area and significant increases 
in the non-ischaemic area. This is likely to be partly
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due to flow changes as some of the changes in activity 
could be simulated by changes in flow rates in whole 
hearts. Free radicals may also have a role as no increase 
in PLA2 activity was seen in the non-ischaemic area of a 
coronary artery ligated heart where the same flow changes 
would be expected to occur as when flow was increased in 
a whole heart. Reduced glutathione, however, was able to 
reduce the activity of PLA 2 seen in the non-ischaemic 
area on reperfusion. Free radicals appear to have a role 
in the injury caused by vascular damage (Wei, Kontos, 
Dietrich, Povlishock and Ellis 1981) thus any damage 
produced by high flow may be potentiated by free radicals 
from the ischaemic area and lead to PLA 2  activation by 
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FIG 32. PROTEIN DEPENDENCE OF PHOSPHOLIPASE A2 
ASSAY IN THE HOMOGENATE OF THE ISOLATED 


























FIG 33. CALCIUM DEPENDENCE OF PHOSPHOLIPASE A2
ACTIVITY IN THE HOMOGENATE OF THE ISOLATED 


























FIG 34. TIME DEPENDENCY OF PHOSPHOLIPASE A2 ASSAY 
IN A HOMOGENATE OF THE ISOLATED RAT HEART. 
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FIG 35. TIME COURSE OF LOSS OF PHOSPHOLIPASE A2 ACTIVITY 







FIG 36. pH PROFILE OF PHOSPHOLIPASE A2 ACTIVITY IN THE 
HOMOGENATE OF THE ISOLATED RAT HEART FOLLOWING 
5 MINUTES CORONARY ARTERY LIGATION. MEAN +_ SEM.
11 “ 3* □  NON-ISCHAEMIC AREA.
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FIG 37. pH PROFILE OF PHOSPHOLIPASE A2 ACTIVITY IN THE 
HOMOGENATE OF THE ISOLATED RAT HEART FOLLOWING 
20 MINUTES CORONARY ARTERY LIGATION. MEAN + SEM. 
n = 3.
□  NON-ISCHAEMIC AREA.
O ISCHAEMIC AREA.
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FIG 38. pH PROFILE OF MITOCHONDRIAL PHOSPHOLIPASE A2 
ACTIVITY IN THE ISOLATED RAT HEART.
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pH PROFILE OF MITOCHONDRIAL PHOSPHOLIPASE A 
ACTIVITY IN THE ISOLATED RAT HEART FOLLOWING 
20 MINUTES CORONARY ARTERY LIGATION. MEAN + 
n = 4-6.
□  NON-ISCHAEMIC AREA.
O ISCHAEMIC AREA.

























FIG 41. CALCIUM DEPENDENCE OF SARCOLEMMAL PHOSPHOLIPASE 
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FIG 42. pH PROFILE OF SARCOLEMMAL PHOSPHOLIPASE A 2 ACTIVITY 
IN THE ISOLATED RAT HEART FOLLOWING 20 MINUTES 
CORONARY ARTERY LIGATION. MEAN _+ SEM. n = 5.
□  NON-ISCHAEMIC AREA.
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FIG 43. EFFECT OF LYSOPHOSPHATIDYLCHOLINE AND PALMITOYLCARNITINE
ON PHOSPHOLIPASE A2 ACTIVITY. MEAN + SEM. n = 4. 












FIG 44. EFFECT OF MEPACRINE ON PHOSPHOLIPASE A2 ACTIVITY. 











FIG 45. EFFECT OF LYSOPHOSPHATIDYLCHOLINE, PALMITOYLCARNITINE AND 
MEPACRINE ON ADP INDUCED PLATELET AGGREGATION. MEAN + SEM. 
n = 3-5. * = p ^  0.05 vs CONTROL.
237
N



























o . s*o CMo
jl|/B iu /)o iij X4 !Aj4 De asedjioi|dsoqd
FIG 46. PHOSPHOLIPASE A- ACTIVITY IN HEART TISSUE SAMPLES FROM THE 
ANAESTHETIZED CAT FOLLOWING INTRACORONARY INFUSION OF LPC. 
























FIG 47. PHOSPHOLIPASE A2 ACTIVITY IN THE LEFT (LV) AND RIGHT 
(RV) VENTRICULAR WALLS OF THE ANAESTHETIZED CAT IN 
HEARTS EXPERIENCING ARRHYTHMIAS FOLLOWING INTRA­
CORONARY INFUSION OF LPC. MEAN + SEM. n = 4.













FIG 48. PHOSPHOLIPASE A2 ACTIVITY IN HEART TISSUE SAMPLES 
FROM THE ANAESTHETIZED CAT FOLLOWING INTRACORONARY 
INFUSION OF PALMITOYLCARNITINE.








FIG 49. PHOSPHOLIPASE A2 ACTIVITY IN THE LEFT (LV) AND
RIGHT (RV) VENTRICULAR WALLS OF THE ANAESTHETIZED 
CAT IN HEARTS EXPERIENCING ARRHYTHMIAS FOLLOWING 
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FIG 50. EFFECT OF 10 MINUTES CORONARY ARTERY OCCLUSION AND 1 
MINUTE^PERFERUSION ON PHOSPHOLIPASE A2 ACTIVITY IN THE 
ISOLATED RAT HEART USING DIFFERENT IONIC COMPOSITION BUFFERS. 
□  NON-ISCHAEMIC AREA. HISCHAEMIC AREA. MEAN + SEM.
* p < 0 . 0 5  vs ISCHAEMIC A R E A , * * p $  0.02 vs ISCHAEMIC AREA, 







FIG 51. EFFECT OF PERFUSATE ELUTED FROM ISCHAEMIC AND
REPERFUSED HEARTS ON PHOSPHOLIPASE A2 ACTIVITY IN THE 
HOMOGENATE OF THE ISOLATED RAT HEART. MEAN +_ SEM. 
n = 3.* p < 0.05 vs A, PAIRED t-TEST. A = CONTROL,
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FIG 52. EFFECT OF LIPID EXTRACT OF PERFUSATE FROM A
REPERFUSED HEART ON PHOSPHOLIPASE A2 ACTIVITY 












FIG 53. EFFECT OF lmM REDUCED GLUTATHIONE ON PHOSPHOLIPASE A2
ACTIVITY IN THE ISOLATED RAT HEART FOLLOWING 10
MINUTES CORONARY ARTERY LIGATION AND 1 MINUTE
REPERFUSION. r“l
□  NON-ISCHAEMIC AREA.
E3 ISCHAEMIC AREA.
MEAN + SEM.*p$0.02 vs ISCHAEMIC AREA, ^> p  $ 0.05 vs
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FIG 54. EFFECT OF A CONSTANT HEAD OF PRESSURE ON PHOSPHOLIPASE
a 2 ACTIVITY IN THE ISOLATED RAT HEART FOLLOWING 10
MINUTES CORONARY ARTERY LIGATION AND 1 MINUTE
REPERFUSION. n  ^LJ NON-ISCHAEMIC AREA.
□  i s c h a e m i c AREA.
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FIG 55. EFFECT OF FLOW CHANGES ON PHOSPHOLIPASE A2 ACTIVITY
IN A HOMOGENATE OF THE ISOLATED RAT HEART. MEAN +_ SEM.
A = 10 MINS HIGH FLOW + 1 MIN NORMAL FLOW ( SIMULATES 
THE NORMAL REGION OF THE REPERFUSED HEART).
B = 10 MINS NO FLOW + 1 MIN NORMAL FLOW (SIMULATES THE 
ISCHAEMIC REGION OF THE REPERFUSED HEART).
C = 10 MINS HIGH FLOW (SIMULATES THE NON-ISCHAEMIC .:..i : 
REGION OF THE CORONARY ARTERY LIGATED HEART).
D = 10 MINS NO FLOW (SIMULATES THE ISCHAEMIC REGION 
OF THE CORONARY ARTERY LIGATED HEART).
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FIG 56. EFFECT OF ADENOSINE IN A RECIRCULATING AND A NON­
RECIRCULATING SYSTEM ON THE PHOSPHOLIPASE A2 ACTIVITY 
INCREASE PRODUCED BY HIGH FLOW PERFUSION. MEAN +_ SEM. 
n = 3-4. * p ^ 0 . 0 5  vs CONTROL
VS ADENOSINE 10_6M 









CV1 0  
<
ai






control 10'^  M
sodium nitroprusside
FIG 57. EFFECT OF SODIUM NITROPRUSSIDE ON THE
PHOSPHOLIPASE A2 ACTIVITY INCREASE PRODUCED 
BY HIGH FLOW PERFUSION. MEAN + SEM.
* p^0.05 vs CONTROL.
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In the isolated rat heart coronary artery ligation 
was shown to produce an increase in lysophospholipid 
concentrations in the ischaemic area by tive minutes post 
ligation. This concentration gradually increased over a 
30 minute time course with the exception of the 25 minute 
time point, when concentrations were at control levels.
Lysophospholipid concentrations increased before the 
onset of arrhythmias, indicating that reported increased 
concentrations seen during ischaemia are unlikely to be 
actually produced by the arrhythmias. It is therefore 
possible that lysophospholipids have a role in the 
production of arrhythmias although the possibility exists 
that the two are independent of each other but have the 
same cause. A maximal lysophospholipid concentration 
a p p e a r e d  to be r e a c h e d ,  p o s s i b l y  r e p r e s e n t i n g  
establishment of an equilibrium of its production and 
catabolism. Concentrations were also increased in the 
non-ischaemic area 1 0  minutes following coronary artery 
ligation. This could represent washout from the ischaemic 
area and recirculation to the non-ischaemic area.
Control hearts showed increases in lysophospholipid 
concentration when perfused with a buffer containing 
increased calcium or decreased potassium concentrations. 
Both of these ionic changes increase the severity of 
ischaemically induced arrhythmias. As lysophospholipids 
appear to be involved in the genesis of arrhythmias the
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perfusate ionic changes may exacerbate ischaemically 
i n d u c e d  a r r h y t h m i a s  by i n c r e a s i n g  c e l l u l a r  
lysophospholipid concentrations prior to any effects of 
ischaemia. There appeared to be a maximal change in 
lysophospholipid concentration that could be caused by 
either changes in perfusate ionic composition or coronary 
artery ligation. This may again represent an equilibrium 
between production and metabolism.
In the anaesthetizea cat infusion of LPC into the 
coronary circulation was shown to be arrhythmogenic by a 
mechanism that did not appear to induce ischaemia. In 
contrast PAL was also arrhythmogenic but resulted in the 
production of ischaemia that could be reversed by the 
infusion of streptokinase. The time courses of both LPC 
and PAL induced arrhythmias were similar to that of 
c o r o n a r y  a r t e r y  l i g a t i o n .  PAL m a y  p r o d u c e  a 
vasoconstrictor effect potentiating the effect of any 
o c c l u s i v e  agg r e g a t e s  but the m e c h a n i s m  by w h i c h  
production of the latter occurs is unknown as PAL had no 
direct effects on platelet aggregation. It is possible 
that haemolysis or interaction with the endothelium 
occurs to produce pro-aggregatory substances.
The role of LPC in producing arrhythmias during 
ischaemia is supported by its production of arrhythmias 
in an in vivo normoxic model which is likely to be less 
sensitive to the electrophysiological d e r a n g e m e n t s  
induced by LPC than ischaemic tissue.
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Phospholipase A2 activity was studied to determine 
its role in the production of LPC during ischaemia. At 
the time of maximal lysophospholipid concentration 
following coronary artery ligation PLA 2 activity was 
inhibited in the ischaemic area. As LPC and PAL were both 
shown to inhibit PLA 2 activity it is possible that the 
inhibition of PLA 2 seen during ischaemia is due to the 
accumulation of tnese two amphiphiles.
Mitochondrial PLA2 , in common with that measured in 
the homogenate, was reduced in activity following 2 0  
minutes coronary artery ligation whilst sarcolemmal PLA2  
showed no difference in activity between the ischaemic 
and non-ischaemic areas. This may represent differences 
in the PLA2 or washout of inhibitory substances from the 
sarcolemma during the isolation procedure.
PLA2 activity was inhibited in the anaesthetized cat 
following infusion of LPC into the coronary artery to 
p r o d u c e  a r r h y t h m i a s .  T h i s  i n d i c a t e s  that LPC 
concentrations capable of producing arrhythmias can lead 
to inhibited PLA2 * Although there was some inhibition of 
PLA2 by PAL infusion this inhibition was not as great as 
with LPC, possibly due to the lower concentrations of PAL 
needed to produce arrhythmias. No difference was seen in 
PLA 2 activity in the ischaemic and non-ischaemic areas 
following coronary artery ligation. This may be due to 
washout of inhibitory substances from the ischaemic
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region as the collateral flow in the cat is substantially 
greater than in the rat heart and blood perfusion will 
enhance the washout of LPC in comparison to Krebs- 
Henseleit perfusion.
Reperfusion of the isolated rat heart produced an 
increase in PLA 2  activity in the non-ischaemic area and 
to a lesser extent in the ischaemic area. This may be 
pa r t i a l l y  due to flow changes as some of the P L A 2  
activity changes could be produced by simulation of flow 
rate changes in whole hearts. Free radical production and 
lipid peroxidation may also activate PLA2 by interacting 
with the lipid membranes and may be potentiated by lipid 
ampniphiles produced during ischaemia.
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